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CHAPTER 1. GENERAL INTRODUCTION 
Two types of porcine circovirus (PCV) exist, referred to as PCV1 and PCV2.  PCV2 
has been associated with disease syndromes in pigs, including that designated 
postweaning multisystemic wasting syndrome (PMWS), which has been identified in 
all regions of the world bar Australia (Hamel et al., 1998; Allan et al., 1999a; Onuki et 
al., 1999;  Martelli et al., 2000; Kyriakis et al., 2000; Wellenberg et al., 2000; Done et 
al., 2001; Trujano et al., 2001; Saradell et al., 2004; Castro et al., 2004; Jemersic et 
al., 2004; Maldonado et al., 2004; Wang et al., 2004; Motovski and Segales, 2004; 
Garkavenko et al., 2005).  PMWS affects young weaner pigs and results in weight 
loss, tachypnea, dyspnea, enlarged lymph nodes and jaundice (Harding, 1998).   
PCV2 may also cause or contribute to other swine diseases such as congential 
tremors (CT) (Stevenson et al., 1999), porcine dermatitis and nephropathy syndrome 
(PDNS) (Rosell et al., 2000), reproductive failure (Meehan et al., 2001) and several 
other emerging disease syndromes.  PCV1 is currently considered to be non-
pathogenic. 
Although PMWS has not been reported in Australia, information on the distribution, 
variation and further characterisation of PCV in Australian pigs was necessary as it 
might provide insights into why there is no PCV-associated disease in this country.   
The results reported in this thesis involved the detection and further study of porcine 
circovirus in Australia. 
This chapter provides an outline of this thesis and the work undertaken, while 
Chapter 2 is a review of the relevant literature with particular reference to circoviral 
diseases.  Chapter 3 describes the detection of both PCV1 and PCV2 in the 
Australian pig herd, using a multiplex PCR designed to differentiate between the two 
viral types. The association of Australian PCV with two disease outbreaks was also 
investigated.  Following the detection of both viruses, it was important to genetically 
compare Australian PCV with overseas strains known to cause disease, and this was 
achieved with a sequencing and phylogenetic study as described in Chapter 4.   
Possible reasons for the genetic groupings and distribution of different PCV2 strains 
worldwide are also discussed in this chapter. 
As PMWS is as yet unidentified in Australian pigs, the importation of pig meat into 
Australia from countries with the disease requires careful monitoring.  Current 
protocols for the cooking of imported pig meat were designed to inactivate porcine 
reproductive and respiratory disease virus (PRRSV), and as such may not be 
effective against PCV.  In this study (Chapter 5), Australian PCV2 was successfully 
infected into cell culture, and detected using a variety of techniques. Subsequently,   2 
thermal stability experiments were performed using a newly-developed 
immunoperoxidase (IPMA) test.  It was anticipated that this study would determine 
whether current importation protocols require revision, and the results would suggest 
that this is the case, with PCV2 unaffected by treatment comparable with current 
cooking protocols. 
While no animal experiments were undertaken in this study, it may become 
necessary to infect pigs with Australian PCV to determine viral pathogenicity.  Cell 
culture inoculums have been used in the past overseas, but problems with 
contamination and viral titre have been encountered (Fenaux et al., 2001).  Viral 
infectious clones can be used to overcome these problems, so an infectious clone of 
Australian PCV2 was constructed, as described in Chapter 6.  While time constraints 
prevented the clone from being infected into culture, it is anticipated that the 
construct would be infectious as it is based on a previously published method 
(Hattermann et al., 2004). 
Chapter 7 is a general discussion of the results and conclusions from this study. 
The detection and characterisation of Australian PCV as described in this study has 
provided further information on the status of PCV in the Australian pig herd, and also 
developed diagnostic tests to assist in future research.  These tools will be important 
when assessing and managing the risk of Australia experiencing PCV-associated 
diseases.   3 
CHAPTER 2.  REVIEW OF THE LITERATURE  
Circoviridae 
The  Circoviridae is a family of single-stranded DNA (ssDNA) viruses, with 
covalently closed, circular genomes (Todd et al., 1991; Todd et al., 2005).  There 
are three genera of animal circoviruses: Circovirus,  Gyrovirus and Anellovirus.  
Porcine circovirus (PCV) is classified as belonging to the genus Circovirus, 
together with beak and feather disease virus (BFDV).  Other animal circoviruses 
originating from geese, pigeons and canaries and cattle have been identified and 
tentatively placed in this genus.  Chicken anaemia virus (CAV) has been assigned 
to the genus Gyrovirus (Todd et al., 2005) and the genus Anellovirus is proposed 
for the 2 human circoviruses, TT virus (TTV) and TTV-like minivirus (TLMV) 
(Phenix et al., 2001; Mankertz et al., 2000; Todd et al., 2001; Miyata et al., 1999; 
Takahashi et al., 2000; Hino 2002).   
The plant circoviruses, such as coconut foliar decay virus (CFDV), banana bunchy 
top virus (BBTV) and subterranean clover stunt virus (SCSV) were previously 
classified as Circoviridae, however they are now classified separately as 
Nanoviridae (Todd et al., 2005).  Although they are no longer in the same family, 
the plant and animal circoviruses do have conserved regions in their genomes 
associated with conserved functions such as replication (Bassami et al., 1998).   
Comparison of the animal circoviruses BFDV, PCV and CAV has revealed no 
common antigenic determinants and no DNA sequence identity (Todd et al., 
1991).  The structure of PCV and BFDV is similar, but the structure of CAV is quite 
different, further supporting their separation into 2 genera (Crowther et al., 2003).  
The recent discovery and characterisation of a goose circovirus (GCV), a pigeon 
circovirus (CoCV), a canary circovirus (CaCV), and TTV and TLMV has provided 
more insight into possible evolution and relationships between members of the 
Circoviridae family. 
Chicken anaemia virus (CAV) 
CAV affects young chickens, causing transient severe anaemia due to the 
destruction of erythroblastoid cells, and immunodeficiency due to depletion of 
cortical thymocytes, which occurs via CAV-induced apoptosis, or programmed cell 
death (Noteborn et al., 1994).  The severity of the disease depends on the age of 
the affected chicks and the presence of secondary infections (Noteborn et al., 
1994).  CAV has a virion diameter of 23-25 nm, and a genome approximately 2.3 
kb in size.  Three partially overlapping open reading frames (ORFs) encode 
potential viral proteins (VP) of molecular weight 52 kDa (VP1), 24 kDa (VP2) and   4 
13 kDa (VP3) (Meehan et al., 1992; Noteborn and Koch, 1995).  The 52 kDa VP1 
protein is the putative capsid protein and is probably encoded by ORF3, the only 
ORF large enough to produce it (Noteborn and Koch, 1995).  VP2 is a putative 
non-structural virus protein required for assembly (Noteborn and Koch, 1995).   
Apoptin, the 13 kDa VP3, is considered to be responsible for depletion of chicken 
lymphoblastoid T-cells by inducing apoptosis.  This is presumably achieved by 
regulating the appropriate genes involved in this process (Noteborn et al., 1994).  
Apoptosis is important in CAV replication as it allows the release of new virus 
particles from the cell. 
High genetic conservation of strains detected worldwide suggests there is only 
one CAV genotype (Kato et al., 1995) although a putative strain of CAV 
designated CIAV-7, antigenically and serologically distinct from the reference 
strain, was recently identified (Spackman et al., 2002a).  The pathogenesis of the 
2 virus types is similar, although some of the lesions produced by CIAV-7 appear 
less severe than those caused by the reference strain of CAV.  There is currently 
no sequence data available for CIAV-7, but Southern blot and PCR results 
suggested there was significant sequence variation between the 2 strains 
(Spackman et al., 2002b).   
Beak and feather disease virus (BFDV) 
Beak and feather disease affects both wild and captive psittacine birds (Pass and 
Perry, 1984; Bassami et al., 1998), although recent evidence suggests that it may 
also affect some non-psittacine species (Rahaus and Wolff, 2003).  In most 
affected birds, the disease is characterised by chronic progressive, symmetrical 
feather dystrophy and occasional beak deformity, and death usually occurs as a 
result of secondary infections (Pass and Perry, 1984; Bassami et al., 1998).  The 
causative agent of beak and feather disease is beak and feather disease virus 
(BFDV), which has a virion diameter of 14-16 nm and a genome 1993 nt in size.  
The virus has 7 potential ORFs, but only 3 are present in all known isolates, 
suggesting there may be only 3 proteins encoded (Niagro et al., 1998; Ritchie et 
al., 1989; Bassami et al., 2001).  Three BFDV proteins have been reported, with 
approximate molecular weights of 19.5, 23.7 and 26.3 kDa (Ritchie et al., 1989).  
Based on similarity between BFDV, PCV and the plant circoviruses, the largest 
BFDV protein, possibly encoded by ORF1, is the putative Rep protein (Bassami et 
al., 2001), while the protein encoded by ORF2 is the capsid protein (Niagro et al., 
1998; Bassami et al., 2001).  From the limited sequence data available, it appears 
that BFDV isolates are genetically conserved, with 84-97% nt homology (Bassami   5 
et al., 2001). 
Recently, isolates of BFDV have been found to cluster phylogenetically according 
to the avian host species in which they were detected, eg. parrots and cockatoos, 
suggesting the presence of BFDV genotypes (Ritchie et al., 2003; Raue et al., 
2004).   
Goose circovirus (GCV) 
GCV was first identified in geese from a German commercial flock with a history of 
increased mortalities and runting (Soike et al., 1999).  Circovirus-like particles were 
detected by electron microscopy, and after sequence analysis, the genome of the 
newly-identified GCV was found to be 1821 nt in length (Todd et al., 2001).  The 
GCV genome had ambisense organisation, with one predicted major ORF on each of 
the viral and complementary strands (Todd et al., 2001).  A potential circovirus-like 
stem-loop structure was also identified (Todd et al., 2001).  The putative Rep protein, 
encoded from the largest ORF on the viral strand, had a predicted size of 293 amino 
acids, while the putative capsid protein, translated from the complementary strand, 
had a predicted size of 250 amino acids (Todd et al., 2001).  Phylogenetic studies 
suggested that GCV was not as closely related to BFDV as was CoCV.  In fact, 
based on capsid amino acid sequences, GCV may have a closer relationship to the 
PCVs than the other avian circoviruses (Todd et al., 2001).  Based on sequence 
variation, it has also been suggested that several distinct groups of GCV are 
circulating in Europe and Asia (Chen et al., 2003).   
Canary circovirus (CaCV) 
CaCV was first detected in neonatal canaries with a condition known as ‘black
 spot’, 
characterised by abdominal
 enlargement, gall bladder congestion and failure to thrive 
(Goldsmith, 1995).  The virus has since been identified by electron microscopy in 
adult canaries that died following a short illness characterised
 by dullness, anorexia, 
lethargy and feather disorder (Todd et
 al., 2001).  The CaCV genome is ambisense 
and 1952 nt in length, with 3 putative protein-encoding ORFs (Phenix et al., 2001).  
The largest ORF, on the viral strand, codes for the putative Rep protein, 290 amino 
acids in length and with a predicted size of 33.4 kDa.  The complementary strand 
encodes a putative capsid protein 250 amino acids in length (30 kDa) and a protein 
134 amino acids in length (14.9 kDa) (Phenix et al., 2001).  A potential stem-loop 
structure was identified (Phenix et al., 2001).  Phylogenetic analysis indicated CaCV 
was most closely related to CoCV, less closely related to BFDV and most distantly 
related to GCV and PCV (Phenix et al., 2001).   
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Columbid (pigeon) circovirus (CoCV) 
A potential circovirus-like infection was first detected in a pigeon in 1993 (Woods et 
al., 1993).  Further electron microscopy studies identified apparent circovirus 
particles in meat pigeons in association with lymphoid depletion (Coletti et al., 2000).  
Although subclinical infection with CoCV seems common, mortality in young birds 
with active infection may approach 10% (Pare et al., 1999).  The pigeon (columbid) 
circovirus (CoCV) has a typical single-stranded circular DNA genome 2037 nt in size 
(Mankertz  et al., 2000).  Putative ORFs were identified on both the viral and 
complementary genome strands and a potential stem-loop structure was identified 
(Mankertz et al., 2000).  The putative Rep protein, encoded from the largest ORF on 
the viral strand, had a predicted size of 316 amino acids (36.3 kDa), while the 
putative capsid protein translated from the complementary strand had a predicted 
size of 273 amino acids (31.9 kDa) (Mankertz et al., 2000).  CoCV was related most 
closely to BFDV and more distantly to CAV, PCV1 and PCV2 (Mankertz et al., 2000).   
Bovine circovirus (BCV) 
Porcine circovirus will replicate in mononuclear cell cultures prepared from the 
peripheral blood of cattle, which has raised questions about the susceptibility of cattle 
to PCV (Allan et al., 1994).  PCV antibody was also detected in approximately 35% of 
cattle sera tested, leading to speculation of a virus closely related to PCV infecting 
cattle (Tischer et al., 1995).  When circovirus DNA was subsequently detected in 
aborted bovine foetuses and in cattle with respiratory disease, the agent was 
tentatively named bovine circovirus (BCV) (Nayar et al., 1999).  This virus, however, 
was nearly identical to PCV2 (99%) therefore it is highly likely that the isolated virus 
was PCV2 replicating in cattle.  It is unclear whether the isolated circovirus could 
have caused the clinical signs of respiratory illness and abortion, as experimentally, 
BCV failed to cause disease in cattle.  Two subsequent studies have failed to find 
PCV antibody in cattle (Allan et al., 2000; Ellis et al., 2001) and the role, if any, of 
BCV or any other circovirus in cattle disease has never been established.   
TT virus (TTV) 
TTV was the first identified human circovirus, initially detected in a Japanese patient 
with post-transfusion hepatitis, which was not caused by any known hepatitis virus 
(Nishizawa et al., 1997).  The genome of the unknown virus was determined to be 
DNA, but no homology to any other known nt or protein sequence could be found, 
and it could not be determined whether the infection was persistent or transient in 
nature (Nishizawa et al., 1997).  Further research revealed that TTV was a single-
stranded circular virus, extremely common in the human population (Mushahwar et   7 
al., 1999) and capable of persisting in the plasma of infected individuals for many 
years (Miyata et al., 1999; Bendinelli et al., 2001; Pollicino et al., 2003).   
The TTV genome is ssDNA approximately 3 kb in size, with 2 large overlapping 
ORFs (Bendinelli et al., 2001).  The largest (ORF1) encodes a protein 770 amino 
acids in size, likely to be the capsid protein (Simmonds, 2002).  It is possible that the 
second ORF, which is divided into ORF2a and ORF2b, may code for non-structural 
proteins.  ORF2a is highly conserved between TTV genotypes, whereas ORF2b is 
highly variable (Kakkola et al., 2002).   
Phylogenetic studies have shown that of the animal circoviruses, CAV appears to be 
most closely related to TTV (Bendinelli et al., 2001).  Both viruses possess large 
genomes with potential coding and untranslated areas, and there is some amino acid 
motif conservation and identity in short areas of nt sequence (Bendinelli et al., 2001).  
However, unusual for circoviruses, there is significant size variation between TTV 
isolates, with genome lengths between 3808 and 3853 nt reported, and nt variation of 
up to 40% (Bendinelli et al., 2001).  Several potential stem-loop structures have been 
identified in the untranslated areas of the TTV genome, but not all of them are 
conserved between all TTV isolates so their potential role in replication is uncertain 
(Bendinelli et al., 2001).   
Several studies have shown that TTV is widespread in the global population, but 
more prevalent in post-transfusion hepatitis patients (Miyata et al., 1999; Bendinelli et 
al., 2001), and it is common for an individual to be infected with multiple strains of 
TTV (Mushahwar et al., 1999; Raffa et al., 2003; DeValle and Niel, 2004).  The 
highest rates of infection detected were in South America and Africa, while the lowest 
rates were detected in the USA and Northern Europe (Bendinelli et al., 2001).  TTV 
has also been identified in USA blood donors and patients suffering liver disease, 
and prior exposure to blood products is associated with an increased risk of TTV 
infection (Charlton et al., 1998).  Although TTV is almost certainly transmitted 
laterally via blood products, it has also been theorised that TTV transmission may be 
vertical, based on the high rate of newborn infants negative for TTV that aquire the 
virus almost immediately after birth (Yokozaki et al., 1999).  It has also been 
speculated that cross-species transmission of some genotypes of TTV can occur as 
TTV and TTV-like viruses are also common in non-human primates (Cong et al., 
2000; Simmonds 2002; Thom et al., 2003).   
The high incidence of viral infection in the absence of clinical disease has led to the 
proposal that TTV is a commensal human and primate virus, and despite some 
correlation with respiratory disease (Maggi et al., 2003) and liver disease (Miyata et   8 
al., 1999), the clinical significance of TTV is yet to be determined.  It has been 
suggested, however, that while TTV infection is extremely common, certain 
genotypes among the many (approximately 28) genotypes identified may be capable 
of causing disease (Takahashi et al., 2000).  It is likely that the number of genotypes 
identified will increase as diagnostic tests are developed further.  Recently, TTV-like 
viruses, highly divergent from those infecting primates, have been identified in pigs, 
cats and dogs (Okamoto et al., 2002) and it seems likely that more species-specific 
and cross-species infecting TTV-like viruses will be identified in non-primate 
mammals or other animals in the future. 
TTV-like minivirus (TLMV) 
TLMV was identified after the detection and characterisation of TTV (Takahashi et 
al., 2000).  It is similar in genomic organisation to TTV and CAV, with a negative-
sense genome approximately 2860 nt in size, including quite highly conserved 
untranslated areas accounting for approximately 25% of the viral genome.  Similar to 
TTV, there are no predicted ORFs of significant size on the viral (positive) strand, 
and different isolates of TLMV differ markedly in genome size and sequence identity 
(Takahashi et al., 2000).  The largest predicted ORF, ORF1, potentially encodes a 
protein about 660 amino acids in length, which is assumed to be a glycoprotein as 
there are several potential N-glycosylation sites, also found in CAV and TTV 
(Takahashi et al., 2000).  A second potential ORF, ORF2, partially overlaps ORF1, 
and potentially encodes a protein approximately 90 amino acids in size (Takahashi et 
al., 2000) which may code for a novel dual-specificity phosphatase (Peters et al., 
2002).  A third potential ORF, ORF3, was originally predicted to encode a protein of 
about 130 amino acids (Takahashi et al., 2000), but this ORF is now suspected to be 
non-functional (Biagini et al., 2001).  Sequence identity for both ORFs in 3 TLMV 
strains was low, but an amino acid motif WX7HX3CXCX5H common to CAV and TTV 
was identified  (Takahashi et al., 2000).  Based largely on its genetic organisation 
and some small areas of sequence identity, it was suggested that TLMV may be an 
intermediate between the rather remotely related CAV and TTV (Takahashi et al., 
2000).   
TLMV is estimated to infect approximately 75% of the human population (Biagini et 
al., 2000) and it has been suggested that co-infection with TTV and TLMV is common 
(Thom et al., 2003).  The low sequence identity found between TLMV strains would 
suggest there are a large number of genotypes infecting humans, similarly to TTV 
(Takahashi et al., 2000).  
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Ostrich circovirus (OCV) 
A circovirus was first identified in the gut of an ostrich suffering from enteritis (Els and 
Josling, 1998).  Since then, circovirus particles have also been found in cases of 
fading chick syndrome (FCS), a worldwide problem in the ostrich-farming industry, 
mostly affecting young chicks, causing depression, weight loss, anorexia and 
eventually death (Eisenberg et al., 2003).  Mortalites of 30-90% have been reported 
(Terzich and Vanhooser, 1993).  The cause of the syndrome is probably 
multifactorial, involving management issues, stress and bacterial and viral infections 
(Eisenberg et al., 2003).  Circovirus DNA was identified by PCR in tissues of FCS 
cases, with partial sequence data indicating that is the virus detected was very 
similar to BFDV (Eisenberg et al., 2003).  At present, however, there is insufficent 
information to determine whether the circovirus identified in ostriches is associated 
with disease, and more sequence data is needed to elucidate the relationship 
between this circovirus and other members of the Circoviridae.   
Gull circovirus 
A possible circovirus infection was identified in a terminally ill young black-backed 
gull in Manawatu, New Zealand (Twentyman et al., 1999).  Suffering from chronic 
airsacculitis due to Aspergillus infection, the bird was one of many dead or dying 
gulls that had been seen in the same area.  Histologically, there was moderately 
severe inflammation in the bursa of Fabricus with large basophilic, intracytoplasmic 
inclusions present that  were similar to those detected in other circovirus infections.  
These pathological findings were considered to be consistent with the possibility that 
lymphocytic depletion and immunosuppression, caused by circovirus infection, 
allowed an overwhelming and ultimately lethal secondary Aspergillus infection 
(Twentyman  et al., 1999).  It was suggested that this circovirus may have been 
present in gulls for a long period, unnoticed previously as gulls are undomesticated 
and therefore not usually subject to pathological examination, and the mild clinical 
signs characteristic of most circoviral infections.  Alternatively, the gull may have 
been an aberrant host for the virus (Twentyman et al., 1999).  No sequence data has 
ever been published for gull circovirus, therefore it is not possible to determine 
whether this circovirus is a new virus specifically infecting gulls, or whether a known 
circovirus such as BFDV was able to infect a new host.   
Duck circovirus (DuCV) 
DuCV was first detected in a mulard duck with a feathering disorder and poor body 
condition (Hatterman et al., 2003).  Electron microscopy revealed small non-
enveloped spherical viral particles in bursal tissue, and it was determined by   10 
sequence analysis that a new type of circovirus was present (Hatterman et al., 2003).  
The DuCV genome was 1996 nt in size, with a genomic organisation similar to the 
previously described avian circoviruses.  The putative Rep ORF, located on the viral 
strand, was a predicted 292 amino acids in length (33.6 kDa), while the putative 
capsid protein was a predicted 257 amino acids in length (29.7 kDa) (Hatterman et 
al., 2003).  Three potential minor ORFs were identified, 2 on the viral strand and one 
on the negative strand, but whether these ORFs encode proteins is uncertain 
(Hatterman  et al., 2003).  Similar to previously described circoviruses, DuCV 
possessed a small intergenic region thought to contain the origin of replication, but a 
second intergenic region was also present between the Rep and capsid ORFs, a 
feature unique to DuCV (Hatterman et al., 2003).  Based on nt and amino acid 
sequences, DuCV is most closely related to GCV (Hatterman et al., 2003).   
Raven circovirus (RaCV) 
RaCV was identified in an Australian raven with feather lesions similar to those whch 
occur in beak and feather disease (Stewart et al., 2006).  The virus was isolated and 
found to be 1898 nt in length, with two ORFs likely to encode a capsid and 
replication-associated protein.  RaCV was found to be most closely related to CaCV 
and CoCV by phylogenetic analysis, however no further information on this virus is 
currently known.  
Starling circovirus (StCV) 
StCV was initially detected in Spanish wild starlings found dead during an outbreak of 
septicaemic salmonellosis (Johne et al., 2006).  The virus was also identified in 
healthy birds from the same population, and no specific pathogenisis has been 
associated with StCV as yet.  The virus was found to have the highest similiarity with 
CaCV, with ORFs potentially coding for capsid and replication-associated proteins 
also present (Johne et al., 2006).   
Porcine circovirus (PCV) 
PCV was first detected in 1974 as a persistent infection in the immortal PK-15 
porcine kidney cell line (Tischer et al., 1974).  Eight years later, it was 
characterised as a small non-enveloped, icosahedral virus with a circular ssDNA 
genome (Tischer et al., 1982).  At 17 nm in diameter and with a DNA genome of 
1759 nt (Tischer et al., 1982), PCV was the smallest animal virus known.  When 
first described, PCV was considered likely to be non-pathogenic, as it produced 
no cytopathic effect in the PK-15 cell line (ATCC CCL-33) (Tischer et al., 1982).  
The virus was reported to replicate in monocyte/macrophage type cells of pigs and 
cattle, although not those of sheep or humans (Allan et al., 1994b), but the   11 
infection did not affect cell function (McNeilly et al., 1996).  However, more recent 
experiments with PCV suggest that it can in fact infect human mononuclear cells, 
and can even cause ultrastructural alterations (Arteaga-Troncoso et al., 2005).   
Later experimental infections of pigs with PCV did not result in any clinical signs of 
disease (Tischer et al., 1986; Allan et al., 1995).    
In 1997, an apparently new syndrome designated postweaning multisystemic 
wasting syndrome (PMWS) was described in Canadian pigs (Clark, 1997; Harding 
et al., 1998).  Retrospective data indicated that the disease may have been 
present in Canada as early as 1991 (Clark, 1997) and as early as 1986 in Spain 
(Rodriguez-Arrioja et al., 2003).  Meehan et al. (1998) found that the PCV strains 
in PMWS-affected pigs in Canada and Europe had more than 96% nt identity 
when sequence homologies were compared, but they shared less than 80% 
identity at the nt level with the PCV infecting PK-15 cells (Hamel et al., 1998).  It 
was concluded that there were 2 types of PCV and Allan et al. (1998) proposed 
that the original PK-15 cell culture isolate should be referred to as PCV1 and the 
genetically different strains isolated from PMWS pigs should be referred to as 
PCV2.  Both types of PCV have since been found to be common in pigs, and PCV 
antibodies and DNA have been detected in pigs in Asia, Europe and America 
(Dulac and Afshar, 1989; Tischer et al., 1986; Allan et al., 1994a; Edwards and 
Sands, 1994; Kiss et al., 2000; Kim and Lyoo, 2002; Toplak et al., 2004).  PCV 
has also been detected in feral pigs (Schulze et al., 2003; Ellis et al., 2003).   
Both types of PCV have multiple potential ORFs, only 3 of which probably encode 
proteins, and are referred to as ORF1, ORF2 and ORF3.  ORF1 encodes a 
protein of approximately 36 kDa, thought to be the Rep protein as it contains 
conserved motifs previously found in proteins involved in rolling circle DNA 
replication (Niagro et al., 1998).  The 27.8 kDa protein encoded by the PCV1 
ORF2 is the putative capsid protein (Mahe et al., 2000).  A slightly larger capsid 
protein (30 kDa) is encoded by PCV2 ORF2 (Liu et al., 2001).  The function of the 
ORF3 protein, if any, is still to be determined, although it may have a role in 
apoptosis (Liu et al., 2005).  However, the ability of PCV2 to cause apoptosis is 
still uncertain. 
The ORF1 proteins of PCV1 and 2 were antigenically related, with cross-reactivity 
shown in serological assays (Mahe et al., 2000).  This correlated with the high 
sequence conservation of ORF1 between PCV1 and PCV2 and suggested 
conservation in the antigenicity and probably functions of the Rep protein (Mahe 
et al., 2000).  Other similarities of PCV1 and PCV2 have also been detected: both   12 
have very similar stem-loop structures, essential for viral replication, and the 
amino acid sequence of the ORF1-encoded proteins of PCV1 and PCV2 are 85% 
similar (Hamel et al., 1998).  However, the capsid proteins from PCV1 and PCV2 
are antigenically distinct, with no serological cross-reactivity, consistent with their 
lower sequence identity (around 56%) (Mahe et al., 2000).  PCV1 and PCV2 have 
been successfully differentiated using antisense ORF2 riboprobes, although 
ORF1 probes failed to differentiate between the 2 types (Nawagitgul et al., 2000).  
When the sequences of PCV1 and PCV2 were compared, Hamel et al. (1998) 
found 65% similarity and Morozov et al. (1998) found 80% similarity.  It was 
suggested that the differences in amino acid sequences between these 2 strains 
may account for variation in pathogenicity (Hamel et al, 1998), and that point 
mutations may have occurred in PCV1, generating a pathogenic variant (PCV2) 
from the non-pathogenic PCV1 (Ellis et al., 1998). 
Comparative genetics 
Genome organisation 
Genome organisation is variable between the genera of animal circoviruses.   
Viruses classified in the genus Circovirus (PCV, BFDV, GCV, CoCV, CaCV and 
DuCV) all have ambisense genomes, that is, proteins are encoded by both the 
viral and complementary DNA strands (Niagro et al., 1998; Mankertz et al., 1998; 
Todd et al., 2001).  Conversely, CAV, TTV and TLMV have negative-stranded 
(antisense) genomes, and only one of the 2 strands of the double-stranded 
replicative form is transcribed to produce mRNA (Thom et al., 2003; Phenix et al., 
1994).  The replication strategy of OCV has not been studied, however it seems 
likely that it would possess an ambisense genome.  PCV, GCV, CaCV, CoCV and 
BFDV all have a compact genomic arrangement, with a small intergenic region 
flanked by 2 ORFs in opposing orientation (Mankertz et al., 2004).  In contrast, the 
3 viruses currently placed in the genera Gyrovirus and Anellovirus (CAV, TTV and 
TLMV) all possess highly conserved untranslated regions (UTR) in their genomes 
(Miyata et al., 1999).  Interestingly, while DuCV is similar in genome organisation 
to the other members of the Circovirus genus, a 231 bp UTR was identified 
between the 3` ends of the Rep and capsid ORFs (Hatterman et al., 2003).  This 
region contains several direct repeat sequences, however the function and 
sequence conservation of this UTR is unknown (Hatterman et al., 2003).   
Transcription 
While CAV produces one large unspliced transcript approximately 2 kb in size 
(Phenix et al., 1994), both PCV1 and PCV2 produce multiple transcripts, many   13 
from the same ORF (Mankertz et al., 1998;Cheung and Bolin, 2002; Cheung, 
2003b).  TTV produces 3 mRNAs of 3 kb, 1.2 kb and 1 kb from the 
complementary DNA strand only, all of which are subsequently spliced (Kamahora 
et al., 2000).  The transcription strategies employed by TLMV, BFDV, GCV, 
CoCV, CaCV, DuCV and OCV have not been studied in detail, although it was 
reported that BFDV and CoCV can both use alternative start codons in different 
virus strains (Bassami et al., 1998; Todd et al., 2001).   
Regulatory elements 
Potential regulatory motifs and direct repeat sequences have been identified in the 
GC-rich UTRs which account for 25% of the TLMV genome, 20% of the CAV 
genome and 30% of the TTV genome (Miyata et al., 1999; Takahashi et al., 2000; 
Phenix et al., 1994).  CAV promoter activity is associated with its UTR, while a 
tandem array of four 19 bp repeats in this region is thought to be an enhancer 
element (Phenix et al., 1994; Noteborn et al., 1994).  Similar tandem repeat 
sequences have also been identified in CaCV, DuCV, PCV and BFDV in their 
much smaller intergenic regions (Mankertz et al., 1997; Bassami et al., 2001; 
Phenix et al., 2001; Hatterman et al., 2003).  While there is very little nt or amino 
acid sequence identity between TTV, TLMV and CAV, the presence and 
organisation of regulatory elements such as ATF/CREB binding sites and TATA 
boxes is similar (Phenix et al., 1994; Miyata et al., 1999; Thom et al., 2003).  No 
TATA box has been identified in the genome of PCV, GCV or CoCV, although 
putative CAAT boxes have been identified in the sequence of all 3 viruses 
(Mankertz et al., 1998; Mankertz et al., 2000).  A putative TATA box has been 
identified in the genome of DuCV but no CAAT box was present (Hatterman et al., 
2003).  Rolling circle replication-associated motifs and P-loop motifs are present in 
the genomes of GCV, DuCV and CoCV (Mankertz et al., 2000; Todd et al., 2001; 
Hatterman et al., 2003).   
Circovirus Rep protein sequences 
The sequence of the ORF encoding the replication-associated (Rep) protein, is 
highly conserved between PCV, BFDV, GCV, CoCV, CaCV, the plant circoviruses 
and some geminiviruses (Bassami et al., 1998; Phenix et al., 2001;Todd et al., 
2001).  The highest similarity was found between BFDV and PCV, where there 
was 65% amino-acid similarity (Bassami et al., 1998).   
The Rep proteins of viruses in the genus Circovirus, the plant nanoviruses and the 
geminiviruses all contain common dNTP-binding motifs, characteristic of proteins 
involved in rolling circle replication (Mankertz et al., 1998a; Niagro et al., 1998).  A   14 
nt-binding site, often referred to as a P-loop motif, is also conserved between the 
Rep proteins of these viruses (Mankertz et al., 1998a; Niagro et al., 1998).  There 
is little variation in these motifs between PCV, BFDV, CFDV, BBTV and 
subterranean clover stunt virus (SCSV), and their Rep proteins exhibit a high 
degree of amino acid similarity (Mankertz et al., 1997).  Based on this similarity, it 
has been suggested that the Rep proteins of these viruses evolved from a 
common ancestor (Bassami et al., 1998). 
Stem-loops  
A 9 nt motif, highly conserved in plant geminiviruses, plant nanoviruses and 
bacterial replicons such as φx174, all of which also have circular, ssDNA 
genomes, is thought to be the initiation site of rolling circle replication (Meehan et 
al., 1997; Mankertz et al., 1998; Mankertz et al., 2000).  Usually located in the 
putative intergenic region in the form of a stem-loop structure (Phenix et al., 2001), 
this nonamer element is conserved
 in circoviruses, with the exceptions of CAV in 
which only the
 nonamer is present, and TTV in which several putative stem-loop 
structures have been reported in the UTR but no nonamer appears to be present 
(Miyata  et al., 1999).  There have been no potential stem-loop structures or 
nonamer sequences reported for TLMV, possibly the result of insufficient 
sequence data.  The nonamer sequence may vary slightly between the 
circoviruses, and the number of bases comprising the stem-loop itself may also 
vary (Meehan et al., 1997; Bassami
 et al., 1998; Todd et al., 2001).  Mutation of 
this nonanucleotide sequence has been shown to prevent replication of PCV 
(Mankertz et al., 1997).  The sequence of the nonanucleotide motifs for the animal 
circoviruses and some plant circoviruses are shown in Table 2.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   15 
Table 2.1.  Stem-loop sequences of the animal and some plant circoviruses.  From 
Harding et al. (1993), Boevink et al. (1995), Miyata et al. (1999), Todd et al. (2001b), 
Phenix et al. (2001), Rohde et al. (1995) and Hattermann et al. (2003). 
 
? indicates a degree of uncertainty. 
 
PCV transcription and replication   
The full transcription pattern of both PCV1 and PCV2 have recently been 
elucidated, and shown to be much more complex than previously thought.   
PCV1 
It was initially thought that 2 transcripts were synthesised from the Rep gene of 
PCV1, one comprising the full-length reading frame producing a protein of 312 
amino acids (Rep), and the second transcript that is differentially spliced and 
encodes the Rep' protein, which was truncated to 168 amino acids (Mankertz and 
Hillenbrand, 2001).  The splicing results in a frame-shifted C-terminal moiety of 
Rep', which deviates from the amino acid sequence of the Rep protein (Mankertz 
and Hillenbrand, 2001).  Both the Rep and Rep` proteins were shown to be 
Virus  9 nt sequence  Stem-loop(s)  Stem-loop size (bp) 
PCV1 TAGTATTAC  Yes  12 
PCV2 AAGTATTAC  Yes  10 
BFDV TAGTATTAC  Yes  10 
CAV TACTATTCC  No  - 
GCV TATTATTAC  Yes  11 
CoCV TAGTATTAC  Yes  20 
CaCV CAGTATTAC  Yes  8 
DuCV TATTATTAC  Yes  10 
TTV  No motif  Yes (?)  - 
TLMV  No motif identified?  ??  - 
OCV Unknown  Unknown  Unknown 
SCSV TAGTATTAC  Yes  11 
BBTV TA(G/T)TATTAC  Yes  11 
CFDV TAGTATTAC  Yes  10   16 
essential for PCV1 replication (Mankertz and Hillenbrand, 2001), and it was 
suggested that the Rep protein may be a helicase while the Rep` protein is a 
nickase (Mankertz et al., 2003), although this has not been confirmed.  The PCV1 
origin of replication was mapped to an 111-bp fragment which included the stem-
loop, and with 4 repeats of the sequence CGGCAG (H1, H2, H3 and H4) located 
adjacent to the stem-loop sequence (Mankertz et al., 1997), which are binding 
sites for the products of the Rep gene (Steinfeldt et al., 2001).  The Rep and Rep` 
proteins both bind to the dsDNA containing the stem-loop and 4 repeat hexamer 
sequences in vitro, but their required binding sequences appear to be different 
(Steinfeldt  et al., 2001).  It is thought that the Rep-associated proteins then 
destabilize and unwind the replication origin DNA, nick the octanucleotide 
sequence (AGTATTAC) between the 6th T and the 7th A to generate a free 3′-OH 
end for initiation of plus-strand DNA replication (Cheung, 2005). Presumably for 
this reason, mutations of the 6
th, 7
th and 8
th nucleotides of this 8 nt sequence are 
lethal to the virus (Cheung, 2005).  The PCV1 Rep gene promoter was mapped to 
an area immediately adjacent to the start of the Rep gene, where it overlapped the 
PCV1 origin of replication and also the intergenic region (Mankertz et al., 1997).  
This Rep promoter is repressed by the Rep protein, but not the spliced Rep` 
protein, the result of the Rep protein binding to 2 of the CGGCAG hexamer 
repeats (H1 and H2, not H3 or H4) (Mankertz and Hillenbrand, 2002).  The Rep` 
protein has not been reported to influence the Rep promoter at all (Mankertz et al., 
2004).   
Based on Northern blotting analyses of PCV1 transcripts, a total of 3 mRNAs were 
initially thought to be transcribed from the PCV1 genome, of 1230 nt , 990 nt and 
750 nt (Mankertz et al., 1998; Cheung and Bolin 2002).  Mankertz et al. (1998) 
reported that 2 mRNAs were encoded by the viral negative strand and one by the 
positive strand.  However, a subsequent study using RT-PCR detected 12 RNA 
transcripts associated with the PCV1 genome: a capsid RNA transcribed from the 
complementary DNA strand, 8 Rep-associated RNAs (Rep, Rep`, Rep3a, Rep 3b, 
Rep 3c-1, Rep 3c-2, Rep 3c-3 and Rep 3c-4), and 3 NS-associated RNAs (NS 
462, NS 642 and NS0) all transcribed from the viral DNA strand (Cheung, 2003b).  
The 8 Rep-associated RNAs were found to share common 5` and 3` nt sequences 
with each other, and to share common 3` nt sequence with the 3 NS RNAs.  It was 
determined that the Rep transcript is the primary transcript that gives rise to the 
other 7 Rep-associated transcripts by alternate splicing (Cheung, 2003b).  The 3 
NS transcripts were transcribed from 3 different promoters inside ORF1, all of   17 
which were independent of the Rep promoter.  The NS0 transcript appeared to be 
unspliced and coded for a potential protein 23 amino acids in length.  The NS 462 
and NS 642 transcripts do not appear to code for functional proteins as no AUG 
initiation codon was found (Cheung, 2003b).  Commonly located in the cell 
nucleus, the PCV1 capsid protein is 234 amino acids in size, arginine-rich with a 
basic end-terminus (Mankertz et al., 2004).  No regulation of the capsid gene by 
any PCV-encoded proteins has yet been demonstrated (Mankertz and 
Hillenbrand, 2002).  The exact function of the Rep 3a, Rep 3b, Rep 3c-1, Rep 3c-
2, Rep 3c-3, Rep 3c-4, NS 462, NS 642, and NS0 transcripts and any proteins 
transcribed from them is unknown (Cheung, 2003b).  Mutational studies of PCV1 
have revealed that only the Rep and Rep` transcripts are essential for PCV1 
replication, and that directed mutation of all other transcripts does not affect Rep-
antigen synthesis or DNA self-replication (Cheung, 2004).   
PCV2 
Nine RNA transcripts were detected from the genome of PCV2 using RT-PCR 
(Cheung, 2003), in contrast to the three transcripts found previously by Northern 
blot (Cheung and Bolin, 2002).  The transcripts identified were the capsid RNA, 5 
Rep-associated transcripts (Rep, Rep`, Rep 3a, Rep 3b and Rep 3c) and 3 non-
structural protein transcripts (NS515, NS672 and NS0).  The 5 Rep-associated 
RNAs all shared common 5` and 3` nt sequences, and they also shared common 
3` nt sequence with the 3 NS transcripts.  As in PCV1, it was suggested that the 
Rep transcript gave rise to the other 4 Rep-associated transcripts by alternate 
splicing and that the 3 NS transcripts were transcribed from 3 different promoters 
inside ORF1 (Cheung, 2003b).   
Similarly to the PCV1 transcripts NS 462 and NS 642, NS 515 and NS 672 do not 
seem to code for functional proteins, and the function of the Rep 3c, Rep 3a, Rep 
3b, NS 515 and NS 672 transcripts is not currently known (Cheung, 2003).  The 
PCV2 capsid, Rep 3a, Rep 3b, Rep 3c, NS 515, NS 672 and NS0 transcripts have 
been demonstrated to be non-essential for PCV2 viral replication, but Rep and 
Rep`are essential for replication (Cheung, 2003c) as was previously reported for 
the equivalent PCV1 transcripts (Mankertz and Hillenbrand, 2001).   
 The requirement of both PCV types for 2 Rep-associated proteins is unusual as 
all other known examples of rolling-circle DNA replication require only one Rep 
protein (Handley-Bowdoin et al., 2000).  The Rep and Rep` proteins of PCV1 have 
been shown to be capable of initiating PCV2 replication (Mankertz and 
Hillenbrand, 2001) and the Rep 3a, Rep 3b and NS0 transcripts and potential   18 
proteins are considered to have equivalent roles in PCV1 and PCV2 replication 
(Cheung, 2003b).  PCV1 NS0 shares 61% nt homology with PCV2 NS0 (Cheung, 
2003b), but there are differences in the expression levels of similar transcripts 
between PCV types.  During PCV1 replication, the NS0 transcript is less abundant 
than the Rep` transcript, but during PCV2 replication the NS0 transcript is more 
abundant than the Rep` transcript (Cheung, 2003b).  The remaining transcripts 
Rep 3c-1, Rep3c-2, Rep 3c-3, Rep 3c-4 and NS 462 and NS 642 (PCV1) and NS 
515 and NS 672 (PCV2) appear unique to each PCV type (Cheung, 2003b).     
The transcription patterns of both PCV types are complex.  Both use similar 
initiation and termination signals at similar areas of the genome, but gene 
expression levels of some transcripts and splice junction selection result in some 
transcripts that are unique to each virus (Cheung, 2003b). Interpretation of the 
role of the transcripts in replication, and differences in the the transcripts of PCV1 
and PCV2, could be important in determining the rates of replication of different 
strains and differences in pathogenicity between PCV1 and PCV2.  Interestingly, 
the Rep and Rep` proteins of each PCV type are able to bind in vitro to the origin 
of replication of the other type, that is, the replication factors of PCV1 and PCV2 
appear to be exchangeable (Mankertz et al., 2003). The implications of this are 
unclear.  
Replication 
Members of the Circoviridae all possess small genomes 1.76 kb (PCV) to 3.8 kb 
(TTV) in size (Todd et al., 2005).  The absence of coding regions for DNA 
polymerases in the circoviruses would suggest that cellular enzymes are required 
for replication (Todd et al., 2001).  Porcine circovirus is probably dependent on 
cellular proteins expressed during the S phase of cell growth (Tischer et al., 1987).  
The dependence of these viruses on cellular enzymes present during cell 
replication is supported by the finding that CAV antigen can be detected in only 
30-40% of infected MSB1 cells in culture, the approximate proportion of cells that 
would have been undergoing cell division (Todd et al., 2001).  The dependence of 
these viruses on dividing cells for replication is reflected in the type of cells that 
are infected in vivo, so circoviruses often replicate well in rapidly dividing tissues 
and cells, such as foetal tissue (Allan et al., 1995; Sanchez et al., 2003) and cells 
of monocyte/macrophage lineage (Rossell et al., 1999; Allan et al., 1994; Gilpin et 
al., 2003; Okamoto et al., 2002).   
The replication of TTV and TMLV seems occur by a different mechanism.  It has 
been suggested that TTV replication involves a dsDNA intermediate form   19 
(Okamoto et al., 2000), and it is presumed that TTV and possibly TLMV replicate 
by rolling circle replication, however this has not been confirmed experimentally 
(Miyata  et al., 1999).  A possible intermediate replicative form of TTV was 
detected in the livers of monkeys experimentally-infected with the virus (Xiao et 
al., 2002).  In TTV and TMLV, and perhaps relevant to their replication, the ORF3 
possesses a degree of homology to the gene encoding DNA topoisomerase 1, a 
protein which catalyses ssDNA cleavage (Takahashi et al., 2000).  It has been 
suggested that the protein encoded by the ORF3 of TTV and TLMV may play a 
role in replication (Takahashi et al., 2000).  It is not certain, however, if the TLMV 
ORF3 is functional as this ORF is not present in all TLMV isolates (Biagini et al., 
2001).   
Circovirus replication probably occurs in the nucleus of the host cell, and OCV, 
PCV, CAV and CoCV have frequently been identified in the cell nucleus after 
infection (Studdert et al., 1993; Tischer et al., 1995; Coletti et al., 2000; Eisenberg 
et al., 2003).  Liu et al. (2001) demonstrated that the nuclear localisation signal of 
the PCV2 capsid protein was conferred by the 41 N-terminal amino acids of 
ORF2.   
A summary of the major steps thought to be involved in circovirus replication is 
shown in Figure 2.1. 
Rolling circle replication  
Viruses belonging to the family Circoviridae are thought to replicate genomic DNA 
by a mechanism known as rolling circle replication, a process of continuous 
elongation of the open positive-strand of DNA via the endless copying around a 
closed circular negative-strand template.  This is a means of DNA replication 
common to the animal circoviruses, plant circoviruses and the geminiviruses   
(Dressler, 1970) (Figure 2.2).   
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Figure 2.1.  Summary of the major steps involved in circovirus replication.  1. The ssDNA 
virus origin is converted into a dsDNA replicative form (RF), presumably by host DNA 
polymerase.  2. Transcription of the RF DNA yields a number of mRNA transcripts.  3. One 
of the mRNA transcripts produced is then translated into the Rep protein.  4. The Rep 
protein introduces a nick into the RF DNA, initiating viral DNA replication.  5. Rolling circle 
replication takes place, producing new progeny virus DNA.  6. Another mRNA transcript is 
translated into the capsid protein.  7. Assembly of the new progeny virus DNA and the 
capsid into new infective virions. 
 
Figure 2.2.  Diagrammatic representation of rolling circle replication.  A circular dsDNA (an 
intermediate replicative form of DNA) molecule is shown in A.  In B a nick opens one 
strand and the free 3’-OH end is extended by DNA polymerase.  The newly synthesised 
strand displaces the original parent strand as it grows (C, D).  By E, the polymerase has 
completed one revolution, and by F, 2 revolutions.  The result is a molecule containing 3 
unit genomes, one old and 2 new.  The displaced strand can then serve as a template for a 
complementary strand.  From King and Stansfield (1990). 
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Porcine circovirus replication 
Within the nucleus, presumably using a polymerase of host cell origin, the naked 
single-stranded viral genome is converted to a double-stranded replicative form 
(Prescott  et al., 1993).  Progeny virus is then produced via the circular dsDNA 
intermediate (Tischer et al., 1995) which is assembled with the capsid protein to 
produce new virions.  The new infective virions are then released when the infected 
cell goes through mitosis, thus infecting new daughter cells (Tischer et al., 1995).   
PCV has similarities with the Microviridae and Geminiviridae, in regions of the Rep 
proteins thought to be associated with DNA rolling-circle replication (Todd et al., 
2005), suggesting PCV replicates by a similar mechanism.  As described above, a 
full-length and intact Rep protein, with a P-loop domain and rolling circle replication 
motifs, is required for replication of PCV1 (Mankertz and Hillenbrand, 2001) and 
PCV2 (Cheung, 2003c).  The Rep and Rep` proteins appear to be co-localised in 
particular areas of the nucleus (Mankertz et al., 2004) and both PCV1 and PCV2 
possess nuclear localisation signals (Cheung and Bolin, 2002).  PCV2 can be 
detected in the nucleus of the host cell immediately after infection, but viral antigen 
becomes perinuclear and cytoplasmic as the infection progresses (Cheung and 
Bolin, 2002).   
Virus evolution and genetic variation 
Genetic change over time occurs in all viruses, due to mutation, recombination and 
reassortment.  A high level of genetic diversity within a viral species may occur as 
a result of a widespread virus infecting a large number of hosts over a long period 
of time, and/or if the virus in question has a high mutation rate, either due to 
selective pressures or an inefficient replicative proofreading mechanism (Ritchie et 
al., 2003).  The most common mutations involve single nt substitutions, deletions 
or insertions, collectively known as point mutations (White and Fenner, 1994).   
The rate of mutation and therefore evolution is faster in RNA viruses than DNA 
viruses, and some RNA viruses evolve at higher rates than others (Ngui et al., 
1999).  Mutations in the RNA viruses are largely caused by the absence of a 3` to 
5` exonuclease proofreading activity in the RNA polymerase (Ngui et al., 1999).  
Retroviral reverse transcription enzymes are particularly error-prone.  Human 
immunodeficiency virus type 1 (HIV-1) reverse transcriptase can introduce base-
substitution errors translating to 5-10 errors per HIV genome per round of 
replication (Preston et al., 1988).  The low fidelity of HIV-1 reverse transcriptase is 
suggested to be responsible, at least in part, for the hypermutability of the virus 
(Preston et al., 1988).  Selection forces, such as the immune response and the   22 
limited availability of appropriate target cells during transmission and persistence, 
can act on new viral variants and are likely to control the diversity and rate of 
evolution, and therefore sequence variation, of highly mutable viruses such as 
retroviruses (Overbaugh and Bangham, 2001).   
The DNA viruses, such as the Circoviridae, are generally more stable and evolve 
more slowly, due to the proofreading ability of DNA polymerase (Ngui et al., 1999).  
Replicative DNA polymerase proteins possess multiple proofreading mechanisms 
to prevent errors in replication (Perlow and Broyde, 2001) resulting in the lower 
mutability and therefore sequence variation of DNA viruses.  The ssDNA viruses, 
however, despite this increased proofreading ability, have the potential for a large 
amount of intra-specific sequence variation, possibly because the DNA lacks the 
stability conferred by a double helix (Lindahl and Nyberg, 1974).  For this reason 
ssDNA is susceptible to spontaneous deamination, which occurs when a cytosine 
or adenine residue loses an amine group through hydrolytic disassociation to form 
uracil or hypoxanthine, respectively (Duncan and Miller, 1980).  This deamination 
is known to be a significant cause of spontaneous mutation (Coulondre et al., 
1978).  Most animal circoviruses, however, with the exception of TTV and TLMV, 
are highly conserved at the nt level.   
Genus Anellovirus 
Strains of CAV generally exhibit very limited genetic variability (Classens et al., 1991; 
Kato et al., 1995; Chowdhury et al., 2003).  One study of 13 CAV isolates detected 
>96% identity at the nt level (Chowdhury et al., 2003), and this included the 
sequence of strains passaged multiple times in cell culture (Meehan et al., 1997b; 
Todd et al., 2002; Scott et al., 1999).  The attenuation of CAV to a less pathogenic 
form in cell culture is well described, although cell culture attenuated strains will 
revert to virulence after inoculation into young chicks (Todd et al., 1995).  Attenuation 
has been associated with minor nt and amino acid changes throughout the CAV 
genome (Scott et al., 1999; Meehan et al., 1997b).  One specific change observed 
was a 21 bp insertion in the CAV UTR in attenuated strains, although this may be 
simply an adaption to replication in MDCC-MSB1 cells as the insertion was also 
found in pathogenic CAV strains (Meehan et al., 1997).  Another possible explanation 
provided for attenuation is that capsid proteins with altered conformation caused by 
amino acid changes may be selected during multiple cell passages, and these 
altered protein may bind more efficiently to the receptor on host MDCC-MSB1 cells 
(Todd et al., 2002).  Amino acid changes within the CAV VP1 (capsid) protein have 
been shown to affect the rate of CAV replication and the ability of CAV to replicate in   23 
different types of MDCC-MSB1 cell lines, therefore it appears that minor amino acid 
changes may affect the cytopathogenicity and cell culture tropism (Renshaw et al., 
1996).  It has also been found that VP1 amino acid 394 is variable between high 
pathogenicity and low pathogenicity non-attenuated field strains (Yamaguchi et al., 
2001).   
TTV and TLMV are the only animal circoviruses that exhibit high genetic variability.  
This is unusual for DNA viruses, but possibly TTV is replicated by machinery with 
poor proofreading ability, leading to the high genome variation.  The variation 
within the TTV genome is uneven: the UTR is conserved between isolates with 
segments more than 90% homologous at the amino acid level.  However, the 
central region of the TTV ORF1 shares poor identity between isolates, with as little 
as 32% amino acid identity (Miyata et al., 1999).  A possible reason for the high 
conservation of the UTR of TTV and TLMV is that they are situated close to TATA 
boxes and other regulatory elements (Thom et al., 2003).   
CAV has been considered the closest known relative of TTV and TLMV (Miyata et 
al., 1999; Takahashi et al., 2000).  While there are no significant nt or amino acid 
homologies between the 3 viruses, CAV and TTV share a similar genome 
organisation, including the presence and location of some putative regulatory 
sequences (Miyata et al., 1999).  There are also some small areas of sequence 
which are conserved between CAV, TLMV and TTV (Thom et al., 2003) and an 
amino acid motif WX7HX3CXCX5H is common to all 3 viruses (Takahashi et al., 
2000).  CAV and TTV share a 36 nt region with approximately 80% homology, but 
whether this area is involved in any function conserved in TTV and CAV is 
unknown.  The ORF1 proteins of all 3 viruses (TTV, CAV and TLMV) are arginine-
rich at the amino terminus.  The amino terminus of TLMV is also tryptophan and 
phenylalanine rich suggesting a common relationship between CAV and TLMV.  
The ORF2-encoded protein of TLMV, approximately 90 amino acids, is much 
shorter than the corresponding protein of CAV or TTV (Takahashi et al., 2000).   
Additional evidence of a distant relationship between CAV and TLMV is the 
observation that the regions of CAV encoding VP2 and the TLMV ORF2 may both 
code for a novel dual-specificity phosphatase (Peters et al., 2002).  Protein 
phosphatases are known to function in the regulation of mitogenesis, gene 
transcription, signal transduction, cell-cell
 interactions, and cellular differentiation 
and in cytokine responses
 of lymphocytes, and VP2 protein phosphatase activity 
during infection
  could be expected to induce regulatory changes in infected 
lymphocyte
 populations (Peters et al., 2002).  Like all circoviruses, CAV is highly   24 
dependent on the host cell for replication and it is possible that a capacity to
 
regulate the cell cycle may be vital for this purpose (Peters et al., 2002).  It is also 
possible that protein phosphatase activity may be required
  for replication, and 
effects on the host cell may be secondary.  A similar situation may exist to that 
which operates during vaccinia virus infection, when the encoded VH1 
phosphatase protein is able to block interferon  signalling, which assists in the 
evasion of the host immune response (Najarro et al., 2001).  This potential function 
of vaccinia VH1, the only
 viral phosphatase with a characterised in vivo function, 
suggests that virus-encoded phosphatases may be involved
 in immune evasion 
and virus persistence (Peters et al., 2002).  The observation that CAV and TLMV 
both have ORFs capable of phosphatase activity would suggest a potential 
common strategy for infection
  and replication between CAV and the human 
circoviruses (Peters et al., 2002).   
Due to the high prevalence of TTV infection in the general human population and 
its apparent inability to cause any overt disease, it has been proposed that TTV is 
a commensal human virus.  Commensal viruses are usually persistent, highly 
transmissible and highly prevalent but fail to produce any lesion (Simmonds, 
2002).  TTV may be an ‘old’ circovirus, and indeed the fact that TTV and TLMV 
both commonly infect humans and non-human primates would suggest that the 
divergence of TTV and TLMV probably occurred before the human/chimp lineage 
split (Thom et al., 2003).  Chimpanzees are infected by a range of TTV and TLMV-
like viruses, some of which are also capable of infecting humans, and therefore it 
may be assumed that TTV and TLMV diverged earlier than chimps and humans 
did, an estimated 5 million years ago (Simmonds, 2002).  Forms of TTV have 
been identified in apes, old world primates, new world primates and the tree shrew 
(the most divergent primate), supporting the theory of a long co-evolution of TTV 
and TLMV-like viruses and their primate hosts over tens of millions of years (Thom 
et al., 2003; Simmonds, 2002).  The TTV and TLMV-related viruses may have split 
from their non-human primate variants, the forms found in African monkeys and 
other apes, around 90 million years ago (Thom et al., 2003).  The long evolution of 
TTV and TMLV is similar to that which seems to have occurred with the 
herpesviruses, which have also shared a long co-evolution with mammals 
(Simmonds, 2002).   
Some suggested reasons for the high genetic diversity evident for TTV and TLMV 
are genetic drift over very long time periods (probably millions of years) and cross-
species transmission between human and non-human primates (Simmonds,   25 
2002).  Mixed infection with multiple TTV genotypes is a frequent occurrence 
(Simmonds, 2002) that would increase the chance of recombination between TTV 
isolates (Worobey, 2000).  Long lasting viral infections such as in TTV and TMLV 
may also allow the host immune system to exert genetic and therefore 
evolutionary pressure.  Other low pathogenicity viruses that may have co-existed 
with primates for millions of years, for example the papillomaviruses, also show 
high levels of genetic variation (Bendinelli et al., 2001).   
It has been estimated that CAV could represent a divergence from the TTV/TLMV 
virus lineage that occurred approximately 300 million years ago (Simmonds, 2002).  
Other animals, including non-primate mammals, reptiles, amphibians and 
marsupials could also have CAV or TTV-like viruses (Simmonds, 2002) that, given 
the high genetic variability of the known TTV-like viruses, may be difficult to detect 
using present PCR methods (Thom et al., 2003).   
Genus Circovirus 
PCV1 and PCV2 have been shown to be genetically stable, with higher genetic 
conservation than BFDV, a close relative (Choi et al., 2002).  All PCV2 strains 
examined so far have shared greater than 90% nt identity (Kim and Lyoo 2002; 
Choi et al., 2002; Larochelle et al., 2002), and a 40 year old PCV1 isolate had 
99% identity to modern strains (Choi et al., 2002).   
Although not as highly conserved as PCV, other animal circoviruses are still 
genetically stable.  In one study of 8 Australian BFDV isolates, the sequence 
variation between isolates was 84-97% (Bassami et al., 2001).  Twelve GCV 
strains varied by only 7.7% (Chen et al., 2003), although 11 of these strains were 
from Taiwan and more data is needed to confirm the genetic variation in GCV 
between countries and over time.  Two strains of CoCV exhibited approximately 
96% nt identity (Todd et al., 2001).  Only one strain of CaCV and one strain of 
DuCV have been sequenced (Phenix et al., 2001; Hatterman et al., 2003) and 
only partial sequence data has been reported for OCV, so the sequence variation 
and genetic variability of these viruses is unknown.   
While inter-specific phylogenetic analysis of the viruses in the genus Circovirus 
has revealed that they all appear to be genetically closely related, PCV1 and 
PCV2 are the circoviruses that share the greatest similarity to each other (Phenix 
et al., 2001; Hatterman et al., 2003).  Based on the amino acid sequences of the 
Rep and capsid proteins of these 2 viruses, the closest relative to PCV is GCV, 
and the 2 viruses sharing the closest relationship with them are GCV and DuCV 
(Hatterman et al., 2003).     26 
In contrast to the Anelloviruses, there has been little research on the theoretical 
evolution of viruses placed in the Circovirus genus.  PCV and BFDV are thought 
to have evolved from plant nanoviruses (Bassami et al., 1998; Gibbs and Weiller, 
1999).  This theory is based on the observation that part of the circovirus nt 
sequence encoding the Rep protein is similar to that of plant nanoviruses, while 
the remainder closely resembles the Rep protein of a single-stranded RNA virus.  
Gibbs and Weiller (1999) considered that plant nanovirus DNA was probably 
transferred from a plant to a vertebrate, possibly by an animal being exposed to 
sap from an infected plant, and that as the transferred DNA included the origin of 
replication the virus was still able to replicate.  They hypothesised that once this 
host switch had taken place, the plant viral DNA recombined with a vertebrate-
infecting RNA virus, most likely a calicivirus, to produce circoviruses capable of 
infecting vertebrates.  This theory was proposed before the characterisation of 
GCV, CaCV, CoCV, DuCV and OCV, and given the nt and amino acid identity and 
the preservation of replication-associated motifs between PCV, BFDV, CaCV, 
CoCV, GCV and OCV, it would be assumed that if such a recombination event did 
occur that it would have involved the ancestor of all these viruses.   
The reason for the very high sequence conservation of the PCV types is unclear.  
Presumably PCV2 evolved from PCV1, or vice versa, by a series of point 
mutations (Ellis et al., 1998).  No intermediate forms have been found to exist, and 
both types of PCV are genetically very stable over time (Choi et al., 2002, 
Larochelle et al., 2002), suggesting that PCV1 and PCV2 have been divergent and 
relatively unchanged for a long period of time.   
Comparative pathology and pathogenicity of circoviruses 
Target cells and sites of replication of circoviruses 
The target cells for replication of CAV, PCV and TTV in vivo have been well studied, 
with less information available for the other circoviruses.   
The main cellular hosts of CAV are considered to be haemocytoblasts in the bone 
marrow and precursor lymphocytes in the thymus (McNulty, 1991; Todd, 2004), 
although CAV antigen has been detected in the thymus, spleen, bone marrow, 
proventriculus and the duodenum of experimentally infected birds (Smyth et al., 
1993).  It was suggested that CAV may be lymphotrophic during the early stages of 
infection, but later infects other cell types (Cardona et al., 2000).  CAV infection in 
chickens seems age-dependent, and CAV-associated disease has only been 
reported in chicks infected before 3-weeks of age, or in older immunosuppressed 
chickens (Cardona et al., 2000).  Adult chickens do not seem to be as susceptible to   27 
CAV as young chicks, which could be due to a lack of suceptible thymocytes in older 
birds (Jeurissen et al., 1992).   
BFDV appears to be epitheliotropic, targeting the actively dividing cells of the basal 
epithelial layer of the feather and feather follicles (Pass and Perry, 1984).  Virus 
particles have also been detected by electron microscopy in the liver and bursa of 
diseased birds (Raidal et al., 1993; Schoemaker et al., 2000), and intracytoplasmic 
inclusions have been demonstrated within macrophage cells in the feather epithelium 
and spleen (Latimer et al., 1991; Sanada et al., 1999).   
It appears that both types of PCV may infect several porcine tissues but the tissues 
infected may vary, possibly depending on the amount of virus circulating in the body 
and the health status and age of the host.  In experimental PCV1 infections, PCV1 
antigen has been detected in the thymus, spleen, mesenteric lymph node, kidney, 
small intestine and lung (Allan et al., 1994 b; Allan et al., 1995).  Allan et al. (1994a) 
reported that PCV1 could infect monocyte/macrophage cell types but not T or B cells 
in vitro.  In experimental PCV2 infections, antigen has been demonstrated in the liver, 
lung, kidney, pancreas, myocardium, intestines, testis, brain and salivary, thyroid and 
adrenal glands (Kennedy et al., 2000), and also tonsil, spleen, lymph nodes and 
ileum (Pogranichnyy et al., 2000).  In naturally infected pigs with PMWS, PCV2 has 
been detected in the lungs, lymph nodes, spleens and tonsils (Hamel et al., 1998).  It 
is thought that PCV2 initially infects the tonsils and lymph nodes (Rosell et al., 1999) 
or the thymus (Darwich et al., 2003) and is disseminated to other tissues by viraemia 
(Krakowka et al., 2002).  It is not certain whether PCV2 can infect and replicate in 
lymphocytes, with some reports supporting infection of B-lymphocytes (Shibahara et 
al., 2000) and others claiming that it does not replicate in any type of lymphocyte 
(Kim and Chae, 2003).  A study using flow cytometry suggested that PCV2 probably 
does not infect resting lymphocytes in vitro, and there was evidence of viral infection 
in both monocyte and macrophage cells (Gilpin et al., 2003).   
Both PCV1 (Choi et al., 2002) and PCV2 (Stevenson et al., 2001) have been 
identified in the neural tissues of pigs suffering from congenital tremors (CT), 
although no causal relationship has been proven.  PCV2 can also infect and persist 
in dendritic cells, although active replication does not seem to occur in these cells 
(Vincent et al., 2003).   
PCV2 has also been shown to replicate in porcine embryos (Mateusen et al., 2004) 
and the demonstration of PCV2 antigen in the tissues of foetuses would suggest that 
prenatal infection with PCV2 does occur (West et al., 1999).  Differences in the 
distribution of PCV2-infected cells in tissues between foetal and postnatal animals   28 
would suggest that PCV2 may target different cells in foetal and newborn animals 
(Sanchez et al., 2003).  Possibly, the differentiating tissues in foetuses may provide 
the rapidly replicating cells suitable for PCV2 replication (Sanchez et al., 2003).   
TTV seems to be widely distributed in the body tissues of patients with liver 
disease, but no causal association between the virus and liver disease has been 
established (Pollicino et al., 2003).  The major TTV replication site is probably the 
liver (Okamoto et al., 2002) although the virus does circulate in the blood and has 
been found to replicate in bone marrow cells and stimulated PBMC (Bendinelli et 
al., 2001; Mariscal et al., 2002).  TTV has also been identified in the brain and 
spinal fluid of patients with liver disease, suggesting that TTV can invade the 
human central nervous system (Pollicino et al., 2003).  It has also been detected 
in the respiratory tract of children with acute respiratory disease (Maggi et al., 
2003).  When inoculated into monkeys, TTV viral DNA was detected in the liver, 
bone marrow and small intestine, suggesting that TTV can replicate in all these 
tissues (Xiao et al., 2002).  It is not certain whether the distribution of TTV in 
tissues is the same in healthy and diseased individuals.   
TLMV DNA has been detected in human plasma and PBMC (Takahashi et al., 
2000; Biagini et al., 2001) but no data was found on the distribution of TLMV in 
human tissues, presumably due to its recent discovery and the invasiveness 
required for tissue testing.   
The target cells for the replication of CoCV, GCV, TLMV, OCV, DuCV and CaCV 
are not known.  CoCV virus has been detected in the bursa, spleen, thymus, liver, 
kidney, brain, crop and intestine of infected pigeons (Smyth et al., 2001; Duchatel 
et al., 2005), and GCV and DuCV DNA have been amplified from the bursa, 
where virus particles had previously been identified by electron microscopy (Todd 
et al., 2001; Ball et al., 2004; Hatterman et al., 2003) with GCV also identified by 
ISH in the liver, small intestine, lung, spleen, thymus, kidney, heart and bone 
marrow of infected birds, with particularly large amounts of virus in the liver 
(Smyth et al., 2005).  OCV has been identified in the gut content of an ostrich (Els 
and Josling, 1998) and also detected in ostrich embryos, suggesting vertical 
transmission is possible, and in liver tissue of young chicks (Eisenberg et al., 
2003).   
The target cells used for replication is a key issue needed to elucidate the 
pathogenesis of virus infections, and while macrophages have been suggested to 
play a key role, there is some uncertainty as to whether circoviruses commonly 
replicate in these type of cells.  PCV1 has been detected in   29 
monocyte/macrophage cell lines (Allan et al., 1994; McNeilly et al., 1996).  BFDV 
antigen has been identified within macrophage cells in the feather epithelium and 
spleen of diseased birds (Latimer et al., 1991; Sanada et al., 1999).  PCV2 has 
been detected in macrophage cells of PMWS-affected pigs (Kiupel et al., 1998; 
Rosell et al., 1999; Kim et al., 2004).  CAV has not been shown to replicate in 
macrophages, although macrophages from CAV-infected birds have reduced IL-1 
production, Fc receptor expression, phagocytosis, and bactericidal activity 
(McConnell et al., 1993).  This may be due to the withdrawal of cytokines essential 
for the maintenance of these functions, which could be caused by viral destruction 
of T-cells and precursor T-cells (McConnell et al., 1993).  The decrease in IL-1 
production can affect T-cell maturation in the thymus, therefore more precursor T-
cells are likely to be available for CAV replication (McConnell et al., 1993b).   
A hypothesis was proposed that the replication of PCV2 in macrophages 
contributed to the PMWS disease process, as experimentally or naturally induced 
immunoproliferation could lead to increased macrophage production and therefore 
increased PCV2 replication, precipitating disease (Krakowka et al., 2001).   
However, while in both naturally occurring and experimentally induced cases of 
PMWS, cells of histiocyte, monocyte and macrophage lineage are often positive 
for PCV2 antigen, the viral DNA is commonly contained in the cell cytoplasm 
rather than the nucleus (Allan et al., 1999; Balasch et al., 1999; Ellis et al., 1999; 
Krakowka et al., 2000; Rosell et al., 2000; Harms et al., 2001; Fenaux et al., 2002; 
Kim et al., 2004) which would suggest that PCV2 replication within these cells is 
very limited or non-existent.  Consequently, it has been suggested that the viral 
material of PCV2 and other circoviruses accumulates in macrophages as a result 
of phagocytosis, and that the presence of circovirus-containing inclusions in the 
cytoplasm of macrophages may result from the phagocytosing activity of these 
cells and is not the result of endogenous replication (Krakowka et al., 2002; 
Shibahara et al., 2000; Todd, 2004).  Chang et al. (2005) demonstrated with in 
vitro studies, that PCV2 can passively enter and accumulate in the cytoplasm of 
alveolar macrophages (AMs), which may assist the virus to evade detection by the 
host immune system. 
Phagocytosis as an explanation for the presence of circovirus antigen in 
macrophages is not universally accepted.  Phagocytosis of CAV by macrophages 
in vitro is rare (Gilpin et al., 2003).  While circoviruses commonly replicate well in 
rapidly dividing cells (Rossell et al., 1999; Allan et al., 1994; Okamoto et al., 2002; 
Gilpin et al., 2003), presumably due to their reliance on host-cell polymerases,   30 
macrophages are considered to be in the terminal stages of monocytic cell 
differentiation.  Their replicative machinery is largely inactive, therefore they were 
considered an unlikely target for PCV replication (Gilpin et al., 2003).  An 
alternative reason for the non-productive circovirus infection of macrophages was 
proposed.  This was that macrophages can express high levels of DNA 
polymerase activity in response to damage to their DNA (Williams et al., 2002), 
and this expression could facilitate PCV replication.   
Persistent PCV2 infection of porcine macrophage and monocyte cells in vitro with 
no increase in infectious virus or production of replicative intermediates has been 
demonstrated (Gilpin et al., 2003).  It has been thought that this type of PCV2 
infection with minimal replication could well contribute to the disease process 
associated with PMWS: PCV2 could be disseminated throughout the body and via 
the persistent ‘silent’ infection of macrophage cells, remain undetected by the host 
immune system (Gilpin et al., 2003).  Support for this hypothesis was a very low 
level of PCV2 replication detected in macrophages in vitro, and replication only in 
cells derived from certain individual pigs (Meerts et al., 2004).  This is an unusual 
finding and the reasons for these differences between animals have not been 
identified.  More investigation is needed to elucidate the possible role of 
macrophage cells in PCV2 infection and dissemination throughout the host 
animal.   
Virus transmission and route of infection of circoviruses 
BFDV is thought to be transmitted primarily by feather dust, faeces and crop 
secretions (Ritchie et al., 1991).  However, research in this area is limited, and 
whether BFDV may be transmitted by any other means is largely unknown.   
Vertical transmission of OCV was demonstrated by the detection of virus in embryos 
(Eisenberg  et al., 2003), but no information is available on other forms of OCV 
transmission.  There is no information available on the transmission of CaCV, GCV, 
DuCV or CoCV, although it would seem likely that shedding through faeces, crop 
dust and feather secretions would occur as it does with BFDV.  The transmission of 
CAV has been studied more extensively, and it has been determined that CAV 
transmission may be both vertical, resulting in increased mortality of young chicks, 
and horizontal once maternal antibody has disappeared, resulting in a subclinical 
disease that can result in decreased productivity in adult chickens (Scott et al., 1999).  
CAV maternal antibody will protect chicks from clinical disease, but it does not 
protect from infection, and it does not prevent virus transmission or 
immunosuppression.  As a consequence of vaccination programs, CAV-associated   31 
clinical disease is rare today, although subclinical infection is ubiquitous (Sommer 
and Cardona, 2003).  CAV can persist in the reproductive organs of specific-
pathogen-free (SPF) chickens long after seroconversion and the virus can also infect 
embryos in the early stages of development (Cardona et al., 2000).   
From the intensive study of TTV since its discovery in 1997, it would appear that the 
virus can be transmitted in a variety of ways, possibly accounting for the virus being 
so common in the human population.  The high prevalence of TTV in donated blood 
would suggest that it could be transmitted by blood transfusion.  The high prevalence 
of infection in very young (7-12 month old) children would also suggest that TTV is 
commonly aquired in infancy (Yokozaki et al., 1999; Peng et al., 2002) and TTV has 
been found in the breast milk of nursing mothers (Matsubara et al., 2001).  TTV has 
also been identified in amniotic fluid (Matsubara et al., 2001) and cord blood 
(Matsubara et al., 2001) providing evidence for vertical transmission.  Faecal-oral 
transmission has been suggested; it is thought that viral excretion in faeces may 
occur via secretion from the liver into the bile (Pollicino et al., 2003).  It has also been 
suggested that TTV may be transmitted sexually (Krekulova et al., 2001).   
Although there is only limited data on the transmission of TLMV, given that co-
infection with TTV and TLMV is common (Matsubara et al., 2001; Thom et al., 2003) 
it could be assumed that TLMV is spread by similar routes to TTV.  TLMV has been 
detected in plasma, PBMC, saliva, faeces and the cervix (Biagini, 2004).  TLMV, like 
TTV, has also been identified in cord blood (Matsubara et al., 2001), suggesting that 
vertical transmission can occurr.   
PCV2 has been identified in a wide variety of tissues, including oropharyngeal and 
nasal swabs, faeces, whole blood and serum after experimental infection, and the 
frequency of PCV2 in whole blood, nasal swabs and faeces from field samples has 
been reported to be 30.4%, 19.2%, and 20.4%, respectively (Shibata et al., 2003).  
Both types of PCV have been isolated from faecal samples and nasal swabs in 
experimentally infected pigs, and from naturally infected field pigs (Tischer et al., 
1986; Shibata et al., 2003; Yang et al., 2003; Sibila et al., 2004; Segales et al., 2005).  
A study involving the experimental inoculation of piglets with PCV2 showed that 
uninoculated piglets in the same room as inoculated piglets could become infected 
with PCV2 through simple contact, viral infection becoming apparent in the in-contact 
pigs one day after the inoculated piglets (Okuda et al., 2003).  This is supported by 
the finding of PCV2 in respiratory and nasal secretions (Segales et al., 2005).   
Sexual transmission of PCV has also been suggested, and both PCV1 and PCV2 
DNA have both been identified in boar semen (Kim et al., 2001); PCV2 has been   32 
shown to be shed in semen for up to 47 days after infection (Larochelle et al., 2000).  
Vertical transmission of PCV is probable: PCV2 appears to cross the placenta and to 
infect foetuses (West et al., 1999), and transplacental infection of foetuses causing 
reproductive failure has also been suggested (Ladekjaer-Mikkelsen et al., 2001).  
Immunosuppression and concurrent infections as factors in circovirus 
infections 
Common features of PMWS, BFD, and GCV and CoCV-associated diseases 
include intracytoplasmic inclusions within macrophages, depletion of T and B 
lymphocytes, ill-thrift and secondary infections, all of which are suggestive of 
immunosuppression (Todd, 2004).  However the mechanisms of 
immunosuppression resulting from circovirus infection probably differ between 
circoviruses.   
The mechanism of immunosuppression in birds suffering from BFD has not been 
fully elucidated.  Damage to the thymus and bursa in diseased birds is thought to 
result in immunosuppression and secondary infections (Latimer et al., 1992).   
However, direct cell destruction of lymphocytes in these organs is probably not 
involved and maybe the immunosuppression is caused by a cytokine-mediated 
reduction in lymphoid tissue development (Todd, 2004).  There may also be 
immunosuppression in association with CoCV infection: virus particles were found 
in association with lymphoid depletion (Coletti et al., 2000) suggesting that the 
virus might damage the immune system (Roy et al., 2003).   
Immune function and immunosuppression in CAV-infected birds has been studied 
more extensively.  A decrease in the levels of CD3, CD4, CD8 and natural killer 
cells has been demonstrated in experimentally infected chicks, providing evidence 
for altered lymphocyte function (Bounous et al., 1995).  The immunosuppression 
is thought to be the result of depressed macrophage function, which may in turn 
result from infection and destruction of activated T-cells and precursor T-cells 
(Adair et al., 1993; McConnell et al., 1993a).  CAV-associated clinical disease 
occurs only in young chicks but adult birds may also be immunosuppressed as a 
consequence of CAV infection (McConnell et al., 1993b).   
The effects of human circovirus infection appear to be clinically mild or inapparent, 
although both TTV and TLMV titres increase in immunosuppressed people, for 
example soldiers undergoing intense training and patients receiving 
immunosuppressive drugs prior to organ transplantation (Moen et al., 2003).  This 
would suggest that these viruses can interact with and possibly affect the human 
immune system.  As a majority of the human population appears to be infected   33 
with TTV and/or TLMV, and sometimes several different isolates of TTV (DeValle 
and Niel, 2004; Raffa et al., 2003; Mushahwar et al., 1999), various theories have 
arisen for the possible consequences of this in inducing immunosuppression.   
One theory is that only high levels of viral replication may affect the immune 
system, and that in most people TTV infection is not associated with 
immunosuppression (Maggi et al., 2003).  It was also hypothesised that infection 
with more than one genotype may lead to lymphocyte subpopulation imbalances, 
including low CD3 (total T lymphocytes), low CD4 (T helper lymphocytes) and high 
CD 19 (B lymphocytes) (Maggi et al., 2003).  It was also suggested that different 
TTV isolates might interact with each other, or alternatively only some isolates are 
responsible for affecting lymphocyte subpopulations (Maggi et al., 2003).  TTV 
infection may also favour the production of type 2 cytokines, thereby leading to 
immunosuppression (Maggi et al., 2003).   
In piglets, artificially-induced immunosuppression seems to potentiate PCV2 
replication and allow the virus to spread to hepatocytes and Kupffer cells as well 
as dendritic cells and macrophages (Krakowka et al., 2002); CD8+ cells are 
mainly responsible for the cytotoxic response, and DP cells are mature 
lymphocytes with properties of memory and effector cells.  This had led to the 
development of a theory that there is a relationship between the immune status of 
the infected pig and PCV2-associated disease development (Krakowka et al., 
2002).  It was reported that PCV2 infection causes a shift in the animals relative 
counts of peripheral blood lymphocyte subsets, specifically a decrease in 
CD4+CD8+ double-positive (DP) and CD8+ cell counts (Darwich et al., 2002).   
Others have detected a decrease in CD4+ cells in PMWS-affected pigs (Segales 
et al., 2001; Sarli et al., 2001) although this may not be a direct affect of PCV2 
infection as decreased CD4+ counts were also detected in wasted PCV2-negative 
pigs (Darwich et al., 2002).  Others have found a decrease in both T and B cells in 
PCV2-infected pigs (Segales et al., 2001; Darwich et al., 2002; Darwich et al., 
2003; Chianini et al., 2003; Kim and Chae, 2003), and depletion of T- and B-cell 
dependent areas in lymphoid tissues have been observed, the intensity of  which 
correlated with the amount of virus present in those tissues (Darwich et al., 2002; 
Darwich et al., 2003; Chianini et al., 2003).   
It was suggested that the destruction of B-lymphocytes leading to 
immunosuppression by PCV2 occurred by apoptosis, with phagocytosis of the 
cellular remains by macrophages, which serve as a source of infection as they 
travel throughout the body (Shibahara et al., 2000).  However, there is conflicting   34 
evidence regarding the ability of PCV2 to induce apoptosis – one study found that 
the incidence of apoptosis in lymphoid tissues of healthy and PMWS-affected pigs 
was inversely correlated with viral load and the severity of microscopic lesions 
(Resendes et al., 2004).  In the lymphoid tissues of healthy pigs, the processes of 
apoptosis and proliferation are in balance to maintain a stable population of cells, 
and if PCV2-mediated apoptosis does not occur then decreased cellular 
proliferation in PMWS-affected pigs may be the primary cause of cell depletion in 
lymphoid tissues (Resendes et al., 2004; Mandrioli et al., 2004).  An alternative 
theory proposed to explain the changes in lymphocyte populations is that virus 
overloading and subsequent neglect of cellular metabolism may contribute to cell 
death and phagocytosis (Krakowka et al., 2002).   
However, a study of a novel PCV2 protein, designated ORF3, found that the 
ORF3 gene product was not essential for virus replication in cell culture, but was 
capable of inducing apoptosis involving the caspase-8 pathway (Liu et al., 2005).  
While the sequence of ORF3 was highly conserved between PCV2 isolates, the 
potential ORF3 sequence of PCV1 shared only moderate homology with that of 
PCV2, suggesting this novel protein and its apoptotic activity may be related to 
pathogenicity (Liu et al., 2005).  In vivo studies using mice demonstrated that this 
ORF3 protein may be involved in viral pathogenesis by altering immune cell 
numbers (Liu et al., 2006b).  Another study also found that PCV2 caused 
apoptosis in the spleens of infected mice, mediated through the activation of 
caspases 3 and 8 (Kiupel et al., 2005).   
PCV2 is also thought to affect the host immune system by stimulating the 
production of pro-inflammatory cytokines, probably causing the typical PMWS 
granulomatous lesions.  This could attract macrophage cells to the affected areas, 
increasing the chances of the virus infecting new target cells (Darwich et al., 
2003b).   
Further evidence for the ability of PCV2 to directly affect the host immune 
response was the finding that within the genome of PCV2, there are a number of 
CpG dinucleotide motifs (Hasslung et al., 2003).  These motifs are thought to be 
responsible for the ability of plasmid DNA to increase and inhibit 
immunostimulatory activity in vertebrates, and as the PCV2 genome is similar in 
size and structure to a plasmid, it is possible that PCV2 is able to stimulate or 
repress the immune response in a similar fashion (Hasslung et al., 2003).  Sixty 
five CpG sequences were identified in the PCV2 genome, 40% of these were 
stimulatory and 60% inhibitory (Hasslung et al., 2003).  Immune modulation was   35 
achieved by induction or repression of IFN-α production, an interferon molecule 
which contributes to the specific immune response to viral infections.  PCV2 
replication has also been shown to be increased by IFN-α in vitro (Meerts et al., 
2005c).  The ability of PCV2 to control IFN-α via CpG motifs may help PCV2 to 
avoid the host immune system (Hasslung et al., 2003).   
Animals infected with circoviruses are commonly infected with other secondary 
pathogens, supporting the theory of immunosuppression.  Birds suffering from BFD 
are commonly infected with secondary bacterial, chlamydial and fungal pathogens: 
cryptosporidiosis, a bacterial infection commonly associated with 
immunosuppression, has been identified in cockatoos with BFDV (Latimer et al., 
1992); septicaemia, peritonitis, chlamydiosis and mycotic ventriculitis were also 
identified by Latimer et al. (1992) and Schoemaker et al. (2000) identified secondary 
bacterial or fungal infections in 9 of 14 African grey parrots infected with BFDV.  A 
high prevalence of secondary infections in pigeons (Escherichia coli,  Salmonella, 
Pasteurella, Aspergillus,  Mycoplasma, candidiasis, nematodiasis, or capillariasis 
infections) and ostriches (E. coli, Klebsiella pneumoniae, Streptococcus and Bacillus 
infections) was detected in association with CoCV and OCV, respectively (Terzich 
and Vanhooser, 1993; Pare et al., 1999; Eisenberg et al., 2003; Roy et al., 2003).  
GCV is also considered to predispose infected birds to secondary infections by 
inducing immunosuppression, and a commercial goose farm affected by GCV 
suffered problems with runting, adverse production and increased mortality, partly 
due to infections with Riemerella anatipestifer and Aspergillus fumigatus (Todd, 
2004).  The only report thus far of circovirus infection in a gull concerned a young 
bird with an overwhelming Aspergillus infection, thought to be an opportunistic 
pathogen secondary to circovirus infection (Twentyman et al., 1999).   
PCV2-infected pigs have been found to be co-infected with a number of different 
pathogens, including Pasteurella multicoda,  Mycoplasma hyopneumoniae, 
Streptococcus sp., swine influenza virus, porcine reproductive and respiratory 
syndrome virus (PRRSV), porcine epidemic diarrhoea virus and porcine parvovirus 
(PPV) (Sato et al., 2000; Allan et al., 1999; Hirai et al., 2001; Pallares et al., 2002).  
The presence of the rare pathogen Cryptosporidium parvum in a pig co-infected with 
PCV2 was suggested to be an indication of immunosuppression (Nunez et al., 2003).  
Sato et al. (2000) found various mixed infections in tissue samples from diseased 
pigs suspected of having PMWS.  Of those animals infected with PCV2, over 90% 
were also infected with another pathogen, including bacteria such as P. multocida, 
but the most common co-infection was with PRRSV, which was present in over 50%   36 
of pigs with PCV2.  A requirement of co-infections in the pathogenesis of PMWS is 
not essential; however, as Cook et al. (2001) could not establish any significant 
association between the presence of PMWS and any other infectious conditions in 
the United Kingdom.  Interestingly, it has been reported consistently that despite the 
presence of secondary bacterial and fungal infections in cases of PMWS, 
antimicrobial treatments are ineffective in controlling the disease (Segales et al., 
2004b).   
Since no co-infecting pathogen seems to be present consistently in PMWS, PDNS 
and CT cases where PCV2 infection might be involved, it has been suggested that 
mixed infections with bacteria and other viruses are opportunistic, and that co-
infection does not precipitate PCV2-associated disease but is the result of 
immunosuppression as a consequence of PCV2 infection (Sato et al., 2000).  This is 
supported by the finding that PCV2 infection may decrease the ability of alveolar 
macrophages to phagocytose bacterial and fungal pathogens (Chang et al., 2006).  
However, it is difficult to tell whether these co-pathogens are necessary for the 
induction of PMWS or if they are simply opportunistic infections as a result of immune 
suppression.  Bacterial lipopolysaccharides are capable of increasing PCV2 
replication in vitro (Chang et al., 2006b) and the co-infection of pigs with PCV2 and 
porcine parvovirus (PPV) or PRRSV does result in more severe disease than 
infection with PCV2 alone (Allan et al., 2000; Ellis et al., 2000c).  In the case of PPV, 
this is possibly because PPV infection stimulates the immune system, providing more 
target cells for PCV2 replication (Krakowka et al., 2000).  In CAV infections, it has 
been suggested that the destruction of B lymphocytes by other agents, for example a 
reovirus, may cause disease because the bird cannot mount an effective antibody 
response to CAV, therefore CAV becomes more pathogenic (Todd 2004).   
Synergistic effects of dual infection with CAV and Cryptosporidium baileyi have been 
reported (Hornok et al., 1998).   
While most circoviruses cause severe disease in young animals, infection of older 
animals can still cause immunosuppression.  As with CAV (see above) subclinical 
PCV2 infection in pigs has been shown to affect performance and immune system 
function (Markowski-Grimsrud et al., 2003).   
Subclinical circovirus infections 
PCV2 has been widely detected in healthy pigs (Done et al., 2001) and antibodies 
have been detected on farms with no history of PMWS (Rodriguez-Arrioja et al., 
2000; Larochelle et al., 1999) which indicates that PCV infections are commonly 
subclinical.  Similarly, CoCV has been detected in clinically normal pigeons (Pare et   37 
al., 1999) and BFDV DNA has also been detected in clinically normal birds (Rahaus 
and Wolff, 2003).  Subclinical CAV infection is very common (Sommer and Cardona, 
2003) and infection with TTV and TLMV in the absence of any specific identified 
disease syndrome suggests these viruses are also principally subclinical infections.   
Subclinical circovirus infection may, however, still cause immunosuppression in 
animals in which there is no specific circovirus-associated disease syndrome.  This is 
thought to occur in CAV and PCV2 infections.  CAV infection in young chicks, after 
the loss of maternally-acquired antibody, may result in a subclinical disease that can 
result in decreased growth and productivity and affect T cell function in adult 
chickens, although anaemia is not observed (McNulty et al., 1991; Scott et al., 1999; 
Markowski-Grimsrud and Schat, 2003; Todd, 2004).  PCV2 infection is common in 
the absence of specific PCV2-associated disease such as PMWS but this might 
result in mild lymphoid depletion (Allan et al., 1999; Ellis et al., 1999).   
Circoviruses infection may be persistent, despite the production of antibody.  CAV 
may persist in chickens long after seroconversion, possibly in reproductive tissues 
(Cardona et al., 2000).  PCV2 infection, thought to occur mainly after the pig nursery 
stage of production, reaches a peak prevalence in 3 to 4-month-old pigs, suggesting 
it persists for a long period after the initial infection (Shibata et al., 2003).  This 
persistence may be due to an inefficient immune response, as is thought to occur 
with TTV where infection is usually persistent, possibly lifelong in some cases 
(Bendinelli et al., 2001).  As circoviruses seem capable of compromising the host 
immune system, it is possible that the weakened immune response would be unable 
to clear the virus.  
It is assumed that the level of circovirus in subclinical infections is low, and that 
factors which lead to increased levels of virus replication may be critical for disease 
development.  Any condition, such as co-infection with another pathogen or 
environmental factors, which promote PCV2 replication might therefore result in virus 
dissemination and disease (Krakowka et al., 2002).  There has been little further 
development of this theory for other circoviruses, although it is thought that high 
levels of TTV replication may cause lymphocyte subpopulation imbalances (Maggie 
et al., 2003).  It is possible that high levels of circovirus replication and the 
subsequent overpowering of the immune system may be a critical factor in 
determining whether an infected animal will develop disease or subclinical infection.   
Severe circovirus-associated diseases commonly affect young animals.  This is the 
case for PMWS, where affected pigs usually develop clinical signs at 6-8 weeks of 
age (Harding et al., 1998), in CAV-associated disease that usually affects young   38 
chicks (Noteborn et al., 1994; McNulty et al., 1991) and BFD, largely identified in 
birds under 3 years of age, although older psittacines may develop a chronic form 
(Pass and Perry, 1984; Schoemaker et al., 2000).  From the information currently 
available, the recently described avian circoviruses also cause disease in young 
birds: CoCV commonly affects pigeons 1-12 months of age (Woods and 
Shivraprasad, 1997); GCV possibly causes ill-thrift in young geese (Soike et al., 
1999); ostrich FCS was associated with death in birds less than 2 weeks of age, 
although in rare cases birds up to 4 years of age can be affected (Terzich and 
Vanhooser, 1993), and CaCV has been detected in diseased neonatal canaries 
(Goldsmith, 1995).  It is possible that the reason for the susceptibility of younger 
animals to circovirus-associated disease is that their immune systems are not as 
developed as older animals.  Todd (2004) suggested that the age resistance of older 
chickens to CAV-induced anaemia and severe immunosuppression was possibly due 
to greater immune competence and therefore a  more rapid immune response of 
older birds.     
Circovirus-associated diseases and their treatment 
Beak and feather disease (BFD) 
Psittacine birds affected by BFD suffer feather dystrophy, plumage loss and 
diarrhoea, with beak deformities a less frequent occurrence.  The feather and beak 
abnormailities are caused by epidermal cell necrosis, epidermal hyperplasia and 
hyperkeratosis in the epidermis of the feathers and beak (Pass and Perry, 1984; 
Latimer et al., 1992).  Liver necrosis, lymphoid necrosis and atrophy in the thymus 
and bursa of affected birds have also been observed (Pass and Perry, 1984; 
Schoemaker et al., 2000).  The condition is progressive and death often occurs from 
secondary infections, so the treatment of affected birds is usually palliative.  Such 
treatment involves antibiotics, a controlled environment and balanced nutrition 
(Jergens et al., 1988), although the use of antibiotics, antifungal agents and nutrient 
supplements may be unhelpful during acute disease (Jacobson et al., 1986).   
CAV-associated disease 
The acute clinical form of CAV-associated disease occurs when vertical transmission 
results in the virus infecting the egg, with subsequent infection of newborn chicks 
(McNulty, 1991).  The disease becomes apparent at 7-14 days of age, when affected 
chicks are depressed and anaemic, with pale bone marrow, thymic, splenic and 
bursal atrophy, and haemorrhagic skin lesions (which are prone to secondary 
bacterial infections) (McNulty, 1991; Crowther et al., 2003).  Histopathological 
changes include atrophy of the haematopoietic elements of the bone marrow and   39 
severe depletion of lymphocytes in the thymus, followed by hyperplasia of reticular 
cells (Adair et al., 1993; Bounous et  al., 1995).  The mortality rate may be as high as 
60% but unlike BFD and PMWS, surviving chicks usually make a full recovery, 
presumably because the CAV-associated disease differs histopathologically from 
BFD, PMWS and CoCV and GCV-associated disease.  The observed lymphocyte 
depletion in CAV-infected chicks only affects T cells, whereas the other animal 
circoviruses affect both T and B cells (Todd, 2004).  This destruction of B cells further 
impairs the host antibody response resulting in a longer term disease condition 
(Todd, 2004).   
As CAV is very stable in the environment (Todd et al., 2001), virus eradication as a 
form of disease control is impractical, and disease control usually involves increased 
hygiene and the prevention of co-infection (Rosenberger and Cloud, 1998).  Ensuring 
that flocks develop antibodies to CAV, usually by vaccination, before laying is thought 
to prevent vertical transmission of the virus (Todd et al., 2001).  CAV vaccination is 
widespread and the severe clinical form of the disease is therefore rare (Sommer and 
Cardona, 2003). 
Circovirus disease of non-psittacine birds 
Circoviral infection of non-psittacine birds is usually accompanied by histological 
changes in the primary and secondary lymphoid tissues, commonly in the bursa 
(Woods and Latimer, 2000; Todd, 2004).   
The macroscopic lesions of CoCV-infected birds include swelling and oedema in the 
bursa and spleen (Mankertz et al., 2000), pneumonia, liver necrosis and lymphoid 
necrosis (Pare et al., 1999).   
FCS, which is associated with OCV, is characterised by depression, weight loss, 
anorexia, occasionally diarrhoea and death after a few days of illness.  Gastric stasis, 
yolk sac infection and enteritis have also been observed (Eisenberg et al., 2003; 
Terzich and Vanhooser, 1993).  Histopathological changes in FCS chicks include 
lymphocyte depletion in the bursa and lymphocytic infiltration of the lamina propria of 
the intestine (Terzich and Vanhooser, 1993).   
CaCV has been identified in neonatal canaries with ‘black
 spot’, characterised by 
abdominal
 enlargement, gall bladder congestion and failure to thrive, and another 
illness in adult canaries which had died following a short illness characterised
 by 
dullness, anorexia, lethargy and feather disorders (Goldsmith, 1995; Todd et
  al., 
2001).   
It should be noted that although GCV, DuCV, CoCV, CaCV and OCV have been 
identified in the tissues of diseased psittacine birds with lesions characteristic of   40 
circoviral infection, such as feathering disorders, poor body condition and secondary 
bacterial or fungal infections, a causal relationship is yet to be established.  Some 
control measures used for BFD may be applicable for these diseases, but quarantine 
is impractical for a disease of free-ranging birds such as pigeons, and thus far there 
has been little investigation into vaccination (Todd, 2004).  Management conditions 
may also play a role in disease control, for example a study of 82 ostriches dead 
from FCS found that the co-infecting E. coli and K. pneumoniae bacteria present 
were antibiotic-resistant, possibly caused by the widespread use of antibiotics on the 
affected farms without veterinary supervision (Terzich and Vanhooser, 1993). 
TTV and TLMV 
No clinical condition has been definitely linked with TTV or TLMV, although TTV may 
be more common in patients with liver disease or those that have been exposed to 
blood products (Miyata et al., 1999; Bendinelli et al., 2001).  It has been suggested 
that certain TTV genotypes may be capable of causing disease (Takahashi et al., 
2000) but no such genotype has ever been identified.  Treatment with interferon has 
been found to decrease TTV and TLMV titres, but only temporarily (Moen et al., 
2003).  Heavy TTV infection was reported to affect human lymphocyte 
subpopulations (Maggi et al., 2003).   
PDNS 
Porcine dermatitis and nephropathy syndrome (PDNS) was first recognised in the 
UK (Smith et al., 1993) and has subsequently been identified in several countries 
including Korea (Choi et al., 2002b), Northern Ireland (Allan et al., 2000), Hungary 
(Dan et al., 2003), Scotland (Thomson et al., 2000); England (Gresham et al., 
2000) and Spain (Segales et al., 1998).  PDNS-affected pigs, which are usually 12 
to 14 weeks of age, develop dark skin lesions, especially on the hindquarters, and 
are pale, dull, depressed and reluctant to move (Done et al., 2001).   
Lymphadenopathy and kidney dysfunction are common, and pneumonia has been 
observed in affected pigs (Done et al., 2001; Thibault et al., 1998).  In acutely 
affected pigs, mortality may approach 80% (Done et al., 2001) and animals that 
do recover may suffer chronic kidney lesions (Segales et al., 1998).  The severe 
glomerulonephritis lesions are consistent with an immune complex disorder 
(Thomson et al., 1998).   
PCV2 nucleic acid has been identified in the tissues of pigs suffering from PDNS 
in Peyer's patches, tonsil, lung, spleen, kidney, liver, and skin.  Viral nucleic acid 
was located mainly within the cytoplasm of monocyte/macrophage lineage cells, 
including follicular dendritic cells, macrophages, histiocytes and Kupffer cells   41 
(Rosell et al., 2000; Gresham et al., 2000; Saoulidis et al., 2002; Choi et al., 
2002b).  PCV2 antigen was found primarily in the lymphoid organs, especially the 
lymph nodes (Saoulidis et al., 2002).   
No causative relationship between PCV2 and PDNS has yet been proven as the 
disease has not been reproduced experimentally, but PDNS development has 
been associated with very high levels of PCV2 antibody (Wellenberg et al., 
2004b).  The condition has also been associated with other pathogens such as 
PRRSV (Thibault et al., 1998; Segales et al., 1998; Choi and Chae, 2001) and P. 
multocida (Thomson et al., 1998).  However, PRRSV is unlikely to be essential for 
PDNS to occur, as the disease was present in Ireland as early as 1990, before 
PRRSV was introduced in 1996 (Allan et al., 2000).  As the pathological changes 
associated with PDNS are consistent with an immune-complex disorder, it is 
possible that viral infection may alter the immune response, allowing the clinical 
expression of the disease (Thomson et al., 2002).  Since both PMWS and PDNS 
appear to be immune-mediated, and affected pigs display similar lesions such as 
lymphadenitis, it has been suggested that the 2 diseases are different 
manifestations of the same pathogenic process (Done et al., 2000).  PMWS and 
PDNS may occur separately, together or following each other, and a recent study 
using a multivariate model suggested that the 2 diseases were strongly 
associated (Cook et al., 2001).   
Sipos et al. (2005) suggested that PCV2 infection may be more recent in PDNS 
animals, as compared to PMWS animals, where the disease may be the end 
result of a longer period of infection.  Also, the pro-inflammatory cytokines IL-1α 
and IL-6 were found to be much increased in PDNS pigs, with the chronic 
inflammation present in the disease possibly suggesting some kind of 
autoimmune condition.   
Congenital tremor (CT) 
Pigs affected by CT suffer from clonic contractions of their skeletal muscles, 
sometimes resulting in a fatal inability to suckle (Stevenson et al., 2001) and while 
most piglets recover by the age of 3 weeks, some continue to shake throughout 
the growing and fattening periods (Lukert and Allan, 1999).  The condition is 
associated with deficient and abnormal myelination of newborn pigs, and one form 
of the disease is possibly due to PCV2 infection of spinal cord motor neurons 
(Stevenson et al., 2001). 
Seemingly healthy neonatal pigs infected with PCV2 are commonly found in the 
same herd as those suffering from CT (Stevenson et al., 2001).  PCV1 has also   42 
been associated with a CT outbreak in the 1960s (Choi et al., 2002).  Despite the 
association between PCV and CT, a definitive link between PCV1 or PCV2 and 
CT has never been established, and one study of 40 CT-affected pigs from 
several different countries found no evidence of PCV infection (Kennedy et al., 
2003).   
Affected litters are usually from young breeding stock recently introduced to the 
affected farm, suggesting that exposure of seronegative stock to a virus at a 
critical time during gestation may precipitate disease (Lukert and Allan, 1999). 
Reproductive failure 
When PCV antibodies were first identified in pigs (at the time using serological 
tests that were not capable of distinguishing between PCV1 and PCV2), no 
correlation between PCV antibody and reproductive disorders was found (Tischer 
et al., 1995).  However, PCV antibody was subsequently found associated with a 
few cases of abortion and stillbirth (Allan et al., 1995) and more definitive evidence 
was discovered with the association of PCV2 with a case of reproductive failure 
involving mummification and stillbirth in an SPF herd that became infected with the 
virus (Ladekjaer-Mikkelsen et al., 1999).  
Reproductive problems associated with PCV2 infection, as with PMWS (see 
below) appears to be a fairly recent phenomenon (Meehan et al., 2001).  Bogdan 
et al. (2001) failed to identify PCV2 in cases of reproductive failure between 1995 
and 1998, suggesting that PCV2-associated reproductive failure was a relatively 
new clinical manifestation.  Although PCV2 sequences isolated from cases of 
reproductive failure possess some amino acid differences to previously described 
strains, there is no evidence to suggest that PCV2-associated reproductive failure 
is caused by a particularly pathogenic isolate of PCV2 (Farnham et al., 2003; 
Meehan et al., 2001).  Whether there is an association between PCV2 infection 
and co-infection with other agents has not been defined, but PCV2 was identified 
in stillborn piglets on a farm experiencing widespread reproductive problems where 
PPV and PRRSV were also present (O’Connor et al., 2001).   
Sanchez et al. (2001) and Pensaert et al. (2004) suggested on the basis of field 
evidence that it was likely that PCV2 could cross the placenta and replicate in the 
foetus, although Mateusen et al. (2004) thought the chances of this event 
occurring in the field were low.  However Park et al. (2005) demonstrated that 
sows infected with PCV2 3 weeks before farrowing experienced abortion and 
premature births, suggesting PCV2 crossed the placenta and replicated in the 
foetal piglets.  PCV2 infection in utero, however, does not automatically mean   43 
disease or death, as PCV2 virus and antibody have been detected in clinically 
normal newborn piglets (Sanchez et al., 2001).  It has been proposed that the 
potential pathogenicity of PCV2 could depend on the age of the foetus at the time 
of infection (Farnham et al., 2003), with infection prior to foetal 
immunocompetence possibly causing foetal death and mummification (Pensaert et 
al., 2004).  The results of experimental inoculation of foetuses 57, 72 and 95 days 
of age with PCV2 (Sanchez et al., 2001) supported this theory: foetuses inoculated 
at 57 days of age had high titres of virus in association with oedema, 
haemorrhages and congestion, and they did not develop antibody to PCV2, but 
foetuses inoculated at 72 and 95 days of age had low virus titres, no lesions, and 
developed antibodies to PCV2.  Johnson et al. (2002) experimentally infected 
foetuses 86, 92 and 93 days of age with PCV2, and found that approximately 35% 
were mummified, stillborn or weak-born.  Although the details are somewhat 
discrepant, both reports indicate that PCV2 can infect and cause reproductive 
abnormalities in late-term foetuses. Intra-uterine spread of PCV2 between foetuses 
is known to occur but progresses slowly (Pensaert et al., 2004), and the extent of 
in utero PCV2 spread may be affected by whether the sows are infected mid-
gestation or late-gestation (Yoon et al., 2004).   
PCV2 has been identified in heart, kidney, liver and lung tissue of aborted, 
mummified and stillborn foetuses (West et al., 1999; Lyoo et al., 2001; Sanchez et 
al., 2001; Park et al., 2005).  Infection of the heart with associated myocarditis is a 
common finding in such cases, suggesting that the main target tissue for PCV2 
replication in foetuses is the heart (West et al., 1999; O’Connor et al., 2001; 
Sanchez  et al., 2001) although PCV2-associated myocarditis has also been 
identified in a weak-born 8-day old piglet (Mikami et al., 2005).  Cardiovascular 
lesions such as granulomatous and necrotizing lymphadenitis have also been 
identified in the hearts of PCV2-infected animals aged 4-7 weeks (Oppreissnig et 
al., 2006).   
While there is field evidence that infection of naïve gilts with PCV2 can cause 
foetal infections leading to mummification, it is unclear if this could occur in sows 
already exposed to PCV2 and with circulating antibody to the virus (Pensaert et al., 
2004).  Reports suggest that reproductive problems are most common in first-
parity gilts: West et al. (1999) found field evidence of vertical transmission and 
associated reproductive failure in first-parity gilts.  The introduction of naïve PCV2 
seronegative gilts into a herd may be necessary for transplacental infection and 
resulting foetal pathogenesis (O’Connor et al., 2001; Mateusen et al., 2004).     44 
Porcine respiratory disease complex (PRDC) 
PRDC is a disease of growing and finishing pigs approximately 16-22 weeks of age.  
It is characterised by slow growth, lethargy, anorexia, fever, coughing and dyspnoea 
(Thacker, 2001).  PRDC is considered to be the clinical manifestation of multiple 
disease agents working in concert with each other and with environmental and 
management factors (Halbur, 2001).  Specifically, M. hyopneumoniae, combined with 
several opportunistic bacterial pathogens such as P. multocida, Actinobacillus 
pleuropneumoniae and Streptococcus suis, cause enzootic pneumonia which in turn 
seems to result in PRDC when combined with respiratory viruses such as various 
types of swine influenza virus and PRRSV (Halbur, 2001; Thacker, 2001; Holko et 
al., 2004).  Although M. hyopneumoniae and PRRSV are considered to be the main 
pathogens responsible for PRDC, in recent years the prevalence of PCV2 in cases of 
PRDC has increased markedly.  A study of pneumonia cases at the Iowa State 
University Veterinary Diagnostic Laboratory from 1993-2000 revealed that the 
incidence of PRRSV in such cases had increased 13-fold, while the incidence of 
PCV2 had increased 456-fold (Halbur, 2001).  In another study of 105 PRDC cases, 
infections with PCV2 (81%), PRRSV (63%), PPV (57%) and swine influenza virus 
(13%) were identified, with PCV2-PRRSV co-infection identified in 55% of cases (Kim 
et al., 2003e).  Interestingly, PCV2 antigen was mainly identified in the nucleus of 
macrophage-like cells in lung tissue (Kim et al., 2003e), whereas in previous studies 
of PCV2 distribution, the virus was found predominantly in the cytoplasm of lymphoid 
cells (Rosell et al., 2000).   
Although it is unclear whether PCV2 is a primary, synergistic, secondary or 
opportunistic pathogen in cases of PRDC, the demonstration of lung lesions such as 
broncho-interstitial pneumonia in association with PCV2 DNA would suggest that 
PCV2 has an important role in PRDC (Kim et al., 2004) and that this and the sharp 
increase of PCV2 identified in cases of swine pneumonia would suggest that the 
clinical scope of PCV2 may be expanding, as suggested by Ellis et al. (2000).   
Proliferative and necrotising pneumonia (PNP) 
PNP was first described in Quebec in 1990 (Morin et al., 1990).  First observed in the 
late 1980s, the condition was found to affect pigs between 15 days and 4 months of 
age, with a peak between the ages of 4 and 10 weeks (Morin et al., 1990).  Adult pigs 
appeared clinically unaffected.  The main clinical signs observed were fever, dyspnea 
and abdominal respiration, and surviving pigs displayed growth retardation and 
wasting (Morin et al., 1990).   
Pneumonic lesions associated with PNP were found to have 3 distinctive features:   45 
extensive lesions often involving the entire lung, fibrin deposits and necrotic cells in 
alveolar spaces, and severe and diffuse proliferation of bronchioalveolar epithelium 
(Morin et al., 1990).  Lesions present in the lungs appeared to vary according to the 
stage of the disease: confluent consolidation of some or all lobes of one or both lungs 
was a common finding (Morin et al., 1990).  Mediastinal and bronchial lymph nodes 
were enlarged and haemorrhagic, and in some cases evidence of heart failure was 
observed (Morin et al., 1990).   
Histological lesions were characterised by alveoli filled with protein-rich oedema and 
large macrophages, with giant cells sometimes present.  A proliferation of type II 
pneumocytes was also characteristic, particularly in the later stages of the disease 
(Morin et al., 1990).   
Several bacterial infections were identified in PNP-affected pigs: P. multocida, 
Haemophilus parasuis, Pneumocystis carinii and S. suis type 2.  Pathogens such as 
PPV and M. hyponeumoniae were also occasionally identified (Morin et al., 1990).  
The presence of these apparently secondary infections in affected animals was 
suggestive of immunosuppression.  There were also reports of stillbirths, 
mummifications and abortions either before or during the respiratory problems in 
some affected herds (Morin et al., 1990).   
The most common pathogen, and postulated cause of PNP, identified from 5 
separate outbreaks, was influenza A virus (Morin et al., 1990).  However, a few years 
after this initial study a virus designated Lelystad virus was identified in the 
Netherlands, associated with a ‘mystery swine disease’ characterised by outbreaks 
of reproductive failure and respiratory disturbances (Wensvoort et al., 1991).   
‘Mystery swine disease’ was subsequently named porcine reproductive and 
respiratory syndrome (PRRS) and Lelystad virus was redesignated PRRSV.   
PRRSV is an enveloped, single-stranded RNA virus, classified in the in the genus 
Arterivirus of the Arteriviridae family (Rossow, 1998).  The presence of PRRSV in 
association with PNP in the absence of influenza virus led to speculation that PRRSV 
was the causative agent of PNP, not influenza.  A study of 38 PNP field cases in 
Quebec between 1988 and 1993 found PRRSV in 28 samples and influenza in only 
one (Larochelle et al., 1994), and a more recent retrospective study of 60 PNP cases 
demonstrated PRRSV in 92% of cases, influenza in 2% and PCV2 in 42% of cases 
(Drolet et al., 2003).  A study of swine pneumonia cases for the year 1999 found 
PRRSV in 35% of cases, swine influenza virus in 21%, M. hyopneumoniae in 23% 
and PCV in 9% of cases (Harms and Sorden, 2000).  This data would appear to 
confirm PRRSV as the causative agent of PNP, however the role, if any, of PCV2 in   46 
this disease remains to be fully investigated.  The fairly high prevalence of PCV2 in 
PNP cases may simply reflect the high infection rate of PCV2 in healthy pigs (Drolet 
et al., 2003).  It was noted that in some cases the amount of PCV2 nucleic acid 
detected was so high that damage to the lungs would be likely (Drolet et al., 2003), 
but this abundance of PCV2 antigen may be a result of increased replication in 
diseased and possibly immunosuppressed pigs.   
Exudative epidermitis (EE) 
EE is a generalised skin infection characterised by a greasy cutaneous exudation, 
exfoliation, vesicle formation and death in suckling or newly weaned piglets (Sato et 
al., 2000; Wegener and Skov-Jensen, 1999).  Mortality may be as high as 70%, and 
during an outbreak all litters on a farm may be affected (Wegener and Skov-Jensen, 
1999).   
Exfoliative toxin-producing strains of Staphylococcus hyicus are thought to be the 
cause of the disease, but predisposing factors seem necessary for it to develop 
(Andresen  et al., 1993; Wegener and Skov-Jensen, 1999).  Both virulent and 
avirulent strains of the bacterium have been reported, and both types may be present 
on the skin of diseased and healthy pigs (Andresen et al., 1993).  While virulent 
strains of S. hyicus may be recovered from the skin of adult pigs, EE has not been 
reproduced experimentally in adult pigs (Wegener and Skov-Jensen, 1999).  The 
disease has been reproduced experimentally in SPF piglets, and conventional pigs 
may be resistant to experimental infection, suggesting that immunological factors in 
the affected herd may be important for disease development (Wegener and Skov-
Jensen, 1999).  The disease may occur sporadically with low morbidity or it may 
affect all litters in an epidemic form, which commonly occurs following the 
introduction of new animals into a closed herd (Wegener and Skov-Jensen, 1999).   
In 1993 a Swedish SPF pig herd suffered an outbreak of EE (Wattrang et al., 2002).  
This herd had been established by caesarean section and was closed to all outside 
material except semen used for AI.  A retrospective serological survey determined 
that the herd was seronegative to PCV2 until approximately 2 months before the EE 
outbreak, all animals had seroconverted by 4 months after the outbreak and all 
animals remained positive for PCV2 antibody for the next 7 years (Wattrang et al., 
2002).  S. hyicus was isolated from all piglets tested, irrespective of clinical signs, 
and PCV2 antigen was isolated from the lymph node of one affected piglet.  An 
increase in the number of stillbirths and small litters was also observed at time of 
PCV2 seroconversion (Wattrang et al., 2002).   
Exudative epidermitis has also been induced experimentally by the infection with   47 
PCV2 of 3-week-old caesarean-derived colostrum-deprived (CD/CD) pigs, but the 
condition was noted in both PCV2-inoculated and sham-inoculated (PCV2-negative) 
piglets (Harms et al., 2001).  Interestingly, the disease was more severe in the PCV2-
inoculated group, and while the PCV2-negative piglets responded to antibiotic 
therapy, the PCV2-inoculated pigs did not (Harms et al., 2001).  This suggests that 
PCV2 could play a role in the development of the disease, possibly as a predisposing 
factor rather than the main cause of the condition (Wattrang et al., 2002).   
A retrospective study conducted on 142 cases of EE between 1997 and 2002 found 
that PCV2 and porcine parvovirus (PPV) were highly prevalent in these cases, 
however both viruses were absent in noninflammed skin from pigs with S. hyicus 
infection and from normal healthy pigs (Kim and Chae, 2004).  This suggests that 
PCV2 and PPV may be involved in lesion development and/or progression during EE 
(Kim and Chae, 2004).   
Various combinations of antibiotics, plus skin disinfectants, vaccination and improved 
herd management and hygiene are recommended for the treatment of EE (Wegener 
and Skov-Jensen, 1999). 
Enteritis 
Enteritis may occur in pigs for a number of reasons including bacterial infections with 
agents such as Yersinia  pseudotuberculosis (Slee and Button, 1990), Salmonella 
enterica and Lawsonia intracellularis (Moxley and Duhamel, 1999).  While pigs 
affected by PMWS may suffer from diarrhoea (Harding et al., 1998), a recent study 
found 6 cases of PCV2-associated enteritis in the absence of any signs of PMWS 
(Kim et al., 2004).  The most unique lesions in these cases were granulomatous 
inflammation affecting Peyer’s patches, characterised by infiltration of epitheliod 
macrophages and multinucleated giant cells.  No microscopic lesions were observed 
in the lymphoid tissues as is found in cases of PMWS, and PCV2 was detected in 
abundance by in situ hybridisation in association with the lesions observed in Peyer’s 
patches (Kim et al., 2004).  Furthermore, no pathogenic bacteria or other viruses 
were detected in the intestines of the affected pigs, suggesting that the enteritis was 
associated with and possibly caused by PCV2.  Other cases of PCV2-associated 
enteritis have not been reported, but as the clinical scope of PCV2 appears to be 
expanding, it would appear likely that more cases will be identified.   
Post-weaning multisystemic wasting syndrome (PMWS) 
Diagnosis 
The major disease syndrome that has been associated with PCV2 is PMWS.  The 
link was first established in 1997 (Clark, 1997), and 3 criteria must be met for a   48 
diagnosis of PMWS to be made: the presence of clinical signs (usually wasting), 
the presence of characteristic histopathological lesions in lymphoid tissue, and the 
presence of PCV2 within those lesions (Sorden, 2000; Quintana et al., 2001).  A 
diagnosis of PMWS is usually confirmed by the presence of microscopic lesions 
such as lymphocyte depletion, multinucleate giant cell infiltration and cytoplasmic 
inclusions (Segales et al., 2004).  However these criteria are not absolute or 
infallible, and it appears that the best samples to use for PMWS diagnosis are 
lymphoid tissues from pigs in the first week of clinical disease (Segales et al., 
2004).  In addition, most of the clinical signs of PMWS, such as wasting and 
respiratory distress, are non-specific and may be present in pigs affected by a 
variety of other swine diseases (Segales et al., 2004).   
Clinical signs and lesions of PMWS 
Pigs suffering from PMWS usually develop clinical signs between 6 and 8 weeks 
of age (Harding et al., 1998).  Major clinical signs are weight loss, tachypnea, 
dyspnea, enlarged lymph nodes and jaundice.  Less common signs are diarrhoea, 
productive coughing and central nervous system disturbances (Harding et al., 
1998).  Anaemia is a common finding in PMWS-affected pigs, and is probably 
caused by gastric ulceration (Segales et al., 2000).  Morbidity is usually low, but 
case fatality may be high.  Death is usually due to respiratory, gastrointestinal 
and/or urinary system failure in the field, although deaths from liver failure have 
been observed in gnotobiotic pigs experimentally infected with PCV2 (Krakowka 
et al., 2002).   
Organ failure is caused by the virus disseminating out of lymph tissues into other 
target organs, accompanied by granulomatous inflammatory cell infiltrates 
(Krakowka et al., 2002).  It is thought that PCV2 may induce monocyte chemo-
attractant protein-1 (MCP-1) expression by macrophages and other inflammatory 
cells in infected lymph nodes, suggesting that MCP-1 could be involved in lesion 
development or progression during PCV2 infection and associated disease (Kim 
and Chae, 2003b).  MCP-1 is known to be produced during granulomatous 
inflammation and to participate in it, and in the case of PMWS, macrophages, 
epithelioid cells and multinucleated giant cells may ‘recruit’ mononuclear cells to a 
site of granulomatous inflammation by producing MCP-1 (Kim and Chae, 2003b).  
This progressive angiocentric granulomatous inflammation compromises organ 
function, leading to death (Krakowka et al., 2002).   
Post-mortem examination of PMWS-affected pigs usually reveals skin pallor and 
muscle wasting, with lymph nodes 3-4 times normal size (Clark, 1997).  The lungs   49 
are rubbery and non-collapsed, the spleen is moderately enlarged, and the liver 
may be mottled or atrophic (Clark, 1997).  Generally, the most consistent 
abnormalities occur in the lymph nodes and lungs (Clark, 1997).  Interstitial 
pneumonia is often present, and apoptosis of liver cells may occur (Meehan et al., 
1998; Clark, 1997).  Gross and histopathologic lesions are found in virtually all 
tissues, but are most common in the lungs, liver, kidneys and lymph nodes 
(Harding et al., 1998).   
The main histopathological findings of PMWS are lymphocyte depletion, interstitial 
pneumonia and hepatitis (Allan et al., 1998; Rosell et al., 1999).  Not all 
histological lymphoid lesions are found together in PMWS-affected pigs, 
suggesting that these lesions may change throughout the course of the disease.  
Quintana et al. (2001) found that histiocytic infiltration and lymphocyte depletion 
were much more common and severe in the early stages of PMWS, and were not 
always found in the later stages of the disease.  Atrophy of the thymus, causing 
severe lymphocyte depletion in peripheral blood and tissues in a similar fashion to 
cases of BFD and CAV-associated disease, has also been observed in PMWS 
cases (Darwich et al., 2003; Todd et al., 2000).  The inflammatory lesions seen in 
PMWS are thought to be immune-mediated, probably antiviral humoral and 
cellular responses to viral antigenic epitopes (Krakowka et al., 2002).   
A major retrospective Japanese study of tissues from affected pigs, collected from 
1985 to 1999, found lesions suggestive of PMWS from 1990 onwards (Sato et al., 
2000).  In this study, histopathological lesions were found mainly in the lymphoid 
organs, and included lymphocellular depletion and apoptosis, with replacement by 
multinucleate giant cells.  In lymph nodes, granulomatous inflammation was present 
in some cases, and spherical inclusion bodies were present in macrophages and 
also occasionally in giant cells (Sato et al., 2000).  Similar changes were noted in the 
spleen, tonsils and Peyer’s patches, but the changes in these organs were less 
severe (Sato et al., 2000).  Cytoplasmic inclusions were also found in the lungs, liver 
and kidneys.  Macrophages and lymphocytes usually accumulated in the kidneys and 
liver, and hepatocytic necrosis was also present in a large percentage of cases (Sato 
et al., 2000).  Interstitial pneumonia was commonly found in the lungs.  PCV2 antigen 
was found mainly in cytoplasmic inclusions of macrophages, but also in lymphatic 
organs, small intestine, lungs, kidney and liver.  Generally, disease was more severe 
in those animals where various tissues were affected, rather than just the tonsils and 
lymph nodes (Sato et al., 2000).   
PCV2 has been found in pigs with wasting disease worldwide (Hamel et al., 1998;   50 
Allan et al., 1999a; Onuki et al., 1999;  Martelli et al., 2000; Kyriakis et al., 2000; 
Wellenberg et al., 2000; Done et al., 2001; Trujano et al., 2001; Saradell et al., 
2004; Castro et al., 2004; Jemersic et al., 2004; Maldonado et al., 2004; Wang et 
al., 2004; Motovski and Segales, 2004; Garkavenko et al., 2005; Vigre et al., 
2005).  Several techniques have been used to demonstrate the presence of 
PCV2.  Ouardani et al.  (1999) used a multiplex PCR to detect PCV2 in 94.2% of 
suspected PMWS-affected pigs tested.  Immunohistochemistry has also been 
used to demonstrate virus antigen in tissues (Sorden et al., 1999).   
PCV1 does not seem to be associated with the condition.  PMWS-affected pigs 
infected with PCV1 are usually co-infected with PCV2 (Ouardani et al., 1999).   
However, LeCann et al.  (1997) detected PCV1 only in piglets in Brittany affected 
by a wasting disease, and the lesions found, such as enlarged lymph nodes and 
respiratory distress, were similar to PMWS.  This is, however, the only report of an 
association between PCV1 and any type of wasting disease.   
Experimental reproduction of PMWS 
Determination of the pathogenesis of PMWS has been frustrated by the 
inconsistency of clinical signs between and within infected herds, and the difficulty 
of inducing PMWS experimentally.  Attempts to reproduce PMWS by experimental 
inoculation of PCV1 or PCV2 into piglets have been largely unsuccessful, with no 
clinical signs of disease recorded in most cases (Tischer et al., 1986; 
Pogranichnyy et al., 2000) although mild to moderate lesions typical of PMWS 
have been induced.  Lesions induced with PCV2 have included lymphoid 
depletion (Allan et al., 1999b), mild pneumonia, lymphoid inflammation (Ellis et al., 
1999; Magar et al., 2000), multinucleated giant cells (Magar et al., 2000) and mild 
nephritis and hepatitis (Ellis et al., 1999).  Pigs inoculated with tissue 
homogenates from PMWS-affected pigs also have not developed major clinical 
signs of the disease, only slight lymphocyte depletion (Balasch et al., 1998), and 
nephritis, hepatitis, pneumonia and myocarditis (Ellis et al., 1999).  Adding to the 
confusion regarding the role of PCV2 in the disease is that PCV2 has also been 
widely detected in clinically normal pigs (Done et al., 2001) and antibodies have 
been detected on farms with no history of PMWS (Rodriguez-Arrioja et al., 2000; 
Larochelle  et al., 1999; Sorden, 2000).  It has been suggested by some that 
another factor must be involved in disease development, such as concurrent 
infections with other organisms and immune activation.   
A frequent suggestion is that other co-pathogens may be required for the 
development of PMWS, accounting for the difficulty of reproducing the disease   51 
using PCV2 alone.  Several studies have provided evidence for this theory, with 
co-infection of pigs with PCV2 and other viral and bacterial pathogens such as 
PPV (Krakowka et al., 2000; Allan et al., 1999b; Ellis et al., 2000; Kim and Chae, 
2004; Cao et al., 2005), PRRSV (Allan et al., 2000c; Krakowka et al., 2000; 
Wellenberg et al., 2004), porcine pseudorabies virus (PRV) (Cao et al., 2005), 
candidiasis (Zlotowski et al., 2006) and M. hyopneumoniae (Opriessnig et al., 
2004) resulting in more severe clinical signs of PMWS than infection with PCV2 
alone. 
Co-infection of pigs with PCV2 and PPV produced more severe clinical signs of 
PMWS, such as depression, anorexia, icterus and liver disease, than infection 
with PCV2 alone (Krakowka et al., 2000).  PPV by itself is not considered a major 
pathogen, so it has been suggested that either temporary PPV infection of 
macrophages could promote higher levels of PCV2 replication, or that PPV is 
immunosuppressive, allowing the spread of PCV2 throughout the body (Krakowka 
et al., 2000).  It is also possible that a similar interaction of PCV2 and PPV could 
occur in cases of EE, with the increased levels of DNA replication and 
macrophage proliferation caused by PPV enhancing the replication of PCV2 (Kim 
and Chae, 2004).  In support of the dual role of PPV and PCV2, experimental 
infection of pigs with PCV2 and PPV produced severe, sometimes fatal disease, 
with lesions in the liver, lymph nodes and kidneys (Allan et al. 1999b).  However, 
only a small percentage of PMWS cases are naturally co-infected with PPV (Ellis 
et al., 2000) and vaccination against PPV does not reduce the incidence of PMWS 
(Opreissnig et al., 2004b), suggesting that the role of PPV is indirect and that the 
effect it induces can be mimicked by other agents or factors. 
Co-infections with PCV2 and PRRSV have also been suggested as a cause of 
PMWS.  PRRS was recognised in the USA in 1987 as causing late-term reproductive 
failure and severe pneumonia in neonatal pigs (Rossow, 1998).  Clinical signs 
include ill-thrift, dyspnea, tachypnea, anorexia, lethargy, pneumonia and rough hair 
coat, and gross lesions such as lung consolidation and enlarged lymph nodes 
(Rossow, 1998).  PRRS can be difficult to differentiate clinically from PMWS and co-
infections with PCV2 and PRRSV have been commonly detected in countries where 
PRRSV is endemic.  Hamel et al.  (2000) found PCV2 in 55% of pigs with respiratory 
signs and lesions similar to PRRS, and respiratory problems have been found to be 
more severe in herds co-infected with PCV2 and PRRSV (LeCann et al., 1997; 
Quintana et al., 2001).  Experimental co-infection of pigs with PCV2 and PRRSV 
resulted in more severe disease than with either agent alone (Krakowka et al., 2000;   52 
Allan et al., 2000c).  PRRSV may enhance PCV2 replication possibly by macrophage 
activation, the enhanced proliferation of PCV2 target cells or a possible release of 
PCV2 from cell-cycle dependence (Krakowka et al., 2000).  Macrophages are the 
only cell type known to support PRRSV replication (Rossow, 1998) and after 
infection, PRRSV replicates in the regional macrophages, followed by a prolonged 
viremia and systemic distribution of virus to other macrophage populations (Rossow, 
1998).  Pigs co-infected with PCV2 and PRRSV frequently suffer from interstitial 
pneumonia, and a recent study has demonstrated that this may be due to high levels 
of interferon alpha (IF-α) and tumor necrosis factor alpha (TNF-α) produced during 
PCV2 and PRRSV co-infection (Chang et al., 2005).   
PCV2 may also facilitate secondary infections by reducing the ability of alveolar 
macrophages to phagocytose other fungal and bacterial pathogens (Chang et al., 
2006).   
The role of immune activation in the pathogenesis of PMWS 
Krakowka et al.  (2001) suggested that activation of the immune system during the 
early phase of PCV2 infection allows the rapid replication and distribution of 
PCV2, producing wasting disease.  These authors injected piglets with keyhole 
limpet haemocyanin (KLH) in Incomplete Freund’s adjuvant (ICFA), which 
stimulated the pigs immune system, inducing mitosis and proliferation of 
histiocytes and macrophages at the injection site, which seemed to provide the 
optimal conditions for PCV2 replication and dissemination in vivo (Krakowka et al., 
2001).  It was theorised that PCV2 could replicate in macrophages, with the 
immunoproliferation induced by the adjuvant and KLH was leading to heightened 
PCV2 replication and therefore greater PCV2 virion production (Krakowka et al., 
2001).  More recent studies have shown that PCV2 will infect macrophages, but 
does not replicate within them.  Instead, it appears likely that macrophages act to 
distribute the virus in vivo to major organs, with the non-productive infection 
helping the virus to escape detection by the host immune system (Shibahara et 
al., 2000; Krakowka et al., 2002; Todd, 2004; Chang et al. 2005).   
The most severe lesion produced in piglets inoculated with the adjuvant and 
PCV2 was liver damage.  All piglets in this group suffered liver cell damage, with 
missing hepatocytes replaced by macrophages, while piglets inoculated with 
PCV2 only did not suffer any liver damage (Krakowka et al., 2001).  The hepatic 
macrophages contained PCV2 inclusion bodies, which were also found in the 
lymph nodes (Krakowka et al., 2001).  This lesion is similar to that detected in a 
more recent study, where there was massive liver damage, liver necrosis and   53 
hepatocellular inclusion bodies in piglets experimentally infected with tissue 
homogenates from PMWS-affected pigs (Hirai et al., 2003).   
It is unclear what secondary agent or factors could activate the immune system 
under field conditions.  PRRSV and PPV have been suggested as possible 
candidates, but PMWS can affect herds free of both these pathogens (Segales et 
al., 2001),  In herds naturally infected with PMWS, the primary organ system 
affected and the mortality rate varies within and between infected herds 
(Krakowka et al., 2001) and it has been suggested that this could be due to the 
effect of  other infectious agents such as PRRSV and PPV, and how they combine 
with PCV2 to influence the major organ system affected (Krakowka et al., 2001).  
For example, pigs co-infected with PCV2 and PRRSV may have more severe lung 
lesions (Krakowka et al., 2001).  
While the results of Krakowka et al. (2001) suggested an important role of 
immunostimulation in the pathogenesis of PMWS, further experiments cast doubt 
on this theory.  Ladekjaer-Mikkelsen et al. (2002) also inoculated young SPF 
piglets with PCV2 and immunostimulated half of them using the same adjuvants 
as Krakowka et al. (2001).  Unexpectedly, 2 of 5 non-stimulated pigs infected with 
PCV2 died and another in the same group had to be euthanased.  These pigs 
developed a persistent fever 12 days after infection, and upon necropsy all had 
gross and histological lesions consistent with PMWS.  In contrast, only one out of 
5 immunostimulated piglets developed wasting disease, the remainder of the 
stimulated and non-stimulated piglets remained clinically normal throughout the 
experiment, although all ten PCV2-infected pigs seroconverted.  Further 
investigation using quantitative PCR revealed that all 4 PMWS-affected piglets 
had high levels of PCV2 in serum, leading to the conclusion that the development 
of PMWS may be correlated with PCV2 titre in serum, rather than 
immunostimulation (Ladekjaer-Mikkelsen et al., 2002).   
A subsequent study by Okuda et al. (2003) involving experimental inoculation of 
CD/CD piglets with a PCV2 isolate originating from a PMWS pig, provided support 
for the theory of Ladekjaer-Mikkelsen et al. (2002) that the development of PMWS 
is associated with PCV2 titre in serum.  In their experiments, 6 of 16 inoculated 
piglets developed PMWS, with PCV2 detected in all tissues tested.  The piglets 
that developed clinical signs of PMWS showed the highest virus titre in all tissues.  
Interestingly, serum antibody to PCV2 was detected in most of the PCV2-infected 
pigs at 14 and 21 days post-infection and antibody was not detected in pigs 
exhibiting clinical signs until 28 days post-infection.  The results suggest the   54 
development of PMWS may depend on quantitative aspects of PCV2 distribution 
in tissues and the antibody response (Okuda et al., 2003).  Two other studies 
involving pigs naturally affected by PMWS also found that healthy pigs had lower 
titres of PCV2 than PMWS-affected pigs (Olvera et al., 2004; Brunborg et al., 
2004) and that PCV2 viral load increased with the severity of microscopic lesions 
(Olvera et al., 2004) and the intensity of immunocytochemical staining (Brunborg 
et al., 2004) in lymphoid tissue.  A more recent study directly correlated the PCV2 
viral load in lymphoid tissues and liver with the severity of PMWS clinical signs 
(Krakowka et al., 2005), and a similar experiment using a PCV2 infectious clone 
as the inoculum also demonstrated that viral load was directly related to the 
severity of PMWS clinical signs.  Interestingly, this study also used 
immunostimulation to enhance disease development.   
Earlier studies on PCV2 infection also suggested that PCV2 viral load may affect 
disease development, although this was not necessarily recognised at the time.  
Experimental inoculation of conventional pigs with PCV2 and PRRSV produced 
increased febrile response in all dual-inoculated pigs and clinical signs of severe 
PMWS in some dual-inoculated pigs and one pig inoculated with PCV2 alone 
(Rovira et al., 2002).  Pigs infected with PCV2 and PRRSV had significantly higher 
PCV2 viral titres than those infected with PCV2 only, and one dual-inoculated pig 
was found to have very high PCV2 viral load at every sampling point and 
subsequently died before the end of the experiment (Rovira et al., 2002).  Another 
study that examined healthy PCV2-positive pigs taken from a farm experiencing 
PMWS (Quintana et al., 2001) found they also had microscopic lymphoid lesions 
typical of the disease, albeit much less severe than affected pigs, and much less 
PCV2 nucleic acid than diseased pigs (Quintana et al., 2001), again suggesting 
that PCV2 viral load may be crucial for disease development.   
Interestingly, it was also found that PDNS-affected pigs had fairly low viral loads 
when compared to PMWS pigs at any stage of the disease, suggesting that PCV2 
viral load probably does not affect PDNS disease development (Olvera et al., 
2004).   
The emergence of PCV2-associated diseases  
Shortly after it was first described, PMWS was detected in several countries, and 
the sudden emergence of the disease has not been explained.  It was not due to 
the emergence of PCV2, as antibodies to this virus were present in sera from 
Japan dating back to 1985 (Sato et al., 2000), in North America from 1987 
(Nawagitgul et al., 2002) and Northern Ireland from 1973 (Walker et al., 2000).     55 
After the reproduction of PMWS by immunostimulation it was proposed that 
pathogenic PCV2 infection and therefore PMWS may have resulted from a 
combination of changed management practises such as early weaning and an 
overwhelming challenge to a pig’s immune system as a result of the growing use 
of a variety of vaccines administered to young pigs (Allan et al., 2001).  To test 
this theory, these authors withdrew a M. hyopneumoniae vaccination program 
from about half the piglets born on a farm over a 4 month period.  In the non-
vaccinated animals, losses due to PMWS were significantly reduced in 4 out of the 
5 groups studied (Allan et al., 2001).  In another study involving vaccination with 
bacterins in PCV2-infected pigs, it was found that vaccination along with PCV2 
infection caused mild transient respiratory disease and diarrhoea (Opriessnig et 
al., 2003).  It was also found that vaccinated pigs were viraemic for longer, had a 
higher copy number of the PCV2 genome in their sera, a wider tissue distribution 
of PCV2 antigen and increased severity of lymphoid depletion compared to 
unvaccinated pigs (Opriessnig et al., 2003).  The age of vaccination was also 
suggested to be important as pigs vaccinated later than 5-weeks-of-age did not 
develop clinical signs of PMWS (Opreissnig et al., 2003).  It was also suggested 
that the vaccination of gilts for PPV and erysipelas separately during their 
‘acclimatisation period’ might increase the risk of PMWS (Rose et al., 2003) but a 
subsequent study of 7 French herds with and without PMWS found no evidence 
linking PMWS to any vaccine (Larochelle et al., 2003).   
While the appearance of PMWS in some countries such as Denmark has 
resembled an infectious disease outbreak (Vigre et al., 2005), suggesting the 
introduction of a new pathogen, the emergence of new genetic variants of PCV2 is 
not currently considered to be a satisfactory explanation for the apparent 
differences in pig and herd susceptibility to PMWS and other PCV2-related 
diseases.  While it has been suggested that PCV2 is a pathogenic variant 
generated from the non-pathogenic PCV1 by point mutation (Ellis et al., 1998), no 
genetic differences have been detected in PCV2 strains from healthy and 
diseased pigs (Larochelle et al., 2002; Pogranichniy et al., 2002; Choi et al., 2002; 
de Boisseson et al., 2004; Grierson et al., 2004).  Although one study of CAV 
identified a single amino acid change as a potential determinant of viral 
pathogenicity (Yamaguchi et al., 2001), no motif or amino acid changes have 
been identified as a basis for explaining the pathogenicity of PCV2 (Choi et al., 
2002; Larochelle et al., 2002).  While different PCV2 sequences isolated from the 
same country may be quite variable, as is the case with Hungary (Dan et al.,   56 
2003), Korea (Kim and Lyoo, 2002) and France (de Boisseson et al., 2004), 
isolates from different continents may be quite similar and not cluster on any 
geographic basis (Choi et al., 2002; Larochelle et al., 2002).  This suggests that 
the existence in some countries of widespread PCV2 infection but no PCV-
associated disease is not due to the presence of an apathogenic PCV2.  For 
example, no PMWS outbreak was confirmed in Sweden until 2003, although the 
virus had been present for 10 years (Wattrang et al., 2002; Wallgren et al., 2004).   
Recently it has been shown that the replication factors of PCV1 and PCV2 are 
exchangeable, and that both types of PCV replicate at a similar rate in vitro.  This 
would suggest that viral replication strategy may not be the main factor 
determining the difference in pathogenicity between PCV1 and PCV2 (Mankertz et 
al., 2003).   
Whether co-infecting pathogens are associated with PCV2-associated disease is 
uncertain.  Certainly, some pathogens such as PPV and PRRSV have been 
shown to act synergistically with PCV2 to produce more severe disease than with 
PCV2 infection alone (Ellis et al., 1998; Allan et al., 2000), and it has been found 
that farms which are positive for PPV and PRRSV have an increased chance of 
experiencing PMWS (Rose et al., 2003).  However, no other infectious agent or 
agents have been consistently identified in cases of PMWS, suggesting either that 
most co-infections are opportunistic in nature, or if they are involved that their 
effect is indirect.  It has been suggested that co-infecting agents which can cause 
cell death and therefore lead to tissue regeneration may provide the rapidly 
dividing cells optimal for PCV2 replication, therefore increasing viral load and 
possibly causing disease (Ellis et al., 2004).  Similarly, an increase in the 
production of cytokines and other growth factors affecting cell division may also 
cause an increase in PCV2 replication by increasing the number of target cells 
(Ellis et al., 2004).  Immune activation, which may be caused by management 
practices such as vaccination, has been demonstrated experimentally to increase 
cytokine secretions in experimentally infected animals which subsequently 
developed PMWS (Krakowka et al., 2001).  Meerts et al. (2005b) demonstrated 
that even gnotobiotic pigs raised and inoculated with PCV2 in identical fashions 
may differ in their responses to the virus, some mounting an efficient immune 
response while others were unable to control viral replication.  The amount of 
maternal antibody can also influence the degree of protection from PCV2 
infection; high titres of maternal antibody can protect against infection, but low 
titres cannot (McKeown et al., 2005).     57 
It seems therefore, despite the fact that the PMWS disease syndrome has 
emerged recently and quite suddenly all over the world, that PCV2 is not a ‘new’ 
pathogen.  It is more likely that changed management and environmental 
conditions are responsible for the emergence of the disease, and that the health 
and immunological status of herds or individual pigs possibly relating to early 
vaccination, high virus prevalence in the environment and low maternal antibody 
status may affect disease development.   
Control of PCV-associated disease 
There is no cure for the various PCV-associated disease syndromes although the 
use of antibiotics to control secondary infections may be of use (Ohlinger et al., 
2000).  As circoviruses are resistant to environmental degradation such as 
changes in temperature and pH (Todd, 2000) these viruses persist in the 
environment and the eradication of PCV is not a practical consideration.  Control 
is focused therefore on altering management conditions on affected farms (Chen, 
2000).  Management practises such as batch mixing, adoptions, litter mixing and 
large pens are not recommended (Guilmoto and Wessel-Robert, 2000).  On-farm 
semen collection, versus the use of insemination centres, may also increase the 
risk of PMWS (Rose et al., 2003).  Management practises such as improving 
hygiene and regular herd treatment against external parasites have been 
recommended (Rose et al., 2003).   
It has been suggested that PCV2 may be carried from farm to farm by some kind 
of secondary vector such as birds (MacKinnon, 2000).  However as most 
circoviruses are host-specific, birds or other small animals as a vector for PMWS-
associated virus spread seems unlikely (Todd, 2004).   
PCV2 vaccination 
As it has been theorised that PCV2-associated disease may occur when 
seronegative animals are exposed to the virus, either in utero or postnatally 
(O’Connor et al., 2001; Lukert and Allan, 1999), treatment of PMWS and PDNS by 
‘serum therapy’ has been tried in the UK.  Serum from older pigs in the herd has 
been administered to young piglets at weaning, to confer passive immunity to 
PCV2 (Dean, 2002).  No data is available on the success rate of this treatment, 
although there is some anecdotal evidence that mortality is reduced.  However, 
the risk of transferring other pathogens by movement of serum from an abbatoir 
back to the farm of origin may be dangerous and somewhat irresponsible (Potter, 
2002).   
PCV2 vaccines have been trialled in several forms.  A DNA vaccine expressing   58 
the capsid protein of PCV2 was found to be effective at raising PCV2 antibodies in 
a mouse model (Kamstrup et al., 2004).  The possibility of vaccination against 
PCV2 using chimeric infectious clones has been considered (Fenaux et al., 2003).  
To create a chimeric clone, PCV2 capsid DNA was cloned into the backbone of 
PCV1, and when inoculated into young pigs, PCV2 antibodies were produced.  A 
subunit vaccine to enhance the immune response of piglets was reported to 
provide protection against severe PMWS but this method remains to be validated 
(Blanchard  et al., 2003).  Recently, recombinant viral vaccines have been 
developed as potential treatments for PCV2; a recombinant pseudorabies virus 
expressing the fused ORF1-ORF2 of PCV2 was shown to induce significant anti-
PCV2 immunity in mice and pigs, although the vaccine has not yet been tested in 
response to experimental PCV2 challenge (Ju et al., 2005).  In addition, a 
recombinant adenovirus expressing the capsid protein of PCV2 was shown to 
elicit immune responses against PCV2 in mice (Wang et al., 2006).   
RNA interference (RNAi) 
RNA interference is a process by which double-stranded RNA directs sequence-
specific post-transcriptional gene silencing, which may be used to reduce viral 
RNA production, and therefore DNA and protein production.  This technique 
reduced PCV2 transcription and translation in PK-15 cells, and also in a mouse 
model (Liu et al., 2006).  Therefore this strategy could be useful to decrease 
PCV2 viral load, shown to be directly correlated with disease severity (Okuda et 
al., 2003; Olvera et al., 2004; Brunborg et al., 2004; Krakowka et al., 2005).   
However, experimental data using pigs is required to validate this technique as a 
potential therapy for PMWS and PCV2-associated diseases.   
Management practises as a factor in PCV-associated diseases 
As the incidence of PMWS and other PCV2-related diseases cannot be explained by 
simple infection with PCV2 (Done et al., 2001) or genotypic variation of PCV2 (Choi 
et al., 2002; Larochelle et al., 2002), management conditions may well play a role in 
disease development.  Draughts, overcrowding, poor air quality, mingling of different 
age groups and infection with other agents may contribute to the occurrence of 
PMWS and PDNS (Choi et al., 2002b).  Both PMWS and PDNS are common in 
eastern Great Britain, and the high prevalence of disease is possibly caused by high 
levels of pig movement, and pigs from up to 15 different sources may be together on 
one farm (MacKinnon, 2000).  A high proportion of PDNS and PMWS cases are 
associated with corporate production, a fairly recent occurrence in the UK 
(MacKinnon, 2000).  Such operations usually have large numbers of pigs from many   59 
different sources on the one farm, and this may contribute to the development of 
PMWS and/or PDNS (MacKinnon, 2000).   
A variety of management-related treatments for PMWS have been proposed but 
there is no clear indication of the efficacy of any of these procedures.  Multivitamin 
supplements and reduced handling and stress were proposed by Baird et al. (2000).  
The use of anti-inflammatory drugs may be beneficial (Yoon et al., 2004).  The 
control of secondary bacterial infections is important, and intramuscular 
corticosteroids may also help, although the improvement is only temporary (Baird et 
al., 2000).  Improved hygiene and segregation of sick animals may be important to 
reduce viral challenge and the spread of infection (Harding, 1997).  Changes in diet 
could be beneficial, and one report suggested that conjugated linoleic acid (CLA), 
when compared to a control diet of soybean oil, appeared to ameliorate PCV2 viral 
disease and reduce the severity of pneumonic lesions (Bassaganya-Riera et al., 
2003).   
While it seems likely that changed pig farm management conditions have contributed 
to the recent increase in PCV2-associated disease, PCV2 has also been identified in 
cases of multisystemic disease in free-range wild pigs (Ellis et al., 2003; Schulze et 
al., 2004).  However, wild pigs are still subject to environmental stresses (Ellis et al., 
2003) which may help to precipitate PCV2-associated disease. 
PCV in Australia 
Analysis of a relatively small number of samples from pigs submitted to this 
laboratory has identified PCV1 and PCV2 in the tissues of pigs originating from 
several Australian states (Raye, personal communication).  Initial sequence analysis 
has shown these strains have very high nt sequence identity, and are very similar to 
strains that have been detected in association with PMWS overseas.  There have 
been no outbreaks of PWMS in Australia, and while PDNS has been detected 
(Cameron, 1995) it has been observed infrequently.  It seems likely that the 
Australian situation is similar to Sweden, where PCV2 infection is widespread and 
the strains present are able to produce PMWS under experimental conditions, but no 
naturally-occurring cases of PMWS were identified until 2003 (Allan et al., 2002; 
Wattrang et al., 2002; Wallgren et al., 2004).  A prevailing hypothesis is therefore that 
there are other, as yet unidentified factors, required for the development of PMWS 
which are not present in Australia.  PRRSV and PPV have been suggested as 
possible co-factors combining with PCV2 to produce disease in other countries 
(Krakowka et al., 2000; Sato et al., 2000) and while PPV was, before the onset of 
vaccination programs, widespread in Australia (Buddle, personal communication),   60 
PRRSV is not present in Australia.  Herd management variables such as early 
weaning, early and extensive vaccination programs and large herd sizes have 
recently been suggested to affect the occurrence of PMWS and PDNS (Allan et al., 
2001, Cook et al., 2001) and perhaps the management practises used in Australian 
pig herds are sufficiently different to explain why PMWS is not present.   61 
CHAPTER 3.  THE DETECTION OF PORCINE CIRCOVIRUS IN THE 
AUSTRALIAN PIG HERD 
Summary 
The objective of this study was to determine if porcine circovirus (PCV) was present 
in the Australian pig herd.  A multiplex polymerase chain reaction (PCR) was utilised 
to detect PCV in tissues from weanling pigs found dead and from pigs originating 
from herds experiencing outbreaks of disease such as congenital tremors (CT).   
Tissues from approximately 350 pigs from Western Australia (WA), New South 
Wales (NSW), South Australia (SA) and Queensland were tested for the presence of 
PCV type 1 (PCV1) and PCV type 2 (PCV2) DNA.  PCV1 DNA was detected in pig 
tissue samples from WA, SA and NSW and PCV2 DNA was detected in pig tissue 
samples from WA, NSW and Queensland.  Sequence analysis of the PCR products 
was conducted to confirm the PCR results.  It was concluded from these results that 
both PCV types (PCV1 and PCV2) were present in Australia, although no causal 
relationship with any disease outbreak was proven.    
Introduction 
Porcine circovirus was first identified in 1974 as a persistent infection of the immortal 
PK-15 pig kidney cell line (Tischer et al., 1974).  As it was non-cytopathic it was 
assumed to be non-pathogenic (Tischer et al., 1982) and it was not possible to 
associate any disease with it, either experimentally or in the field (Tischer et al., 
1986).  The virus infecting the PK-15 cell line was subsequently designated PCV1 
(Meehan et al.  1998).  A second type of PCV, designated PCV2 was  identified and 
characterised (Meehan et al., 1998) and has since been detected in pigs suffering 
from a number of conditions, including PMWS (Hamel et al., 1998; Meehan et al., 
1998; Allan et al., 1999a; Onuki et al., 1999; Kyriakis et al., 2000; Martelli et al., 2000; 
Wellenberg et al., 2000; Done et al., 2001; Trujano et al., 2001), porcine dermatitis 
and nephropathy syndrome (PDNS) (Gresham et al., 2000; Rosell et al., 2000; Choi 
et al., 2002b; Saoulidis et al., 2002) and congenital tremor (CT) (Stevenson et al., 
2001; Choi et al., 2002).  The clinical scope of PCV2 may be expanding, with recent 
increases in the prevalence of PCV2 found in cases of reproductive problems (West 
et al., 1999; Lyoo et al., 2001; Sanchez et al., 2001), proliferative and necrotising 
pneumonia (Drolet et al., 2003) and porcine respiratory disease complex (Halbur, 
2001; Kim et al., 2003).   
Although PMWS was not formally described until 1997, the disease was found to 
have been present in Canada since 1991 (Clark, 1997).  Furthermore, retrospective 
studies of archival pig sera have demonstrated that PCV2 has been present in pigs   62 
from Japan, dating from 1985 (Sato et al., 2000), America from 1987 (Nawagitgul et 
al., 2002) and Northern Ireland from 1973 (Walker et al., 2000), suggesting that the 
virus has been circulating in pigs for some time.   
One of the difficulties associated with the study of PCV-associated disease is that 
both PCV1 and PCV2 are common in clinically normal pigs (Tischer et al., 1995b; 
Done et al., 2001).  It is common for pig herds to be seropositive to PCV2 without 
experiencing disease and individual pigs within a diseased herd may be infected with 
PCV2 yet remain healthy (Larochelle et al., 1999; Rodriguez-Arrioja et al., 2000; 
Sorden, 2000).  Studies of the dynamics of PCV2 infection within and between pig 
herds have not provided conclusive answers to how it is associated with disease, but 
recent research suggests that the presence or absence of PMWS and its 
development may depend on the response of individual pigs to infection.  Factors 
such as the age of the pig at the time of PCV2 infection, the immune status of the pig 
and PCV2 viral load are thought to influence PMWS development (Ladekjaer-
Mikkelsen et al., 2002; Okuda et al., 2003; Olvera et al., 2004). 
It seems that PCV2 is not a new virus and that unknown factors or conditions are 
causing this previously non-pathogenic or mildly pathogenic virus to produce 
disease.  For example, for a long time after PCV2 was detected, Sweden remained 
free of PMWS but clinical disease was reproduced experimentally in Irish and 
Swedish pigs using a Swedish PCV2 isolate taken from a healthy pig (Allan et al., 
2002; Hasslung et al., 2005) before the disease appeared in 2003 (Wallgren et al., 
2004).  The available evidence seems to suggest that PCV2 occurs in all pig 
populations as a subclinical viral infection, and that there are other factors which 
operate in conjunction with PCV2 to produce PMWS (see Chapter 2).  There is no 
evidence that there are variations in pathogenicity of different strains of PCV2.   
Very little is known of the status of PCV infection in the Australian pig herd.  Initial 
investigations by this laboratory have identified both PCV1 and PCV2 in pigs in 
Australia, but there have been no reported outbreaks of PMWS in Australia.  Both CT 
and PDNS have been reported in Australia and there is some evidence from other 
countries that both these diseases might be associated with PCV (see Chapter 2).   
Assuming that PCV2 is present in Australia, the reasons for the absence of PMWS 
are unknown.  In the absence of PMWS, a unique opportunity existed to examine 
strains of PCV in Australia and to compare them with strains detected elsewhere 
where PMWS has occurred.  Tissues from Australian pigs were therefore examined 
to provide information on the presence and prevalence of PCV infection, especially in 
weanling pigs but also in tissues of any other young pigs that could be obtained.  The   63 
prevalence of PCV in one farm with a low prevalence of ill-thrift, and another 2 farms 
with CT cases, was also investigated.   
Materials and methods 
Tissue samples  
Pig tissues were sent by consulting veterinarians when weaned pigs on farms were 
found dead or presenting with signs of ill-thrift.  The most common tissue sent for 
testing was spleen, but liver, lymph node, brain, spinal cord and lung tissue were also 
received on some occasions.  Pig tissue samples were transported to Murdoch 
University under refrigeration and were received from WA, NSW, SA and 
Queensland.    
DNA extraction and PCR 
Viral DNA was extracted from approximately 5 mg of tissue using a Qiagen DNeasy 
tissue kit (QIAGEN) as recommended by the manufacturer, or by using the phenol-
chloroform method described by Sambrook et al. (1989).   Pigs infected with PCV 
were identified using multiplex PCR based on a previously published method, which 
employed primers able to differentially amplify fragments of PCV1 or PCV2 
(Larochelle et al., 1999a).   PCR assays were performed in a 25 μL reaction mix 
consisting of 3 μL extracted sample DNA, 1X PCR reaction buffer, 2 mM MgCl2, 1 
mM each dNTPs, 6.4 pmol each primer and 0.5 U AmpliTaq® DNA polymerase 
(PerkinElmer).   Amplification was performed with an initial denaturation step of 5 
min, followed by 35 cycles of amplification at 95
oC for 1 min, 65
oC for 1 min, and 
72
oC for 1 min, with a final extension step of 72
oC for 10 min.  PCR products were 
electrophoresed in a 2% agarose gel at 80 V for 1 h and visualised using an ultra-
violet transilluminator (UVP).   
Cloning and transformation 
To confirm that positive PCR results were PCV, amplified PCR products were cloned 
into the pCR®2.1 TOPO® vector (Invitrogen) and sequenced.    
The various PCR products were cloned into the pCR®2.1 TOPO® vector using a TA 
cloning kit, Version M (Invitrogen) as recommended by the manufacturer.   
Constructed plasmids were used to transform competent Top 10 F’ E. coli 
(Invitrogen).   Plasmids containing the desired PCV1 or PCV2 inserts were identified 
by α-complementation blue/white screening, and purified recombinant plasmids were 
digested with Eco R1 restriction endonuclease to confirm the presence of the insert.   
Sequence analysis of PCR products 
Plasmids containing the PCV1 and PCV2 fragments were sequenced using the M13 
forward (5`-GTAAAACGACGGCCAG-3`) and reverse (5`-CAGGAAACAGCTATGAC-  64 
3`) primers.  Sequencing was performed using rhodamine dye terminator 
(PerkinElmer), and an ABI PRISM™ fluorescent cycle sequencing system 
(PerkinElmer).  Data was analysed using the SeqEd program (v 1.0.3).  The 
sequences obtained were then compared using the BlastN program (version 2.0) to 
PCV sequences available from the National Centre for Biotechnology Information 
(NCBI), USA. 
Case studies 
Case study 1.  Unthrifty weaner pigs, September-November 2002 
This case study involved unthrifty weaner pigs from a single WA herd, with clinical 
signs of ill-thrift that could have been consistent with PMWS.  Twelve affected pigs 5-
13 weeks of age were submitted for examination over a I month period, and each pig 
was subjected to a thorough haematological, gross pathological and 
histopathological examination.  In addition, tissue samples were collected from the 12 
pigs and tested for PCV DNA by PCR as described above. 
Case study 2.  Congenital tremor (CT) cases, October 2002 – February 2003 
An outbreak of CT occurred in a WA pig herd (Farm A) in mid 2002.  Although CT 
has occurred in WA herds before, this outbreak was considered to be unusually 
severe, with the epidemiology of a classical infectious disease outbreak.  As the 
Farm A outbreak appeared to be resolving, another WA farm (Farm B) was also 
affected by an outbreak of CT.  Two CT-affected pigs from Farm A and 15 affected 
pigs from Farm B were necropsied at Murdoch University and tissue samples were 
collected.  Brain and spinal cord samples were selected for analysis as these tissues 
have been shown to contain the most PCV2 infected cells in CT-affected animals 
(Stevenson et al., 2001).  DNA from these tissues was extracted and tested for PCV 
DNA by PCR as described above.  Semen samples were also collected from Farm B 
on the 18
th of November 2002, and DNA was extracted using a DNeasy kit (QIAGEN) 
using methods recommended by the manufacturer for cultured animal cells.   
Results 
Multiplex PCR 
A multiplex PCR was used to identify PCV1 and PCV2 from tissue samples received 
from 4 Australian states.  An example of the multiplex PCR is shown in Figure 3.1.   
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Figure 3.1.  Amplification of a 350 bp fragment of PCV1 and a 260 bp fragment of PCV2 by 
multiplex PCR.   Lane 1, negative tissue control; lane 2, negative PCR control; lane 3, PCV1 
positive reaction; lane 4, PCV2 positive reaction, lane 5, 100 bp DNA ladder (Lifetech).  The 
size of the bands in the DNA ladder is indicated on the right, and the expected size of the 
PCR product on the left. 
 
PCV1 was detected in tissues received from WA, NSW and SA.  PCV2 was detected 
in tissues received from WA, NSW and Queensland.  The multiplex PCR results are 
summarised in Table 3.1.   
 
Table 3.1.  Multiplex PCR results on porcine tissues from farms in 4 Australian States. 
State 
Number 
of farms 
sampled 
PCV-
positive 
farms  
Total number 
of samples 
received 
Percent 
PCV1 
positive 
Percent 
PCV2 
positive 
Percent 
dual 
infection 
PCV1 and 
PCV2 
WA 14  12  190  30.5  22  2.1 
NSW  7 5  112  10 10.5  2.7 
Queensland 4  1  29  0  31  0 
SA 2  1  17  6 0  0 
Total 27  19 348  20  18 2 
 
Sequence analysis of PCR products 
The multiplex PCR used in this study produced PCV1 DNA fragments of 350 bp, and 
PCV2 fragments of 260 bp.  These DNA fragments were sequenced to confirm that 
PCR positive results were PCV.  Two samples originating from WA and NSW that 
200 bp 
300 bp 
400 bp  350 bp 
260 bp 
1         2             3         4         5   66 
were PCV1 positive, and a further 2 samples also originating from WA and NSW that 
were PCV2 positive were cloned, sequenced and compared to previously sequenced 
isolates of PCV available on the NCBI and Genbank databases (Table 2).   
 
Table 3.2.  Similarity of Australian strains of PCV to overseas PCV isolates. 
Nucleotide identity (%) to overseas PCV isolates  
Isolate 
PCV1 PCV2 
PCV1 NSW  98.9 - 99.7  89.6 - 90.2 
PCV1 WA  98.6 - 99.4  89.5 - 90.2 
PCV2 Queensland  60.6 - 63.2  94.4 - 97.7 
PCV2 WA  60.9 - 63.2  94.0 - 98.1 
 
Case studies 
Case study 1.  Unthrifty weaner pigs  
Of the 12 pigs submitted, 2 were considered to be possible PMWS cases based on 
their haematological, gross pathological and histopathological examinations. Of the 
remaining ten pigs, seven were not considered to be PMWS-affected while the 
diagnosis of the remaining three was uncertain.  Although there were limited 
histopathological lesions in some of these pigs that could have been considered 
consistent with PMWS, the small number of such lesions and their very mild nature 
resulted in an uncertain diagnosis.  Several pigs had respiratory signs with 
pneumonia present in 8 of the 12 pigs. Lymph enlargement was a common finding 
and two pigs had multinucleated giant cells in lymph nodes. However the lesions 
were very inconsistent between pigs, and several were infected with various bacteria 
which could have accounted for their low body weight.  IPMA (see Chapter 5) was 
performed on several sections from the unthrifty pigs, but no PCV2 antigen was 
demonstrated anywhere in any of the sections. PCV2 nucleic acid was, however, 
identified by PCR in all 12 pigs, while PCV1 was detected in 9 of the 12 pigs (Table 
3.3).  The most common PCV2-positive tissues were the mesenteric lymph node and 
the lung, followed by the spleen and the tonsil (Table 3.3).  The most common PCV1-
positive tissue was the spleen, followed by the lung, mesenteric lymph node and the 
tonsil (Table 3.3). 
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Table 3.3.  Multiplex PCR results from the 12 unthrifty weaner pigs. 
Mesenteric 
lymph node  Lung Spleen  Tonsil 
Pig  Age 
(wks) 
PCV-1 PCV-2 PCV-1 PCV-2 PCV-1 PCV-2 PCV-1 PCV-2 
02/635  5  - - - + + + - - 
02/622  6  - + - + - - - - 
02/728  7  - + - + + + - - 
02/728  7  - + - + - - - + 
02/714  7-8  + + - + + + - + 
02/715  7-8  + + - + + + - + 
02/716  7-8  - + - - + - - + 
02/634  8  - + + + - + -  - 
02/726  9  - + + + - - + - 
02/623  10  - + - + - + - + 
02/633  12  - + + + -  -  -  - 
02/624  13  + + + + + + + - 
 
Case study 2.  CT outbreaks 
No histopathological lesions were detected in the brain or spinal cord of any of the 
affected pigs, and PCV2 could not be detected by IPMA in any tissue sections. 
The brains and spinal cords of 2 pigs from Farm A and 15 pigs from Farm B, plus 4 
semen samples from boars originating from Farm B, were tested for the presence of 
PCV1 and PCV2 DNA using the multiplex PCR.  The results are given in Table 3.4.   
PCV2 was detected in brain and spinal cord tissues of both CT-affected pigs from 
Farm A, while PVC1 was detected in brain or spinal cord tissues of 8 of 15 pigs from 
Farm B.  One semen sample from boars used to inseminate the gilts on Farm B, 
sample 400, was positive for PCV1. 
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Table 3.4.  Multiplex PCR results from CT-affected pigs received from 2 farms in Western 
Australia.  
Pigs Brain  Spinal  cord  Semen 
 PCV1  PCV2  PCV1  PCV2 PCV1 PCV2 
Farm A        
02/016  -  + -  + NT  NT 
02/017  -  + -  + NT  NT 
Farm B        
02/992  - - - - NT  NT 
02/993  - - - - NT  NT 
02/994  +  - +  - NT  NT 
02/995  +  - +  - NT  NT 
02/996  +  - +  - NT  NT 
02/997  +  - +  - NT  NT 
02/998  +  - +  - NT  NT 
02/999  - - +  - NT  NT 
02/1000  +  - +  - NT  NT 
02/1001  +  - +  - NT  NT 
02/1002  - - - - NT  NT 
02/1003  - - - - NT  NT 
02/1004  - - - - NT  NT 
02/1005  - - - - NT  NT 
02/1006  - - - - NT  NT 
331  Semen    NT NT NT NT -  - 
400  Semen    NT NT NT NT +/- - 
1050  Semen    NT NT NT NT -  - 
1070  Semen    NT NT NT NT -  - 
 
NT denotes not tested.   69 
 
Discussion 
In this study of PCV in Australian pigs, a multiplex PCR that was developed 
elsewhere (Larochelle et al., 1999a) was used to detect PCV infection.  At the time of 
the study, this was the only available assay.  No suitable type-specific serological 
tests were available, and no PCV-specific monoclonal antibodies were available for 
the development of immunocytochemical tests.  The overall prevalence of PCV1 and 
PCV2 detected in pigs by the multiplex PCR was 20% and 18%, respectively.   
The prevalence of PCV2 in the Australian pig herd (18%) was lower in comparison to 
some other studies but prevalence rates seem to reflect the presence or absence of 
PCV2-associated disease, and the 18% prevalence seems approximately equivalent 
to what has been detected elsewhere in regions where PMWS has not been 
detected.  This is illustrated by the results of a study by Calsamiglia et al. (2002) who 
found that in pigs without PMWS lesions there was a 29% prevalence of PCV2 
infection, much less than the 96% prevalence detected in pigs with PMWS lesions.  
Similarly, PCV2 was identified in 26.8% of pigs in Germany that were not affected by 
PMWS (Mankertz et al., 2000b).  In a retrospective study of Japanese archived 
tissue blocks, PCV2 prevalence rates were 21% in 1991, 27% in 1994, rising to 50% 
in 1999 (Sato et al., 2000) when PMWS had begun to affect Japanese pig herds 
(Onuki et al., 1999).   
The 20% prevalence of PCV1 in Australia detected by PCR appears higher than the 
approximately 5–10% PCV1 prevalence rates reported globally (Larochelle et al., 
1999b; Ouardani et al., 1999; Quintana et al., 2001; Calsamiglia et al., 2002).   
Although PCR detection methods have generally indicated prevalence rates of less 
than 10%, serological studies have indicated that infection rates with PCV1 are 
higher than that.  A Spanish serological study based on the use of an 
immunoperoxidase assay (IPMA) and sera from 90 pigs from 37 farms detected 
PCV1 antibody in 52.2% of samples and PCV2 antibody in 97.8% of samples 
(Rodriguez-Arrioja et al., 2000).  While PCV2 was shown to be more prevalent than 
PCV1, the rate of detection of PCV1 was still high.  Quintana et al. (2001) also tested 
for both types of PCV antibody using IPMA, and found that although PCV1 and PCV2 
nucleic acid were present in 9% and 67% of samples respectively, and all pigs had 
seroconverted to PCV2, PCV1 antibodies were also present in all but one pig (94% 
seroprevalence rate).  A retrospective serological survey using sera from 1985, 1989 
and 1997 also found a high rate of PCV1 antibodies; 8%, 41.4% and 38.1% 
respectively (Magar et al., 2000b).  The extent to which these high rates of PCV1   70 
antibody in these reports might represent cross-reaction to PCV2 antigen is unknown 
but it is a factor that does need consideration.  
The interpretation of prevalence rates of PCV1 and PCV2 based on serological 
results is difficult due to problems of interpreting the specificity of the assays used.  
Due to problems of serological cross-reactivity, not realised at the time but since well 
documented (Dulac and Afshar, 1989; Allan et al., 1998; Rodriguez-Arrioja et al., 
2000), tests such as immunofluorescence assays in these early studies probably 
detected antibody to both PCV1 and PCV2 and did not differentiate one from the 
other.  In addition, after 1997 when it became clear that there were two types of PCV 
and that only PCV2 appeared to be pathogenic, PCV1 was considered of little 
interest and it became common practice to survey pig herds for the presence of 
PCV2 only.  A retrospective serological survey of Canadian pigs from the years 1985, 
1989 and 1997, using indirect immunofluorescence which does not discriminate 
between PCV1 and PCV2 antibodies, found a higher prevalence of PCV2 in all 3 
years, suggesting that PCV2 may have been more common than PCV1 in the 
Canadian pig herd even before PMWS became a recognised problem (Magar et al., 
2000b).   
Prevalence rates detected using serological tests are difficult to compare with 
detection of virus based on PCR: serological tests detect past infections and not 
necessarily current infections, and PCR detects current infection only.  In a Canadian 
study using multiplex PCR, 94.2% of 35 pigs were infected with PCV2, compared 
with only 5.7% infected with PCV1, and both PCV1-positive pigs were also infected 
with PCV2 (Ouardani et al., 1999).  Similar results were reported in a study of a 
PMWS-affected farm, with PCV1 DNA found in 9% of 33 pigs, while PCV2 was found 
in 67% of the same 33 pigs (Quintana et al., 2001).  This high rate of PCV2 infection 
is supported by another study using multiplex PCR where 97.6% of pigs were PCV2-
positive, while only 4.8% of samples were positive for PCV1 (Larochelle et al., 
1999b).  It should be noted however that all 3 of these studies used tissue samples 
from pigs with various clinical signs and conditions, including respiratory signs, 
weight loss (Ouardani et al., 1999), pneumonia, tremors and PDNS (Larochelle et al., 
1999b) and PMWS (Quintana et al., 2001).  All these signs have been observed in 
cases of PCV2-associated disease, so a high rate of PCV2 would perhaps be 
expected.   
The reason for the apparently lower prevalence of PCV1 than PCV2 globally is 
unknown.  The non-pathogenic PCV1 is probably capable of faecal-oral transmission 
(Tischer  et al., 1986; Shibata et al., 2003; Sibila et al., 2004) and widespread   71 
subclinical replication might be expected, much like TTV in humans (Mushahwar et 
al., 1999).  A possible explanation is the low efficiency of PCV1 replication, resulting 
in virus titres too low for efficient infection of pigs, quite different to the widespread 
TTV which produces at least 3·8x10
10 virus particles per day in chronically infected 
patients (Maggi et al., 2003).  It is also possible that there is competition between 
PCV1 and PCV2, evidence for which is that PCV1 has not been detected by PCR in 
any samples from PMWS affected and non-affected farms in the French region of 
Brittany since PMWS became a problem in the area, possibly due to the massive 
multiplication of PCV2 (De Boisseson et al., 2004).  Another possible explanation is 
that PCV1 infection in pigs may be cleared by the immune system more rapidly than 
PCV2, with less persistence of infection. 
The question of whether the Australian strains of PCV2 are different from those 
reported elsewhere in association with PMWS will be addressed in a subsequent 
Chapter (Chapter 4).  The sequence analysis that was conducted during the 
investigation reported in this current Chapter was conducted only to validate the 
identity of the PCR amplification products that were obtained with the multiplex PCR.  
This limited analysis does demonstrate that the Australian PCV1 and PCV2 strains 
were genetically similar to PCV strains examined elsewhere.  The initial data 
obtained also indicated that Australian PCV1 had a higher similarity to overseas 
isolates than the Australian PCV2 strains, but the PCR primers utilised to amplify 
PCV1 were situated in the highly conserved viral ORF1, while the PCV2 primers 
were situated in the more variable ORF2 (Mahe et al., 2000), and direct comparison 
of the sequencing results would not be valid.   
It is evident that in Australia there is no widespread PMWS disease, but whether 
there is a low prevalence of PMWS-like lesions in individual weanling pigs in 
Australia is unknown.  One property in WA was investigated over a 1-month period, 
and 12 unthrifty weaner piglets were examined.  The criteria for a diagnosis of 
PMWS were those suggested by Sorden (2000) and Quintana et al. (2001) and were 
three-fold: the presence of clinical signs (usually wasting), the presence of 
characteristic histopathological lesions in lymphoid tissue, and the presence of PCV2 
within those lesions.  While some pigs had signs typical of PMWS such as 
pneumonia, poor body condition and coughing, a diagnosis of PMWS was eliminated 
in 10 of the 12 pigs due to the absence of PMWS histopathological lesions in the 
lymph nodes.  Two of the 12 pigs exhibited wasting, pneumonia, bronchitis, 
multinucleated giant cells in the lung, liver inflammation, secondary bacterial infection 
in the colon, rhinitis and anaemia; however no PCV2 antigen could be detected by   72 
the newly-developed IPMA in any tissues from these two pigs.     
In all 12 unthrifty pigs, PCV2 DNA was detected in tissues by PCR with the most 
common positive tissues being the mesenteric lymph node and the lung.  The next 
most common PCV2-positive tissue was the spleen, followed by the tonsil.  PCV1 
was also identified in 9 of the 12 pigs, with the most common infected tissue being 
the spleen, followed by the lung, mesenteric lymph node and the tonsil (Table 3.3).  
Comparison of these results with those reported in a study of 50 PMWS-affected pigs 
by Segales et al. (2004) showed there was a similar frequency of PCV2 infection in 
the mesenteric lymph node, tonsil and lung; however infection in the spleen was less 
common at around 70% (Table 3.5). 
 
Table 3.5.  Distribution and frequency of detection of PCV2 nucleic acid by in situ 
hybridisation in different tissues from 50 PMWS-affected pigs.  From Segales et al.  (2004). 
 
 
 
While the diagnosis of PMWS in these unthrifty pigs was ruled out due to the 
absence of PCV2 in association with microscopic lesions, retrospective studies in 
some countries have shown that sporadic and isolated cases of PMWS in 
association with PCV2 may occur many years or even decades before severe PMWS 
outbreaks are reported.  For example, PCV2 has been detected in association with 
typical PMWS microscopic lesions and clinical signs by ISH and immunoperoxidase 
in archived tissue blocks and sera from 1986 (Rosell et al., 2000c) and 1985 
(Rodriguez-Arrioja et al., 2003).  As PMWS was not recognised at these times, these 
lesions in these pigs were initially thought to be due to stress and management   73 
conditions, Glasser’s disease, gastric ulcers and colitis, with the presence of 
secondary agents also confusing the diagnosis (Rosell et al., 2000c; Rodriguez-
Arrioja  et al., 2003).  PCV2 was also detected in isolated cases of PMWS from 
Thailand in 1993 (Kiatipattanasakul-Banlunara et al., 2002) and Japan in 1990 (Sato 
et al., 2000) and in sporadic cases of PCV2-associated PDNS in the United Kingdom 
dating back to the 1980s (Allan et al., 2000e; Grierson et al., 2004b).  It was thought 
that the low prevalence of PMWS, along with the presence of secondary agents and 
the non-specificity of clinical signs, may have helped PMWS to remain undiagnosed 
for many years (Rodriguez-Arrioja et al., 2003).  This has also been demonstrated in 
Denmark, where PMWS was officially identified in 2001, but two suspicious cases 
had occurred the previous year, and histopathological changes suggesting PMWS 
were seen in archived tissue from 1989.  Similiarly to the present case in Australia, 
these cases were initially suspected to be PMWS, but the histopathological criteria 
required to diagnose the disease were not completely fulfilled (Vigre et al., 2005).   
It has been established that the worldwide outbreaks of PMWS, beginning in the late 
1990s, were not due to the emergence of a new pathogen, as PCV2 has been 
identified in archival tissues and sera decades before PMWS became a recognised 
disease.  PCV2 antibodies have been identified in sera from Japan in 1985 (Sato et 
al., 2000), America in 1987 (Nawagitgul et al., 2002), Northern Ireland in 1973 
(Walker et al., 2000) and the United Kingdom in the 1970s (Grierson et al., 2004b) 
and both PCV1 and PCV2-positive sera have been present in Belgium since at least 
1985, 14 years before PMWS was recognised in that country (Vyt et al., 2000).   
Immunohistochemistry on archival lymph tissues also demonstrated that PCV2 was 
present in Swiss pigs since at least 1986, long before the first description of PMWS 
in Switzerland in 2001 (Staebler et al., 2005).  It appears that PCV2 was present in 
many countries, causing isolated cases of PMWS in some situations, for several 
decades at least before PMWS was first officially described.  Presumably, as yet 
unidentified factors or agents caused an increase in numbers of the previously 
isolated and sporadic cases of PMWS to severe epidemic proportions.  Presumably 
the secondary factors or agents that are required to produce epidemic PMWS are not 
yet present in Australia; the situation in Australia seems to be similar to Switzerland, 
where PCV2 is widespread in pigs but has only been associated with a handful of 
PMWS cases to date (Staebler et al., 2004). 
The opportunity to investigate cases of CT on WA farms occurred during 2002 and 
2003, and although CT had been identified in WA herds before, these outbreaks 
were considered to be unusually severe, with the epidemiology of a classical   74 
infectious disease outbreak.  Previous reports have identified PCV1 (Choi et al., 
2002) and PCV2 (Stevenson et al., 2001) in the neural tissues of CT-affected piglets, 
but there is debate as to whether one or either type of PCV is the cause of CT.  A 
definitive link between PCV1 or PCV2 and CT has never been established and 
recent studies of CT-affected pigs from several different countries found no evidence 
of PCV infection at all (Kennedy et al., 2003; Ha et al., 2005).  CT-affected litters are 
usually from young breeding stock recently introduced to the affected farm (Lukert 
and Allan, 1999) or, as may have happened in the WA outbreak, seronegative first-
parity gilts moved during pregnancy to a farrowing area where they may be exposed 
to whichever agent causes CT, suggesting that exposure of seronegative stock to a 
virus at a critical time during gestation may precipitate disease (Lukert and Allan, 
1999).   
The first outbreak of CT in WA was detected in September 2002 on Farm A, a 
nucleus breeding herd that sold breeding stock and semen to other WA herds.  Farm 
A was considered a ‘closed herd’ except for semen and hysterectomy-derived piglets 
from high-health herds in the eastern states that were owned by the same breeding 
company.  The CT-affected litters initially came from fourth to sixth parity sows, with 
first-parity sows not affected until the fourth week of the outbreak.  By the eighth 
week, affected litters were mostly from younger sows, suggesting a cycling of the 
virus through the herd via pregnant sows.  As the outbreak on Farm A appeared to 
be resolving, cases were detected on Farm B, where up to 60% of litters affected and 
up to 30% pre-weaning mortality due to CT occurred at the peak of the outbreak.  
Although the boars on Farm B were sourced from Farm A, the last delivery to Farm B 
was some 5 weeks prior to clinical signs emerging in Farm A, therefore a delay of 3-4 
months was seen between the introduction of boars to Farm B and the start of the CT 
outbreak.  After the initial outbreaks at Farms A and B, several other farms were 
subsequently affected, although not as severely as Farm B.  These pig herds were all 
owned by the same breeding company, they had all received boars and/or semen 
from Farm A and all farms had been established within the previous 8 years.   
Tissues from CT-affected piglets from Farms A and B and semen from 4 boars that 
may have been associated with the transmission of CT from Farm A to Farm B were 
all tested by multiplex PCR for PCV (Table 3.2).  Strangely, pigs from Farm A were 
positive for PCV2, while pigs from Farm B were positive for PCV1.  One semen 
sample was PCV1-positive, suggesting that PCV could have been transmitted in 
semen as was reported by Kim et al. (2001) and Larochelle et al. (2000).  There are 
at least 2 possible conclusions that may be drawn from this data: either the presence   75 
of either PCV type in the neural tissues of the affected pigs was unrelated to the 
occurrence of CT, or that PCV1 and PCV2 acted alone or in combination to cause 
the CT outbreak.   
The prevalence of PCV in the brain and spinal cord of the Australian CT-affected pigs 
was high, which does suggest that the viruses were involved in the condition, as the 
neural tissues are not commonly infected with either type of PCV.  Lymphoid tissues, 
lungs, spleen, thymus and the liver are the most common sites for the recovery of 
virus in infected pigs (Allan et al., 1995; Hamel et al., 1998; Rosell et al., 1999; 
Pogranichnyy et al., 2000).  PCV2 antigen, however, has been found in the brain of 
pigs experimentally infected with a PCV2 infectious clone (Fenaux et al., 2002) and 
with a cultured isolate of the virus (Kennedy et al., 2000).  The presence of virus in 
brain tissue does not therefore necessarily indicate an association between PCV and 
CT.  There is little information available on the incidence of PCV1 infection in the 
brain or spinal cord of healthy or diseased pigs, so it is not possible to say whether 
the presence of PCV1 in neural tissues is commonplace or not.  If the presence of 
PCV in the neural tissues of these CT-affected pigs is indeed purely coincidental, 
then it is possible that an unknown agent was responsible for the Australian CT 
outbreak.  If this is so, the unknown agent may have acted in concert with PCV1 or 
PCV2, perhaps in a similar fashion to the synergistic effect observed when pigs are 
co-infected with PCV2 and PPV (Krakowka et al., 2000; Kim and Chae, 2004), where 
the increased levels of DNA replication and macrophage proliferation caused by PPV 
might enhance the replication of PCV2.  Therefore the presence of PCV in the brains 
and spines of CT-affected pigs could have been a result of increased PCV replication 
and possibly dissemination throughout the body, facilitated by an unknown organism. 
If this CT outbreak in WA was caused by a virus or other microorganism, either PCV 
or another agent, presumably this agent must already be present in Australia and 
cause a subclinical infection most of the time.  Therefore the WA outbreak may have 
been due to the increased use of genes from a large breeding company, and the 
start of several new pig herds, possibly naïve to whichever agent was causing the CT 
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CHAPTER 4.  GENETIC CHARACTERIZATION AND PHYLOGENETIC ANALYSIS 
OF AUSTRALIAN PORCINE CIRCOVIRUS STRAINS 
Summary 
Genetic characterisation of Australian porcine circovirus (PCV) strains, including 3 
strains of PCV1 from WA and NSW and 7 strains of PCV2 from WA, NSW and Qld, 
was conducted and phylogenetic analysis of the results was performed to determine 
the similarity or otherwise of Australian PCV to overseas strains.  Based on the 
results, several conclusions were made regarding the status and possible history of 
PCV in Australia. 
Australian PCV1 strains were very similar to PCV1 strains detected in other 
countries.  Six of the 7 Australian PCV2 strains were very similar to each other, and 
were most closely related to a Japanese PCV2 strain associated with an outbreak of 
PMWS.  The seventh PCV2 strain was genetically distinct, and was most closely 
related to a Chinese strain and a Japanese strain associated with an unspecified 
clinical syndrome and PMWS, respectively. No unique amino acid motifs could be 
identified in the genomes of Australian PCV2, and there was no apparent genetic 
reason to believe that Australian PCV2 strains would not be capable of producing 
diseases such as PMWS given suitable conditions, which are as yet undefined.  
The high degree of genomic conservation in PCV2 around the world and including 
Australia indicate a very low error rate in the transcription of the PCV genome for 
replication and the long term evolutionary history of the porcine host, in particular 
possible genetic bottleneck events resulting in the very limited diversity of modern 
pigs.  
The reason for why 6 of the 7 Australian PCV2 strains were very similar and the 
seventh was genetically distinct was not determined but possible reasons were 
discussed.  The reasons included the possibility of a long coevolution of PCV and 
pigs, and multiple introductions of PCV2 into the country.  
Introduction 
Australia is one of the only countries in the world where PCV is present in pig herds, 
yet confirmed PCV-associated disease has not been detected.  It was assumed that 
either Australian PCV2 strains were non-pathogenic due to unique genetic 
properties, or that the viruses were the same as detected elsewhere and that co-
factors required for PCV-associated disease development are not present or not 
operating under Australian conditions. There is no evidence of any marked variation 
in the genotype of PCV2 strains or any evidence of correlation between genotype 
and pathogenicity (Choi et al., 2002; Larochelle et al., 2002; Pogranichniy et al.,   77 
2002; de Boisseson et al., 2004; Grierson et al., 2004) but in the absence of any 
sequence data on PCV strains in Australia, strain variation was a possibility that 
needed to be considered.  
In Chapter 3, DNA of PCV1 and PCV2 was identified in a large number of pigs from 
herds within Australia.  Preliminary analysis indicated this DNA was genetically 
similar to that of PCV strains detected in other countries, and to virus strains 
associated with PMWS.  To confirm whether Australian PCV was genetically similar 
to strains associated with PMWS overseas, the complete genomes of viruses 
detected in pigs in Australia were sequenced and subjected to phylogenetic analysis.  
The objective of this analysis was to provide information on the genetic 
characteristics of Australian strains of PCV and to therefore determine if the strains 
present in Australia were likely to have the potential to cause PMWS, and if the 
reason for the absence of PMWS was due to genomic differences or to a probable 
lack of accessory factors required for PCV2 to cause disease.  It was anticipated that 
this data would provide further information on the risk of Australia experiencing 
PMWS and other PCV-associated diseases in the future.  
Materials and methods 
Tissue samples and the PCV1-infected PK-15 cell line 
The pig tissue samples used as a source of PCV1 and PCV2 DNA were those 
previously described in Chapter 3.  Four PCV1 and 7 PCV2 strains were sequenced 
in this study, with their origins shown in Table 4.1 and 4.2 respectively.  One of the 
PCV1 strains was derived from DNA extracted from the PCV1-infected PK-15 cells 
(ATCC-CCL31), a pig kidney cell line persistently infected with PCV1, purchased 
from the American Type Culture Collection and cultured by conventional methods.   
DNA extraction and PCR 
Viral DNA was extracted from approximately 5 mg of tissue or cultured PK-15 cells 
using a DNeasy tissue kit (QIAGEN) using the methods described by the 
manufacturer, or by a phenol-chloroform method as described by Sambrook et al. 
(1989).  Pigs infected with PCV were identified using a multiplex PCR as described in 
Chapter 3, which employed primers able to differentially amplify fragments of PCV1 
or PCV2.  Additional primers were then used to amplify the whole genome of PCV1 
(JM4, JM5, JM4Comp and JM5Comp) and PCV2 (PCV2SeqA, PCV2SeqB, 
PCV2SeqAComp, PCV2SeqBComp) from the DNA samples as shown in Table 4.3.   
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Table 4.1.  Source of PCV1 DNA sequenced. 
 
Virus strain  Date Isolated  Origin of virus   Tissue type 
PCV1 Farm A NSW  2000  Pig found dead  Spleen 
PCV1 Farm C WA  2002  Unthrifty weaner pig  Lymph node 
PCV1 Farm D WA  2002  Pig suffering CT  Spinal cord 
PCV1 PK-15A  2003  PK-15 cell line  Porcine kidney cells 
 
Table 4.2.  Source of strains of PCV2 subjected to sequence analysis. 
 
Virus strain  Date Isolated  Origin of virus  Tissue type 
PCV2 Farm B WA  1999  Pig found dead  Spleen 
PCV2 Farm A NSW  2000  Pig found dead  Spleen 
PCV2 Farm A WA  2000  Pig found dead  Lymph node 
PCV2 Farm A (1) Qld  2000  Pig found dead  Lymph node 
PCV2 Farm A (2) Qld  2000  Pig found dead  Spleen 
PCV2 Farm B NSW  2000  Pig found dead  Spleen 
PCV2 Farm C WA  2002  Unthrifty weaner pig  Lymph node 
 
Table 4.3. Primers used to amplify whole genomes of Australian PCV. 
 
Primer Sequence  Position in 
genome  PCV type 
JM4  5`-GGGATGATCTACTGAGACTGTG-3`  705 - 727  PCV1 
JM5  5`-CCTTCAGAAACCGTTACAGATG-3`  1627 - 1605  PCV1 
JM4Comp  5`-CACAGTCTCAGTAGATCATCCC-3`  727 - 705  PCV1 
JM5Comp  5`-CATCTGTAACGGTTTCTGAAGG-3`  1605 - 1627  PCV1 
PCV2SeqA 5`-AATGGTAC(T/C)CCTC(A/G)(A/G)CTGC-3`  832 - 850  PCV2 
PCV2SeqB 5`-G(A/C)TATGACGT(A/T)TCCAAGGAG-3`  1719 - 1738  PCV2 
PCV2SeqAComp  5`-GCAG(T/C)(T/C)GAGG(A/G)GTACCATTC-3`  850 - 832  PCV2 
PCV2SeqBComp 5`-CTCCTTGGA(T/A)ACGTCATA(G/T)C-3`  1738 - 1719  PCV2 
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PCR assays were performed in a 25 μL reaction mixture consisting of 3 μL extracted 
sample DNA, 1X PCR reaction buffer, 2 mM MgCl2, 1 mM each dNTPs, 6.4 ρmol 
each primer and 0.5 U AmpliTaq® DNA polymerase (PerkinElmer).  Amplification 
was performed with an initial denaturation step of 5 min, followed by 35 cycles of 
amplification (95
oC for 1 min, 60
oC for 1 min, 72
oC for 2 min), with a final extension 
step of 72
oC for 10 min for all the primers, except PCV2SeqAComp and 
PCV2SeqBComp, where the annealing temperature step was 62
oC.  PCR products 
were electrophoresed in a 2% agarose gel at 80 V for 1 h and visualised using an 
ultra-violet transilluminator.    
Cloning and sequence analysis of viral DNA 
The various PCV1 and PCV2 PCR products were cloned into the pCR®2.1 TOPO® 
vector using a TA cloning kit, Version M (Invitrogen) as recommended by the 
manufacturer.  Constructed plasmids were used to transform competent Top 10 F’ E. 
coli cells (Invitrogen).  Plasmids containing the desired inserts were identified by α-
complementation blue/white screening, and purified recombinant plasmids were 
digested with Eco R1 restriction enzyme to confirm the presence of the insert.  
Plasmids containing the correct fragments were sequenced using the M13 forward 
(5`-GTAAAACGACGGCCAG- 3`) and reverse (5`-CAGGAAACAGCTATGAC-3`) 
primers.  Sequencing was performed using rhodamine dye terminator or Big Dye 
terminator Version 3.1 (Applied Biosystems), with the ABI PRISM™ fluorescent cycle 
sequencing system (Applied Biosystems).  Sequence data was analysed using the 
SeqEd program (v 1.0.3). The sequences obtained were then compared, using the 
BlastN program (version 2.0), to existing sequences available from the National 
Centre for Biotechnology Information (NCBI). 
The virus sequence produced was compared to the nucleotide sequences of 8 PCV1 
strains and 28 PCV2 strains available from GenBank and NCBI databases as shown 
in Table 4.5.  
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Table 4.5.  Overseas PCV strains used for phylogenetic analysis. 
 
Accession number  Country of origin  Disease association  Year isolated 
PCV1 strains 
AF071879  Canada   From PK-15 cells  1998 
AY193712  China   From PK-15 cells  2003 
PCCOMGEN  Germany PK-15  From PK-15 cells  1996 
PCU49186  Ireland   From PK-15 cells  1997 
AY184287  USA   From PK-15 cells  2003 
AF012107  France   PMWS-like disease  1997 
AY219836 Taiwan   Unknown  2003 
AY099501 USA    CT  1960s 
PCV2 strains 
AY424401 Austria  (1)  PMWS  2003 
AF117753 Canada  (1)  Unknown  1999 
AF109398  Canada (2)  Unspecified clinical syndrome  1998 
AF055392 Canada  (3)  PMWS  1998 
AF118097 Canada  (4)  PMWS  2000 
AF408635  Canada (5)  CPE in cell culture  2001 
AF381177  China (1)  Unspecified clinical syndrome  2001 
AF381175  China (2)  Unspecified clinical syndrome  2001 
AY181946 China  (3)  PMWS  2002 
AY181947 China  (4)  PMWS  2002 
AY181945 China  (5)  PDNS  2002 
AF055394 France  (1)  PMWS  1998 
AF201311 France  (2)  PMWS  1999 
AY321993 France  (3)  Unknown  2003 
AF201307 Germany  (1)  PMWS  1999 
AY256459 Hungary  (1)  PMWS  2003 
AY256455 Hungary  (2)  PDNS  2003 
AB072302 Japan  (1)  PMWS  2001 
AB072303 Japan  (2)  PMWS  2001 
AF520783 Korea  (1)  PDNS  2002 
AF544024 Korea  (2)  Unknown  2002 
AF201897 Netherlands  (1)  PMWS  1999 
AF201309 Spain  (1)  PMWS  2000 
AY325495  South Africa (1)  PMWS  2003 
AF166528  Taiwan (1)  Unspecified clinical syndrome  1999 
AY146991  Taiwan (2)  Unspecified clinical syndrome  2002 
AY180397  Taiwan (3)  Unspecified clinical syndrome  2002 
AF364094 Taiwan  (4)  Unknown  2001 
AJ293869  UK (1)  PDNS, abortion  2000 
AF055391 USA  (1) PMWS  1998 
AF147751 USA  (2) Unknown  1999 
AF264039 USA  (3) PMWS  2000 
AY099500 USA  (4) CT  2002 
AY099497 USA  (5) PMWS  2002   81 
 
Sequence alignments were obtained using the ClustalW program.  The Seqboot 
program (1000 datasets) was used for bootstrap resampling, before the DNAdist, 
Fitch, and Consense programs (Felsenstein, 1989) were used to obtain a consensus 
tree diagram.  This diagram was visualised and edited using Treeview (Page, 1996). 
Results 
Sequence analysis of Australian PCV1 strains 
The full genomes of 3 Australian strains of PCV1were successfully sequenced, as 
was the PCV1 strain persistently infecting the PK-15 cell line. 
The 3 PCV1 strains were either 1759 nt (Farm D WA) or 1760 nt (Farm C WA, Farm 
A NSW) in length.  The 3 strains shared 98-99% nucleotide identity to each other and 
98-99% nucleotide identity to the other overseas PCV1 sequences used for 
comparison.  A potential stem-loop structure was identified in all 3 sequences, with 
the sequence TAGTATTAC.  Four potential ORFs with the ability to encode proteins 
longer than 80 amino acids were consistently identified in each strain, including the 
putative replication-associated (Rep) protein (nt 46–985) and capsid protein (nt 
1724–1023).  Two other minor ORFs were also identified in each strain, both on the 
complementary DNA strand (nt 658–46 and nt 552–205 (the nt locations were 
calculated based on the PCV sequence beginning at the stem-loop sequence 
ACCA).   
An unrooted phylogenetic tree was constructed based on the nucleotide sequences 
of the 4 Australian strains (including the Australian PK-15 sequence) plus 8 other 
PCV1 sequences available on GenBank and NCBI (Figure 4.1).  The PCV1 strains 
examined appeared to be divided into 3 clusters, the first containing PK-15 cell 
culture strains from Germany, Australia and the USA, the second containing field 
strains from Australia, the USA and France and the third containing the remaining 
PK-15 strains and the Taiwanese field strain.  The 3 Australian field strains did not 
cluster together in a distinct branch.  
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Figure 4.1.  Unrooted phylogenetic tree based on the complete nt sequence of PCV1 strains.  
Sequence accession numbers are given in Table 4.4.  The bar represents a 1% difference in 
nucleotide homology between 2 sequences. 
 
Sequence analysis of Australian PCV2 strains 
The complete genomes of 7 Australian strains of PCV2 were sequenced.  All 7 were 
1768 nt in length.  The 7 strains shared 95-99% nucleotide identity to each other and 
94-99% identity to overseas PCV2 strains.  The total nucleotide sequence variation 
between all 41 PCV2 sequences (from Australia and overseas) was 93-99%.  A 
potential stem-loop structure was identified in all 7 Australian sequences, with the 
sequence AAGTATTAC.  Three potential ORFs with proteins longer than 80 amino 
acids were consistently identified in each strain, including the putative replication-
associated (Rep) protein (nt 51–995) and capsid protein (nt 1735–1034).  One other 
minor ORF was also identified for each strain, located on the complementary DNA 
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strand (nt 671–357).  The strain from Farm C WA had 4 potential ORFs, the 3 
described above plus one other potential ORF on the positive DNA strand (nt 1016–
1363).  
An unrooted phylogenetic tree was constructed based on the nucleotide sequences 
of the 7 Australian strains plus 34 other PCV2 sequences available on GenBank and 
NCBI (Figure 4.2).  Phylogenetic analysis of the 41 PCV2 strains showed most of the 
PCV2 strains clustered into 5 genetic groups.  The first group contained all the 
Australian strains except Farm C WA, plus Japan (1), Canada (1) and Canada (3).  
The second group contained all 3 French strains, plus China (3), China (4) and China 
(5), Netherlands (1) and UK (1).  The third group contained all 4 Taiwanese strains.  
The fourth group contained the 2 Hungarian strains plus Spain (1), and the fifth and 
largest group contained all the USA strains, both the Korean strains, Canada (2), 
Canada (4) and Canada (5), Farm C WA, Japan (2), China (1) and (2), and South 
Africa (1).  The Germany (1) and Austria (1) strains did not cluster with any particular 
group.   
Amino acid variation and motifs in PCV1 and PCV2 
Variable and conserved areas were identified in the aligned ORF2 amino acid 
sequences of the Australian and overseas PCV1 and PCV2 strains.  In PCV2, amino 
acids 137-177 were highly conserved in all 41 strains (95-100% similarity, or a 
maximum of 2 amino acid changes) while amino acids 72-92 were much more 
variable (57-100% similarity, or a maximum of 9 amino acid changes).  In all strains 
of PCV1, amino acids 137-177 were also conserved (95-100% similarity or a 
maximum of 2 amino acid changes) as were all the PCV1 ORF2 amino acid 
sequences with the exception of the region between amino acids 51-74 (73-100% 
similarity, or a maximum of 6 amino acid changes). 
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Figure 4.2.  Unrooted phylogenetic tree based on complete nt sequences of PCV2 strains.  
Sequence accession numbers are given in Table 4.4.  The bar represents a 1% difference in 
nucleotide homology between 2 sequences. 
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Discussion 
The Australian PCV1 strains were very similar to each other and to the reported 
sequence of other strains of PCV1.  The 3 Australian strains were 1759 nt (Farm D 
WA) or 1760 nt (strains Farm C WA and Farm A NSW) in length, and shared 98-99% 
nucleotide identity with each other and 98-99% nucleotide identity with overseas 
strains of PCV1.  Likewise, the 7 Australian PCV2 strains were all 1768 nt in length, 
and very similar to each other.  They shared 95-99% nucleotide identity with each 
other and 94-99% identity to overseas PCV2 strains.  The total nucleotide sequence 
variation between all 41 PCV2 sequences from Australia and overseas was 93-99%.  
All PCV sequences had higher nt variability in the ORF2 than ORF1 as has been 
previously reported (Fenaux et al., 2000; Larochelle et al., 2002).   
The intergenic region between ORF1 and ORF2 was between 38 (PCV1) and 39 
(PCV2) nt in length.  This region was 100% conserved in all PCV1 sequences 
examined except for a 1 nt insertion at nt 949 in strains WA C and NSW A.  The 41 
PCV2 strains were found to have 97-100% nt conservation in this area, with several 
strains having a maximum of 1 nt change only.  This high conservation may indicate 
a possible regulatory function of this area, and it has been speculated that disruption 
of this intergenic region may affect the stability and viability of PCV2 (Cheung, 2004).  
When subjected to phylogenetic analysis, the 12 PCV1 strains for which sequence 
data was available separated into 3 clusters, the first containing the same PK-15 cell 
culture strain but sequenced in Germany, Australia and the USA, the second 
containing field strains from Australia, the USA and France and the third containing 
the remaining sequences of the PK-15 strain and a Taiwanese field strain (Figure 
4.1).  As all 12 PCV1 strains analysed shared 98-99 % nt identity, the phylogenetic 
clusters were based on a very small number of nucleotide changes and therefore this 
division into clusters could be artificial.   
When the nucleotide and amino acid sequences from all the PCV1 sequences were 
aligned (data not shown), there were only 4 nucleotide positions where bases from 
the 3 clusters were consistently different: at nt positions 1028 (T Æ C), 1044 (T Æ C), 
1197 (G Æ C) and 1538 (A Æ G).  All these changes are located in ORF2.  When 
ORF2 was translated, 3 of these base changes were translated to amino acid 
changes, at amino acid positions 63 (Y or F Æ H, from nt change at 1538), 176 (H Æ 
Q, from nt change at 1197), and 233 (K Æ E, from nt change at 1028).  The change 
at amino acid 176 is located on an immunorelevant epitope identified by Mahe et al. 
(2000). 
While both PCV1 and PCV2 have been identified in the tissues of pigs with CT type   86 
A2 (Stevenson et al., 2001; Choi et al., 2002), PCV has not been detected in other 
CT pigs (Kennedy et al., 2003; Ha et al., 2005).  The PCV1 detected in the neural 
tissue of 2 pigs in one outbreak of CT (Chapter 3) did not differ from the other PCV1 
strains, which suggest that these outbreaks of CT were not associated with a unique 
genotype of PCV1.  The CT-associated PCV1 strains differed in only 9 nt positions 
(resulting in 3 amino acid differences) from the strain identified in a CT outbreak in 
the 1960s (USA (1)).   
The 6 different analyses by different groups of the sequence of the PCV1 present in 
the PK-15 cell line were all very similar and the differences could represent 
sequencing errors, although minor nt changes with time in culture may have 
occurred.  Although the data is limited to only a few strains of PCV1, it is apparent 
that PCV1 appears to have changed very little in culture and in the pig population 
over a 40 year period.   
Seven Australian PCV2 strains were sequenced, 3 from WA and 2 each from NSW 
and Qld.  When subjected to phylogenetic analysis, these strains and the other PCV2 
strains used for the phylogenetic analysis separated into 5 major clusters, with all but 
one of the Australian strains appearing closely related (Figure 4.2).  None of the 
PCV2 strains, Australian or international, clustered according to time of detection 
(from 1998 to 2003) or disease condition (PMWS, PDNS or CT).  This conclusion is 
in agreement with previous phylogenetic studies of PCV2 (Choi et al., 2002; Fenaux 
et al., 2000; Larochelle et al., 2002) and indicates that the same or genetically similar 
forms of PCV2 are associated with the variety of diseases identified as possibly 
caused by PCV2.  While viral genetic variation may be responsible for differences in 
pathogenicity and virulence of other viruses, such as chicken anaemia virus 
(Yamaguchi et al., 2001), herpes simplex virus (Griffiths and Coen, 2003) and white 
spot bacilliform virus (Lan et al., 2002), this does not appear to be the case with PCV.  
Some PCV2 strains appeared to cluster according to geographic origin, particularly 
the Taiwanese and French strains, but other PCV2 strains, from geographically 
distinct areas such as Japan, China, the USA and Australia were closely related.  
One of the Australian strains (Farm C WA) which differed from the other Australian 
strains appeared to be most closely related to a Japanese strain (Japan 2) and a 
Chinese strain (China 2), while the remaining Australian strains were most closely 
related to another Japanese strain (Japan 1) and a Canadian strain (Canada 1).  It is 
possible that PCV2 may have travelled from Asia and North America to Australia or 
vice versa, or this result may just reflect the genetic diversity of PCV2 strains found 
worldwide, with the country of origin being incidental.     87 
Nucleotide variations are significant in terms of their potential to cause amino acid 
changes which can affect function and antigenicity of individual virus proteins.   
Larochelle  et al. (2002) identified 3 main regions of amino acid heterogeneity in 
PCV2 strains on ORF2, between amino acids 59-80, 121-136 and 180-191, the first 2 
of these regions also being dominant immuno-reactive areas (Mahe et al., 2000).  
Variation at these sites could result in variability of regions at the external surface of 
the capsid protein, possibly affecting immune recognition (de Boisseson et al., 2004).  
These areas could be involved in the development of PCV2 variants and potential 
changes in pathogenicity (Larochelle et al., 2000).  In the Australian and overseas 
PCV2 ORF2 strains these 3 amino acid regions displayed some variation but were 
not as variable as the region between amino acids 72-92.  The region from amino 
acids 137-77 is well conserved between PCV1 and PCV2 strains, suggesting that it 
may be a possible key region for virus–host interactions or
 virus assembly, such as 
receptor binding or interactions between
  capsid monomers (de Boisseson et al., 
2004), and it is therefore not surprising that very little variation was found in this 
region. 
Amino acid motifs previously identified as being important for nuclear localisation and 
potential posttranslational modification sites (Liu et al., 2001) were present and 
generally well conserved in the Australian and overseas strains, and 2 amino acid 
mutations which contribute to the possible enhancement of PCV2 replication in vitro 
and the attenuation of the virus in vivo (Fenaux et al., 2004b) were unchanged in the 
Australian PCV2 sequences. 
Although 4 of the Australian PCV2 strains (Farm C WA, Farm A WA, Farm B NSW 
and Farm B WA) possessed unique amino acid point mutations, the 7 Australian 
strains did not consistently contain any unique amino acid changes in either ORF1 or 
ORF2 when compared to the 35 overseas strains.  The Farm C WA strain was 
genetically different to the other 6 other Australian PCV2 strains, which appeared 
closely related to a Japanese strain associated with PMWS (Figure 4.2), but the 
significance of this is unknown although no particular unique motifs were identified in 
this strains.  Viral virulence determinants may be multigenic (Larochelle et al., 2002), 
so it is possible that other gene regions may be involved in PCV pathogenicity.   
However, as a genetic basis for PCV2 pathogenicity has not been identified (Choi et 
al., 2002; Larochelle et al., 2002).  It appears likely that non-genetic factors are more 
likely responsible for absence of any confirmed PCV-associated disease.   
Despite Australia being an isolated country, the Australian strains of PCV seem to be 
essentially indistinguishable to overseas strains.  Clearly, both PCV1 and PCV2 are   88 
highly conserved all over the world.  This is in agreement with previous observations 
that the degree of conservation in PCV2 is very high, considering the large range of 
their
  geographical origins and the general prevalence of the virus in pig herds 
worldwide (de Boisseson et al., 2004).  The similarity of all strains sequenced so far 
would suggest that viral mutations are rare and that PCV has evolved and continues 
to evolve very slowly.   
PCV infections are often persistent and the persistent infection of animals by PCV 
and many other small DNA viruses may help to confer genome stability by 
maintaining viral genotypes in host populations (Shadan and Villarreal, 1993).  Like 
other readily transmitted and environmentally resistant viruses such as the influenza 
viruses (Ina and Gojobori, 1994) and picornaviruses (Saiz et al., 1993), PCV is 
probably able to spread rapidly across and between geographic regions, resulting in 
similar strains of the virus being found worldwide.  
The genetic stability of PCV may also be partly due to the low error rate in the 
transcription process.  The replication of small DNA viruses is thought to linked to the 
host cell metabolic machinery, and that this is associated with low-error and species-
specific replication (Eki et al., 1991).  DNA viruses such as circoviruses which 
replicate using a DNA polymerase of the host cell (Todd et al., 2001), are assumed to 
have mutation rates similar to those of the host DNA, usually somewhere in the 
vicinity of 10
-8 to 10
-9 nucleotide changes per replication (Shadan and Villarreal, 
1993).  The newly-identified starling circovirus (StCV) has undergone co-evolution 
with its avian host, demonstrated by phylogenetic analysis of the virus and the 
starling cytochrome b gene (Johne et al., 2006).   
The reliance of small DNA viruses on the host cell for replication has probably 
allowed host-pathogen co-evolution and co-speciation (Shadan and Villarreal, 1993).  
If PCV and pigs have shared a long co-evolutionary history, this may explain why 
strains of PCV do not appear to group phylogenetically according to the country of 
origin, as the infection of modern pigs with PCV may predate the current isolation of 
pig herds according to country and breed.  If this is the case, the high conservation of 
the PCV genome could also be connected with the long term evolutionary history of 
the pig host.  Genetic bottlenecks could therefore have limited the number of 
individual hosts that were available to maintain the strain, and could lead to the 
extinction of rare and/or divergent forms of a virus (Stewart et al., 1996). The 
relationship between humans and human papillomavirus (HPV) is an example of this 
effect, with the pattern of HPV variation indicative of a severe host bottleneck, then 
subsequent expansion, resulting in widespread extinction of most ancestral forms of   89 
HPV, and the modern-day separation of HPV into discrete viral types with some 
variation within each type (Stewart et al., 1996).   
As suggested by de Boisseson et al. (2004), PCV might also have been subjected to 
one or more genetic bottlenecks, possibly linked to the history of the modern pig.  
Many modern pig breeds are ‘hybrids’ of Asian and European ancestors, and 
subspecies of European wild pigs and South-East Asian pigs are thought to be the 
main contributors to the genetics of modern pigs (Clutton-Brock, 1987; Giuffra et al., 
2000).  Currently recognised pig breeds group into one of 2 clusters, an Asian cluster 
or a European cluster (Giuffra et al., 2000; Kim et al., 2002).  Molecular
 evidence 
suggests that the domestication of the pig occurred approximately 9000 years ago, 
and there was a massive introduction of Asian
 pigs into European breeds during the 
18th and 19th centuries
 (Giuffra et al., 2000).  There is very little genetic variation 
between individual pig breeds, in contrast to other domestic animals such as horses 
where much larger variations between breeds and between individual animals are 
found (Kim et al., 1999).  There is also evidence of genetic bottlenecks within the 
Asian and European groups, with some groups of breeds possibly descended from a 
single ancestor.  This limited genetic diversity and the possibility of common ancestry 
both between and within the Asian and European pig lineages could partially explain 
why PCV is so homogenous.  Maybe current strains of PCV are descended from a 
very few viral forms circulating in a small number of ancestors to the modern pig, 
assuming that the virus has been infecting pigs before the Asian and European pig 
groups diverged (Kim et al., 2002).  A phylogenetic study of French PCV2 suggested 
that the very close relationship shared by most French PCV2 strains could be 
indicative of their derivation
 from a very restricted genetic pool of PCV2 disseminated 
throughout
  the country, with variant strains possibly associated with multiple 
introductions of PCV2 into France (de Boisseson et al., 2004).  The close similarity of 
6 of the 7 Australian strains could also be due divergence from a restricted genetic 
pool, and the genetically different seventh strain (Farm C WA) may have been due to 
a more recent introduction of PCV2 into Australia.   
Genetic bottleneck events may also explain why there are no PCV types intermediate 
between PCV1 and PCV2.  PCV1 and PCV2 are likely to have evolved from a 
common ancestor (Fenaux et al., 2000) but recent divergence from the 2 types has 
not occurred (Choi et al., 2002).  The occurrence of the 2 discrete PCV types may 
indicate a genetic bottleneck in the host with subsequent expansion, and the loss of 
ancestral intermediate viral forms, as is suggested for HPV (Stewart et al., 1996).  
Alternatively, it is possible that each PCV type may have evolved separately in either   90 
European or Asian-origin breeds for many thousands of years after divergence of the 
two pig genetic groups.  
The theory of PCV diversity being constrained by the genetic history of pigs relies on 
PCV only infecting pigs, with no other animal species acting as a reservoir.  Indeed, 
cross-species transmission of PCV1 or PCV2 has never been demonstrated to occur 
under natural conditions.  Although there was one report of PCV2 in cattle (Nayar et 
al., 1999) this has not been confirmed by other investigators.  There is no evidence 
that recombination between PCV isolates is a common event, indeed it is very 
unusual to find more than one isolate of PCV2 infecting one pig at the same time (de 
Boisseson et al., 2004). This is in contrast to the highly variable TTV that has cross-
infected other primates such as apes, old world primates, new world primates and 
the tree shrew (the most divergent primate) (Simmonds, 2002; Thom et al., 2003).  
Non-human primates seem to be infected by a range of TTV and TTV-like viruses, 
some of which are also capable of infecting humans (Simmonds, 2002) and mixed 
infections with multiple TTV genotypes is a frequent occurrence (Simmonds 2002) 
and the chance of recombination between TTV strains is high.   
Due to poor and incomplete records, it is not certain how pigs were first introduced to 
Australia.  There are records of pig introductions with the first European settlement of 
Sydney in 1788 (Tisdell, 1982), as well as smaller introductions of pigs from Timor in 
1827 to the Northern Territory, from New Guinea into North Queensland before 1900, 
from the Indonesian Island of Kisar to the Northern Territory in 1838 (Letts, 1962).  It 
is also possible that small numbers of pigs were brought to Australia by the Chinese 
during the gold rush (Pullar, 1950).  Genetic evidence has also been found 
suggesting a relatively recent introduction of Asian pigs into the Northern Australian 
feral pig herd, possibly from the release of Asian pigs during early settlement, or 
alternatively Asian pigs may have been traded by early Asian traders with indigenous 
Australians (Gongora et al., 2004).  PCV is known to infect wild boar populations 
(Schulze et al., 2004; Ellis et al., 2003; Toplak et al., 2004), and PCV2 found in wild 
boars is very similar in sequence to other isolates found in domestic pigs (Toplak et 
al., 2004).  Therefore multiple introductions of pigs into Australia from Asia and 
Europe may be responsible for variety of PCV2 isolates found in this study, in 
particular the divergence of the Australian PCV2 isolate Farm C from the other six 
isolates sequenced (Figure 2).  It was not determined in this study whether Australian 
wild boars are infected with PCV, however it seems likely. Interestingly, a Slovenian 
study of PCV2 infecting wild boars found very high sequence diversity between 
PCV2 isolates within a small region, suggesting that PCV2 may have been infecting   91 
these feral populations over a long period of time, or that the virus may have been 
introduced into Slovenian wild pigs several times (Toplak et al., 2004).  A large-scale 
sequencing survey conducted on feral and domestic pigs would be required to test 
the theory that there are many different types of PCV2 circulating in Australia, as 
appears to be the case in Canada, the USA and China (Figure 2).    92 
CHAPTER 5.  THERMAL STABILITY OF PCV2 IN CELL CULTURE 
Summary 
To enable an investigation of the thermal stability of porcine circovirus type 2 (PCV2), 
an Australian strain of PCV2 was successfully adapted to replicate in the PK-15 pig 
kidney cell line.  To quantitate the virus in cell culture, an immunoperoxidase 
monolayer assay (IPMA) was developed using a monoclonal developed in this 
laboratory against the recombinant PCV2 capsid protein, and compared to detection 
using a previously published RT-PCR procedure to detect viral RNA transcripts.  The 
IPMA was used to investigate the thermal stability of Australian PCV2, where it was 
found that the virus was able to tolerate heating at 56°C, 65°C and 70°C for 15 
minutes with no apparent loss of infectivity, with partial loss of infectivity at 85°C for 
15 min, but was completely inactivated when heated at 95°C for 15 min. 
Introduction 
PCV1 and PCV2 are able to be cultured in variety of cell lines, both porcine and 
other, usually with no cytopathic effect observed (Tischer et al., 1982; Allan et al., 
1994b; McNeilly et al., 1996; Allan et al., 1994c; Harms et al., 2001; Cheung and 
Bolin, 2002; Meerts et al., 2005).  One study found evidence of PCV2-mediated 
apoptosis in PK-15 cells (Liu et al., 2005), and although some CPE was also 
observed after the infection of PCV2 into human Rd cells (Hattermann et al., 2004) 
this has not been confirmed.  PCV1 has also been reported to cause some 
ultrastructural alterations in human mononuclear cells, although cell death was not 
observed (Arteaga-Troncoso et al., 2005).  Due to the general absence of a 
cytopathic effect in cell culture, other methods are required to detect PCV infection 
and replication in vitro.  PCR detects viral genetic material, but will not discriminate 
between live and inactivated virus.  Immunofluorescence assays (IFA) with antisera 
to whole virus may also be used, but this technique is time-consuming and prone to 
cross-reaction between PCV types (Dulac and Afshar, 1989; Allan et al., 1998).   
Immunoperoxidase assays based on the use of monoclonal antibody against the 
capsid protein (IPMA) are commonly used for the detection of PCV in cell culture 
(Dulac and Afshar 1989; Harms et al., 2001; Gilpin et al., 2003; Meerts et al., 2005; 
Emmoth et al., 2004) and allow visualisation of antigen within infected cells and are 
specific for each PCV type.  Reverse transcription PCR (RT-PCR) assays are also 
useful as they detect viral RNA transcripts and can therefore differentiate between 
replicating and inactivated virus.  The assays used to detect replicating virus and to 
quantitate infectious virus and reported in this Chapter were a PCV2-specific IPMA 
based on a monoclonal antibody produced at Murdoch University against a   93 
recombinant capsid protein of PCV2 and a previously published RT-PCR (Yu et al., 
2005).  
While sequence analysis of Australian strains of PCV2 (reported in Chapter 4) failed 
to detect differences in these strains from those associated elsewhere with 
postweaning multisystemic wasting disease (PMWS), the possibility that there may 
be unrecognised biotypes that could be imported into Australia and cause PMWS 
exists and has not been refuted scientifically.  Amid considerable controversy, 
Australia has maintained restrictions on the importation of pig meat from other 
countries, requiring that all pig meat products be cooked at a temperature of 70°C for 
11 minutes before distribution and sale in Australia, conditions based on inactivation 
data for PRRSV (Australian IRA for pig meat, 2004).  
The aim of the studies reported in this Chapter were to examine the thermal stability 
of PCV2 to determine if the virus would indeed survive at the temperatures required 
for the heat treatment (cooking) of pork meat prior to distribution within Australia.  For 
this, it was required to adapt an Australian strain of PCV2 to replicate in cell culture, 
to develop a method of titrating viable virus in the culture, and to determine the effect 
of a variety of heat treatments on the viability of the virus.   
Materials and Methods 
Cell cultures 
PCV-free PK-15 cells (PK-15A) were obtained from Mr Chris Morrissey (Australian 
Animal Health Laboratory, Geelong).  This cell line was cultured in vitro in 25 cm
2 
tissue culture flasks (Nunc) at 37°C in a 7% CO2-in-air atmosphere.  When confluent 
monolayers were formed, the medium was removed from the culture flask and the 
cells washed in 2 mL phosphate buffered saline (PBS).  The PBS was removed and 
discarded and cells were then treated with 0.5 mL trypsin solution (NaCl 80 g L
-1, KCl 
4 g L
-1, glucose 10 g L
-1, NaHCO3 6 g L
-1, trypsin (Difco 1:250) 5 g L
-1, 
ethylenediaminetetra-acetic acid (EDTA) 2 g L
-1, phenol red [1%] 4 mL, dH2O to 1L) 
for 10-15 min at 37°C.  Cells were then suspended in 14 mL of Dulbecco’s modified 
Eagle’s medium (DMEM; Thermo) supplemented with amphotericin B (2.5 μg mL
-1), 
penicillin (100 units mL
-1), streptomycin (100 μg mL
-1), gentamycin (4 μg mL
-1) and 
4% (v/v) newborn calf serum.  Aliquots of 7 mL were dispensed into 25 cm
2 sterile 
tissue culture flasks and incubated at 37°C in 7% CO2-in-air atmosphere.   
PCV2 infection of cell cultures 
Approximately 0.2 g of liver or lung tissue from a pig from Farm C in Western 
Australia infected with PCV2 and detected by multiplex PCR as previously described 
(Chapter 3) was frozen, then ground in 1 mL of semi-frozen media using a cold   94 
mortar and pestle.  The resulting mixture was frozen and thawed, before being mixed 
with 1 mL of trypsinised PCV-free cells (containing approximately 3.1 x 10
6 cells).  
The cells were incubated at 37
oC on a rocker for 2 h, washed 3 times with PBS, 
divided into 2 aliquots and each suspended in 7 mL of DMEM supplemented with 4% 
newborn calf sera and incubated overnight at 37°C in 7% CO2-in-air atmosphere.  
When the cells were 80% confluent they were treated with D-glucosamine HCl 
(Sigma) prepared as a 300 mM solution in Hank’s salt solution (ICN Biomedicals) 
and stored at –20
oC until required.  For treatment with glucosamine, infected and 
control cells were washed, trypsinised and pelleted at 300 rpm, before being 
resuspended in 500 μL 300 mM glucosamine solution at 37
oC for 45 min.  Following 
incubation, the cells were pelleted at 300 rpm, resuspended in DMEM growth 
medium, split 1:2, dispensed into 25 cm
2 flasks and left for at least 4 days at 37°C in 
7% CO2-in-air atmosphere. 
Infected cells were passaged either in the conventional manner, as outlined above, 
or by freeze-thawing.  To passage by freeze-thawing, cells were washed, trypsinised 
and resuspended in 0.5 mL of DMEM growth medium.  The resulting mixture was 
freeze-thawed 5 times and used to infect fresh PK-15 cells using the same method 
outlined above for the initial PCV infection. 
To enhance PCV2 infection and replication in culture, a technique described by Allan 
et al. (1998) designated “superinfection” was used.  Briefly, infected cells were split 
into 2 flasks, one flask was freeze-thawed and used to re-infect the other.  These 
super-infected cells were then incubated at 37°C in 7% CO2-in-air atmosphere and 
treated with glucosamine when 80% confluent as described earlier. 
Thermal stability of virus 
An Australian PCV2 isolate (Farm C WA) inoculated into cells using the methods 
described above, was detected in the cells by PCR and IPMA.  After the virus was 
passaged in culture 3 times, the infected cells were freeze-thawed and the resulting 
virus-cell suspension divided into 1 mL aliquots for use in PCV2 thermal stability 
assays.   
Each 1 mL of virus suspension in thin-walled glass tubes was heated at 56
oC, 65
oC, 
70
oC, 75
oC, 85
oC or 95
oC in a heated water bath.  Positive and negative controls 
were kept at room temperature (about 23
oC).  After treatment, the virus suspensions 
were immediately chilled on ice and used to infect PCV-free PK-15 cells in 25 cm
2 
culture flasks, one flask for each temperature.  After infection, the cells were left for at 
least 24 h then treated with 500 μl glucosamine by removing the medium from each 
flask and washing the cells in 2 mL PBS.  The PBS was then removed and 500 μL   95 
mL 300mM D-glucosamine was added to each flask, before incubation for 30 min at 
37°C in 7% CO2-in-air atmosphere.  The glucosamine was then removed and the 
cells were washed twice with 2 mL PBS for 5 min each time.  Following the addition 
of 5 mL of growth media to each flask, cells were incubated for at least 7 days.  The 
cultures were tested for the presence of PCV2 by IPMA.   
DNA and RNA extraction 
Viral DNA was extracted from approximately 3.1 x 10
6 cultured PK-15 cells using a 
DNeasy tissue kit (QIAGEN) using the methods described by the manufacturer, with 
the exception that DNA was eluted in 100 μL of elution buffer instead of the 
recommended 200 μL.   
Viral RNA was extracted from approximately 3.1 x 10
6 cultured PK-15 cells using a 
RNeasy mini kit (QIAGEN) according to the manufacturer’s instructions.   
PCR 
PCR primers for detecting PCV2 in vitro (PCV2 5`F and PCV2 5`R) were based on 
the sequence of the isolate (FC-WA) that was used to infect the cell cultures and are 
shown in Table 5.1.   
 
Table 5.1.  PCR primers used to detect Australian PCV2 in vitro 
Primer  Sequence 
Position in 
genome 
PCV2 5`F  5`-TGGAAAGCTTGAGATTTAATATTGACGACT-3`  1451 – 1480 
PCV2 5`R  5`-GTGAGGTACCGGGAGTGTTAGGA-3`  1201 – 1223 
 
PCR assays were performed in a 25 μL reaction mixture consisting of 3 μL 
extracted sample DNA, 1X PCR reaction buffer with 2 mM MgCl2 (Roche), 1 mM 
each dNTPs, 6.4 pmol each primer and 1.16 U Expand high-fidelity DNA 
polymerase (Roche).  Amplification was performed with an initial denaturation step 
of 5 min, followed by 35 cycles of amplification (95
oC for 1 min, 57
oC for 1 min, 
72
oC for 2 min), with a final extension step of 72
oC for 7 min.  PCR products were 
electrophoresed in a 2% agarose gel at 80 V for 1 h and visualised using an ultra-
violet transilluminator (UVP). 
RT-PCR 
The RT-PCR used to detect PCV2 in cultured cells was based on the test 
developed by Yu et al. (2005) with the primers modified slightly (Table 2) to detect 
the Australian strain (Farm C WA) that had been adapted to replicate in cell   96 
culture. 
 
   
 
Table 5.2.  RT-PCR primers used to detect Australian FC-WA strain of PCV2 in cell culture. 
Primer Sequence 
Position in 
genome 
CapF014  5`- GGAGTCAAGAACAGGTTTGGGTG  -3`  1229 - 1251 
CapR014  5`- AGACTCCCGCTCTCCAACAAG -3`  425 - 445 
 
RT-PCR assays were performed using a Superscript II kit (Invitrogen).  Extracted 
RNA was diluted 1:10 with DEPC water and 1 μL added to a reaction mixture with 1 
μL oligo DT(12-18) (Invitrogen), 10 mM each dNTP (Invitrogen) and 7 μL DEPC water.  
Following incubation at 65
oC for 5 min, samples were place on ice for 1 min.  The 10 
μL reaction was added to a prepared mixture with 1X RT buffer (Invitrogen), 25mM 
MgCl2 (Applied Biosystems), 0.1 M DTT, 1 μL 40 U/μL RNase OUT (Invitrogen), 1 μL 
50U/mL Superscript II (Invitrogen) except for the –RT control sample, and DEPC 
water to a total of 20 μL.  Following incubation at 50
oC for 50 min, the reaction was 
terminated by incubation at 85
oC for 5 min and then chilled on ice.  After the addition 
of 1 μL RNase H (Invitrogen) to each sample, tubes were incubated at 37
oC for 20 
min.  Two μL of the resulting cDNA was added to a PCR mix with 10X PCR buffer 
(Applied Biosystems), 5 mM MgCl2 (Applied Biosystems), 10 mM each dNTPs 
(Invitrogen), 3.2 pmol of each primer (CapF014 and CapR014), 0.1 μL Taq 
polymerase (Applied Biosystems) and DEPC water to 50 μL.  Amplification was 
performed with an initial denaturation step of 5 min, followed by 35 cycles of 
amplification (95
oC for 1 min, 64
oC for 1 min, 72
oC for 2 min), with a final extension 
step of 72
oC for 7 min.  PCR products were electrophoresed in a 2% agarose gel at 
80 V for 1 h and visualised using an ultra-violet transilluminator (UVP). 
IPMA 
PCV2-infected and uninfected PK-15A control cells were grown in 8-chambered 
culture slides (BD Biosciences).  When the monolayers were confluent, the medium 
was removed from the slides and the cells washed with PBS.  The cells were fixed 
using cold acetone for 10 min, washed 3 times in PBS and blocked using NBCS in 
PBS (1:5) at room temperature.  Excess blocking solution was removed and then   97 
reacted with a PCV2 monoclonal antibody prepared against a recombinant PCV2 
capsid protein (mAb) diluted 1:1,000 in 10% NBCS in PBS for 1h at room 
temperature.  Slides were washed 3 times in PBS and a biotinylated secondary anti-
mouse (DakoCytomation LSAB 2 System-HRP) was applied for 10 min at room 
temperature.  Slides were washed 3 times in PBS and a streptavidin-HRP conjugate 
(DakoCytomation) was applied for 10 min at room temperature.  Slides were washed 
a further 3 times in PBS and cells were stained with DAB (DakoCytomation) for 5 min 
at room temperature.  Slides were finally washed 3 times with distilled water and cells 
were counterstained with haematoxylin.  After dehydration with 100% ethanol, cells 
were mounted in permanent mounting medium (DPX) and examined by light 
microscopy. 
As a control, the IPMA was performed on both fixed cultured PK-15 cells and 
tissue sections originating from New Zealand and French pigs with PMWS.  When 
using the IPMA to detect PCV2 in fixed tissues, sections were deparaffinised and 
rehydrated as described by Lillie (1965), washed with PBS then processed in the 
same way as the fixed cultured cell monolayers. 
Titration of PCV2 in cell culture 
Ten-fold dilutions of freeze-thawed cell cultures were serially diluted up to 10
-5 and 
used to infect PCV-free PK-15 cells as described above.  When the infected cells 
were confluent, IPMA was used to detect PCV2 infection and an approximate viral 
titre.  An approximate titre was determined as the highest dilution producing a 
positive IPMA result in cell culture. 
Results 
Inoculation of PCV2 into cell culture 
PCV2 was successfully inoculated into cell culture and was detected using PCR 
(Figure 5.1) and subsequently RT-PCR (Figure 5.2) and IPMA (Figure 5.3).  The 
IPMA developed with the mAb against the capsid protein of PCV2 detected PCV2 
in both cultured PK-15 cells (Figure 5.3) and in tissues originating from PMWS-
affected pigs from New Zealand (Figure 5.4) and France (Figure 5.5).  PCV2-
specific staining was mostly observed in the nucleus, with occasional cytoplasmic 
staining.  To ensure no cross-reaction of the IPMA with PCV1, the PK-15 
persistently PCV1-infected cell line was also tested and no staining was observed.   
Viral infection was monitored by PCR for 26 passages, and the cell cultures 
remained PCR positive throughout.  Using titration based on IPMA, the titre was 
found to be approximately 1x10
3 virus particles per mL of infectious material after 
superinfection was adopted.  Superinfection, or re-infecting PCV2-positive cells using   98 
previously freeze-thawed cultures, was very successful, increasing the number of 
positive cells observed by IPMA from below 10 per slide chamber to approximately 5-
10% of cells (Figure 5.3).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1.  Detection of PCV2 DNA in PK-15 cell culture by PCR. Lane 1, 100 bp 
molecular weight marker (Lifetech); lane 2, negative PCR control; lane 3, FCWA PCV2 
positive cell cultrue sample. The size of the bands in the DNA ladder is indicated on the 
left, and the expected size of the PCR product on the right. 
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Figure 5.2.  Detection of PCV2 replication in PK-15 cell culture by RT-PCR. Lane 1, 1 kb 
plus molecular weight marker (Promega); lane 2, FCWA DNA extraction from tissue; lane 
3, negative PCR control; lane 4, negative cell culture control; lane 5, FCWA PCV2 positive 
cell culture sample, lane 6, FCWA PCV2 positive cell culture sample diluted 1:10. The size 
of the bands in the DNA ladder is indicated on the left, and the expected size of the PCR 
product on the right. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.  Detection of PCV2 antigen in PK-15 cell culture by IPMA. Brown staining 
indicates an infected cell. 
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Figure 5.4.  Detection of PCV2 antigen by IPMA in the lymph node of a PMWS-affected pig 
originating from New Zealand. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.5.  Detection of PCV2 antigen by IPMA in the gut of a PMWS-affected pig 
originating from France.   
 
Thermal stability of PCV2 
PCV2 positive cells were observed in cell cultures after viral inocula had been 
heated at 56
oC, 65
oC, 70
oC, 75
oC and 85
oC for 15 min, while no positive cells were 
seen at 95
oC or in the negative control slide (Table 5.1, Figures 5.6 to 5.13).   
Higher numbers of positive cells were observed in the cells infected with the 
inocula heated at 65
oC and 70
oC (Table 5.1, Figures 5.8 and 5.9).  101 
 
Figure 5.6. Positive control, PCV2 thermal                              Figure 5.7. Detection of PCV2 antigen following 
                  stability experiment                                                                  heat treatment at 56 degrees (
oC). 
Figure 5.8. Detection of PCV2 antigen following                     Figure 5.9. Detection of PCV2 antigen following 
                  heat treatment at 65 degrees (
oC).                                          heat treatment at 70 degrees (
oC). 
 
Figure 5.10. Detection of PCV2 antigen following                  Figure 5.11. Detection of PCV2 antigen following 
                    heat treatment at 75 degrees                                          heat treatment at 85 degrees (
oC). 
 
Figure 5.12. No PCV2 antigen detected following                 Figure 5.13. Negative control, PCV2 thermal 
                    heat treatment at 95 degrees (
oC).                                        stability experiment.   102 
Table 5.3. Average number of PCV2-positive cells observed per well by IPMA following 
heat treatment for 15 minutes at temperatures from 56
oC to 95
oC.   
 
Temperature (
oC)  Average number positive cells/well 
56 ~4  500 
65 ~17  000 
70 ~18  000 
75 ~3  000 
85 160 
95 0 
+ve control  800 
-ve control  0 
 
Discussion 
The primary aims of this study were to determine the thermal stability of PCV2.   
Prerequisites for this study were the adaptation of an Australian strain of PCV2 to 
replicate in the PK-15 continuous cell line, and as the virus failed to induce a 
cytopathic effect, an efficient method of detecting virus in cell cultures.   
The IPMA was a suitable method, relatively easy to perform, and because it utilised a 
capsid-specific mAb, a specific method of detecting viral antigen in the cell cultures.  
PK-15 cells persistently infected with PCV1 were also tested as controls, and no 
positive cells were observed.  Although the number of PCV2-infected cells initially 
positive by IPMA was low, as has been previously reported (Fenaux et al., 2004b) 
when the technique was applied to tissue sections from French and New Zealand 
PMWS-affected pigs, abundant PCV2 antigen was detected (Figures 5.4 and 5.5).  
Therefore the small number of positive cells originally detected by IPMA in cell 
culture is most likely a reflection of a low infection rate rather than a lack of sensitivity 
of the IPMA.  The IPMA allowed visualisation of PCV2 antigen within infected cells, 
and staining was observed mostly in the nucleus, with cytoplasmic staining rare.   
IPMA has been utilised by several research groups for the detection of PCV antigen 
(Dulac and Afshar 1989; Harms et al., 2001; Gilpin et al., 2003; Meerts et al., 2005; 
Emmoth et al., 2004) but it is only one of several methods have been used to detect 
PCV in cell culture.  Other techniques have included various immunofluorescence 
assays (Tischer et al., 1982; Tischer et al., 1987; Dulac and Afshar 1989; Allan et al., 
1998; Allan et al., 1994a; Gilpin et al., 2003; Fenaux et al., 2002; Allan et al., 1994b; 
Allan  et al., 1994c; Tischer et al., 1995a; McNeilly et al., 1996; Liu et al., 2001; 
McNeilly  et al., 2001; Vincent et al., 2003; Hattermann et al., 2004), electron 
microscopy (Stevenson et al., 1999), in-situ hybridisation (ISH) (Allan et al., 1998),   103 
PCR (Hattermann et al., 2004; Fenaux et al., 2004b), RT-PCR (Cheung, 2003; 
Cheung, 2003b; Yu et al., 2005) and Northern blot (Mankertz et al., 1998; Cheung 
and Bolin, 2002).  The techniques used are usually tailored to the specific 
requirements of the study, for example electron microscopy is useful for studying the 
structure of PCV (Stevenson et al., 1999), Northern blot and RT-PCR to detect PCV-
specific transcripts, indicating viral replication (Yu et al., 2005; Cheung, 2003; 
Cheung, 2003b; Mankertz et al., 1998; Cheung and Bolin, 2002) and techniques 
such as immunofluorescence, ISH and IPMA are useful for the visualisation of PCV 
antigen within infected cells (Allan et al., 1994b; Allan et al., 1998; Gilpin et al., 2003).  
Detection of antigen is particularly important when attempting to infect cells other 
than the PK-15 cell line with PCV, as cytoplasmic staining of the PCV antigen in the 
absence of nuclear staining can indicate a non-productive infection (Gilpin et al., 
2003; Vincent et al., 2003; Allan et al., 1994c).   
The successful replication of PCV2 in the PCV-free PK-15 cell line was confirmed not 
only by IPMA, but also by PCR and RT-PCR, and persisted for at least 26 passages 
as confirmed by PCR.  PCR was also initially used to detect PCV2 from infected cell 
cultures but was of limited usefulness as the PCR used was not quantitative and 
given that PCV may replicate at a very low level in culture (Fenaux et al., 2004b), it 
became clear that a test that allowed PCV2 antigen to be seen in infected cells would 
be advantageous, so the IPMA was preferred.  This was particularly important for the 
thermal stability experiments where heat treatment at high temperatures was 
expected to inactivate a large percentage of the viral particles, meaning that a 
reasonable titre of PCV2 would be required initially.   
Treatment of the infected cells with glucosamine was essential to maintain a 
reasonable level of PCV2 infection in the cultures, but even with glucosamine 
treatment the number of PCV2-infected cells in the cultures was very low.   
Superinfection, however, dramatically increased the number of infected cells, to a 
maximum of about 10% of the cells in the culture (Figure 5.3).  IPMA indicated that 
the majority of the virus was nuclear.  Titration of the virus in the freeze-thawed 
superinfected cells indicated that there were approximately 1x10
3 infectious virus 
particles per mL present in the culture.   
The initial problem of very low viral titre was not unexpected, as previous studies of 
PCV1 as a persistent infection in the PK-15 cell line have found only a small number 
of cells (less than 1%) contained antigen when tested by IFA (Tischer et al., 1982; 
Dulac and Afshar, 1989).  Also, attempts to retrieve PCV1 DNA from persistently-
infected culture have resulted in very small amounts (nanograms) of PCV1 DNA from   104 
several litres of PK-15 culture (Dulac and Afshar, 1989).   
It is well recognised that PCV replicates at a fairly low titre (usually below 10
5 TCID50
 
per mL in PK-15 cells (Fenaux et al., 2004b), and that the number of infected cells is 
much higher in persistently infected or high-passage cultures than newly-infected 
cultures (Tischer et al., 1987).  Titration of virus present in cultures has indicated that 
PCV2 after 120 passages in PK-15 cells, and PCV1 from persistently infected cells, 
both replicate much more efficiently than PCV2 after one passage (Fenaux et al., 
2004b).   
While the initial low titre of the Australian strain of PCV2 in cultures was expected, 
glucosamine treatment appeared to have a limited effect on virus replication and this 
was not expected.  Glucosamine treatment at the time of initial infection did enable 
establishment of infection in the PK-15 cells whereas this was not achieved when 
glucosamine treatment was not used (data not shown) but despite a report by 
Tischer et al. (1987) that this treatment increased the number of infected cells in 
cultures by up to 50-fold, in the current attempts glucosamine resulted in doubling of 
the number of infected cells only.   
The increase in the number of infected cells in culture following glucosamine 
treatment is due to enhanced PCV replication (Tischer et al., 1987).  It was theorised 
that PCV replication is dependent on cellular enzymes expressed in the S phase of 
cell growth, and that glucosamine treatment allows the PCV genome to enter the cell 
nucleus, where viral replication occurs (Tischer et al., 1987).  Under normal 
conditions, the size and charge of the PCV molecule prevents the virus from 
penetrating the nuclear envelope, and viral DNA only becomes included in the 
daughter nuclei at the end of mitosis, therefore viral replication can only begin when 
the host cells have passed mitosis.  However, this requirement is removed if cells are 
treated with glucosamine, possibly because glucosamine can bind to the PCV 
molecule and neutralise it, therefore enabling the viral DNA to pass through the 
nuclear pores and into the cell nucleus (Tischer et al., 1987).   
The results obtained clearly demonstrated that PCV2 was able to survive heat at 
85°C but not 95°C for 15 min.  These results indicate that PCV2 may be capable of 
surviving in meat cooked at the current importation standard of 70°C for 11 minutes 
(Australian IRA for pig meat, 2004), and therefore cooking of pig meat prior to 
importation into Australia would be most unlikely to inactivate PCV2.   
Other interesting results were obtained in the thermal inactivation experiment.  It was 
thought that there would be a linear relationship between the temperature used to 
treat the virus and the viral titre.  However, the number of positive cells detected in   105 
cultures infected with heat treated inocula actually increased from 56°C to 65°C, then 
from 65°C to 70°C, before decreasing at 75°C and 85°C.  The reasons for this are 
not certain, however given that most of the IPMA staining was observed in the cell 
nucleus, the major location of virus replication, it is possible that heating up to 70°C 
assisted in releasing virus from the cell material after it was freeze-thawed.  However 
this was only effective up to a certain point, and above 70°C it was likely that the 
virus was actually inactivated by the heat treatment. 
The results demonstrating the thermal stability of PCV2 are similar to those reported 
previously for PCV by others.  Emmoth et al. (2004) showed that PCV2 will tolerate 
heating at 70°C for 15 minutes with no loss of infectivity, 80°C and 90°C for 15 
minutes with moderate loss of infectivity, and that PCV2 may resist heating at 95°C 
for 5 seconds, although with a very large loss in infectivity.  This is in agreement with 
the results from this experiment, where PCV2 was unaffected or perhaps even 
assisted by treatment at 56°C, 65°C and 70°C, while treatment at 75°C and 85°C for 
15 minutes resulted in a much reduced rate of infection and treatment at 95°C for 15 
minutes inactivated the virus (Table 5.1).  Further study is required to elucidate more 
information on the kinetics of PCV2 and also PCV1 when subjected to heat 
treatment. 
PCV1 was also previously shown to be unaffected by treatment at 70°C for 15 min 
(Allan  et al., 1994c) and studies on PPV have demonstrated that viral heat 
inactivation is caused by destruction of the viral capsid protein, and that differences 
in heat resistance between viruses could be due to differences in the properties or 
structures of their capsid proteins (Blumel et al., 2002).  
It could be expected that PCV would resist heat treatment more successfully than 
many other viruses.  PCV is known to be resistant to adverse chemical and physical 
conditions, e.g. PCV1 is resistant to treatment at pH 3 (Allan et al., 1994c) and also 
to chloroform (Allan et al., 1994c), and PCV2 has been shown to be resistant to a 
number of common disinfectants (Royer et al., 2001).  Some other non-enveloped 
viruses are also very heat stable, e.g. the non-enveloped beak and feather disease 
circovirus, in the same genus as PCV, survives heating at 80°C for 30 min with only a 
minimal reduction in titre, and 85°C for 30 minutes with only some reduction in titre 
(Raidal, 1994), and the porcine parvovirus, a particularly heat-resistant virus is able 
to tolerate treatment at 60°C for 1 h (Blumel et al., 2002) and 70°C for 15 min 
(Emmoth et al., 2004) with no loss of infectivity.  In contrast, other non-enveloped 
viruses are less resistant, e.g. poliovirus and human B19 viruses have are inactivated 
after 30 min at 50°C (Shiomi et al., 2004) and immediately at 60°C (Blumel et al.,   106 
2002), respectively.  The non-enveloped feline and canine caliciviruses are easier to 
inactivate than the circoviruses, and are inactivated at 71.3°C after 1 min (Duizer et 
al., 2004).  The enveloped viruses have normally even less stability after heat 
treatment: West Nile virus is completely inactivated at 60°C for 30 min (Remington et 
al., 2004); the SARS coronavirus is largely inactivated after 5 min at 56°C (Kariwa et 
al., 2004); cytomegalovirus (CMV) is inactivated at 62.5°C for 30 min and 72°C for 5 
seconds (Hamprecht et al., 2004).  
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CHAPTER 6.  CONSTRUCTION OF A POTENTIALLY INFECTIOUS CLONE OF 
AN AUSTRALIAN STRAIN OF PCV2 
Summary 
Three methods for the construction of an infectious clone of an Australian strain of 
PCV2 were attempted.  One of these methods, based on that described by 
Hattermann  et al. (2004) resulted in the construction of a full-length clone of an 
Australian PCV2 strain.   
Introduction 
Viral infectious clones, commonly constructed by the ligation of all or part of a viral 
genome into a plasmid vector, have many applications.  Infectious viral DNA or RNA 
may be recovered and manipulated, and segments may be exchanged between 
strains to produce chimaeras.  This could enable examination of the function(s) of 
different regions of the viral genome, for example, regions controlling host range and 
pathogenicity determinants (Bloom et al., 1990).  Viral clones can also be 
manipulated to determine how structural differences in different viral strains can 
translate to significant differences in biological behaviour. 
Infectious clones are particularly useful when a virus cannot be cultured in vitro.  For 
example, a tissue culture system supporting TTV replication is not yet available, so 
the construction of a full-length molecular clone provided important information about 
TTV replication and gene expression (Hino, 2002).  The study of hepatitis C virus has 
also been severely hampered by the inability to culture the virus in vitro and the lack 
of a suitable animal model (Shimizu et al., 1993).  However, the construction of HCV 
molecular clones has provided more information on the life cycle of this significant 
human pathogen (Ikeda et al., 2002; Zhong et al., 2005). 
Although both PCV1 and PCV2 may be grown in culture, infectious PCV clones have 
other applications for the study of the virus.  Several PCV2 infectious clones have 
been constructed previously, for investigation into viral gene function, kinetics and 
replication  in vitro (Liu et al., 2001; Cheung and Bolin, 2002; Mankertz and 
Hillenbrand, 2002; Cheung, 2003c; Mankertz et al., 2003; Cheung, 2004b; Fenaux et 
al., 2004b) and the ability of PCV1 and PCV2 to infect different continuous cell lines 
(Hattermann et al., 2004).  Also, chimaeric clones constructed using PCV1 and PCV2 
DNA have provided information on epitope mapping (Lekcharoensuk et al., 2004) 
and potential PCV vaccines against PCV2-associated diseases such as PMWS 
(Fenaux et al., 2003; Fenaux et al., 2004). 
The aim of this study was to construct a PCV2 infectious clone, based on an 
Australian PCV2 isolate, that could be used in cell culture experiments and in future   108 
animal experimental work. 
Materials and methods 
DNA extraction and PCR 
The method used for the construction of a PCV2 infectious clone was based on the 
method used by Hattermann et al. (2004), where single linear copies of the PCV2 
genome are re-ligated to form infectious particles. 
PCV2 DNA for virus amplification was from a previously extracted sample from pig 
tissue in Farm B NSW (Chapter 4).  The primers used for amplification were based 
around the unique Sac1 enzyme restriction site located in PCV2 ORF1 (Table 6.1).   
 
Table 6.1.  Primers based on the unique Sac1 restriction site used to amplify PCV2 DNA 
from tissue.   
Primer Sequence 
Position  
in genome 
PCV type 
Sac1bF(T) 5`-TGGAGCTCCTAGATCTCAAGGACA-3`  322-345  PCV2 
Sac1bR(A) 5`-AGGAGCTCCACATTCCATCAGTAA-3`  305-328 PCV2 
 
PCR was performed using the Expand High Fidelity kit (Roche) in a 50 μL reaction 
mixture consisting of 3 μL extracted sample DNA, 1X PCR reaction buffer with Mg 
(Roche), 2 mM MgCl2 (Roche), 1 mM each dNTP (Applied Biosystems), 6.4 pmol 
each primer and 1.3 U high fidelity polymerase (Roche).  Amplification was 
performed with an initial denaturation step of 5 min, followed by 35 cycles of 
amplification (95
oC for 1 min, 57
oC for 1 min, 72
oC for 2 min), with a final extension 
step of 72
oC for 10 min.  PCR products were electrophoresed in a 2% agarose gel at 
80 V for 1h and visualised using an ultra-violet transilluminator (UVP). 
Cloning and ligation 
Fresh PCR products were cloned into the pCR®2.1 TOPO® vector using a TA 
cloning kit, Version M (Invitrogen), according to the methods recommended by the 
manufacturer.  Constructed plasmids were used to transform competent Top 10 F’ E. 
coli cells (Invitrogen).  Plasmids containing the desired inserts were identified by α-
complementation blue/white screening, and purified recombinant plasmids were 
digested with Eco R1 and Sac1 restriction enzymes to confirm the presence of the 
insert.   
Sequence analysis 
Plasmids containing the correct fragments were sequenced using the M13 forward 
(5`-GTAAAACGACGGCCAG- 3`) and reverse (5`-CAGGAAACAGCTATGAC-3`) 
primers.  Sequencing was performed using rhodamine dye terminator or Big Dye   109 
terminator Version 3.1 (Applied Biosystems), with the ABI PRISM™ fluorescent 
cycle sequencing system (Applied Biosystems).  Sequence data was analysed 
using the SeqEd program (v 1.0.3).  The sequences obtained were then 
compared, using the BlastN program (version 2.0), with sequences available from 
the National Centre for Biotechnology Information (NCBI), USA.   
Construction of an infectious clone  
Top 10 F’ E. coli cells containing a plasmid with the correct insert (as confirmed by 
restriction digestion and sequencing) were grown overnight in a volume of 250 mL 
2YT media.  Plasmid DNA was extracted using a Plasmid MidiPrep kit (BioRad) and 
the resulting elution reduced to 25 μL using ethanol precipitation.  This solution was 
digested using 25 U Sac1 endonuclease (NEB), 1X NEB buffer 1 (NEB), 100 μg/mL 
BSA (NEB) and 10 mL of Ultra-Pure water (Fisher Biotec) at 37
oC overnight.   
Digested DNA was electrophoresed in a 2% agarose gel at 60 V for 2 h and 
visualised using an ultra-violet transilluminator (UVP).  Bands of the correct size 
(1768 bp) were excised using a clean scalpel and DNA was extracted using a 
QIAquick Gel Extraction kit (QIAGEN) according to the manufacturer’s methods.   
The DNA elutions were pooled and diluted to a volume of 200 μL with Ultra-Pure 
water (Fisher Biotec) and DNA was ligated using 400 U T4 DNA ligase (NEB), 50 μL 
10X T4 DNA ligase reaction buffer (NEB) and 249 μL Ultra-Pure water (Fisher 
Biotec) to give a total reaction volume of 500 μL.  The ligation reaction was incubated 
at 16
oC for 48 h then reduced to a volume of 70 μL using ethanol precipitation.   
Ligated fragments were electrophoresed in a 2% agarose gel at 60 V for 2.5 h and 
visualised using an ultra-violet transilluminator (UVP).  Bands of the correct size 
(approximately 1000 bp) were excised using a clean scalpel and DNA was extracted 
using a QIAquick Gel Extraction kit (QIAGEN) according to the manufacturer’s 
protocol. 
To confirm that purified DNA was recircularised PCV2 genome, 2 different PCR 
assays were performed to amplify the region across the PCV2 unique Sac1 site at nt 
373 (Table 6.2).  The PCR assays were performed using the Expand PCR system 
(Roche) as described above.  Amplification was performed with an initial denaturation 
step of 5 min, followed by 35 cycles of amplification (95
oC for 1 min, 62
oC [PCV2Seq 
Comp primers] or 64
oC [Cap primers] for 1 min, 72
oC for 2 min), with a final extension 
step of 72
oC for 10 min.  PCR products were electrophoresed in a 2% agarose gel at 
80 V for 1 h and visualised using an ultra-violet transilluminator (UVP). 
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Table 6.2.  Primers used to amplify across Sac1 site to confirm PCV2 genome re-ligation. 
Primer Sequence 
Position in 
genome 
PCV type 
PCV2SeqA Comp  5`-GCAG(T/C)(T/C)GAGG(A/G)GTACCATTC-3`  850 - 832  PCV2 
PCV2SeqB Comp  5`-CTCCTTGGA(T/A)ACGTCATA(G/T)C-3`  1738 - 1719  PCV2 
Cap F  5`- CCCATCAAGGACAGGTTTGGGGG  -3`  1229 - 1251  PCV2 
Cap R  5`- AGACTCCCGCTCTCCAACAAG -3`  425 - 445  PCV2 
 
Results 
The whole genome of the PCV2 isolate Farm B NSW was successfully amplified 
using primers based around the unique Sac1 site at nt 373 (Figure 6.1).   
One pCR 2.1 plasmid containing the correct insert, as confirmed by restriction 
endonuclease digestion and sequencing, was digested using the Sac1 enzyme, 
yielding bands 3.9 kb (plasmid) and 1.76 kb (insert) in size (Figure 6.2). 
 
 
   111 
 
Figure 6.1.  Amplification of the whole genome of PCV2 from tissues of a pig in Farm B NSW 
using primers PCV2 Sac1bF and PCV2 Sac1R.  Lane 1, 1kb plus DNA ladder (Promega); 
lane 2, negative tissue control; lane , negative PCR control; lane 3, PCV2 isolate Farm C WA; 
lane 4, PCV2 isolate Farm B NSW.  The size of the bands in the DNA ladder is indicated on 
the left, and the expected size of the PCR product on the right. 
 
 
 
Figure 6.2.  Endonuclease digestion of pCR 2.1 construct containing whole genome of PCV2 
using Sac1 endonuclease.  Lane 1, 1kb plus DNA ladder (Promega); lanes 2-8, digested 
plasmid construct.  The size of the bands in the DNA ladder is indicated on the left, and the 
expected sizes of the digested plasmid and released linear genome on the right. 
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Linear genomes were successfully recircularised using T4 DNA ligase, with the 
circular genomes running at approximately 1000 bp on an agarose gel (Figure 6.3).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.  T4 ligation of the linear PCV2 genome, recircularised particles are at 
approximately 1000 bp.  Lane 1, 1kb plus DNA ladder (Promega); Lanes 2-8, T4 DNA ligase 
reactions.  The size of the bands in the DNA ladder is indicated on the left, and the size of the 
recircularised PCV2 genomes on the right.   
 
 
The DNA was confirmed to be recircularised PCV2 genome by two PCRs, designed 
to amplify across the Sac1 restriction site (Figure 6.4).   
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Figure 6.4.  Amplification of the recircularised PCV2 genome using PCR assays designed to 
incorporate the Sac1 endonuclease restriction site.  Lane 1, 1kb plus DNA ladder (Promega); 
lane 2, PCR negative control; lane 3, recircularised PCV2 DNA (PCV2 Seq Comp primers); 
lane 4, recircularised PCV2 DNA 1:10 dilution (PCV2 Seq Comp primers); lane 5, negative 
PCR control; lane 6, recircularised PCV2 DNA (Cap primers); lane 7, recircularised PCV2 
DNA 1:10 dilution (Cap primers).  The size of the bands in the DNA ladder is indicated on the 
left, and the expected size of the PCR products on the right. 
 
Discussion 
The method used to construct an infectious clone of an Australian strain of PCV2 
was closely modelled on the method of Hattermann et al. (2004), where the entire 
PCV2 genome was amplified, ligated into a holding vector, removed by restriction 
endonuclease digestion and then re-ligated before transfection into animal cells.   
Although the methods and results were not reported, 2 other methods of constructing 
a PCV2 infectious clone were also attempted before this method was tried.  The 
other 2 methods involved the ligation of 2 copies of the PCV2 genome into an 
expression vector (Fenaux et al., 2002) and the ligation of several segments of the 
PCV2 genome into a holding vector (Roca et al., 2004).  Infectious clones were not 
produced with either of these methods: while the initial amplification of the PCV2 
genome was easily achieved, the ligation of different DNA fragments to each other 
and into various plasmid vectors was not achieved.   
While the recircularised clone was confirmed by PCR, the infectious nature of the 
construct was not confirmed.  Unfortunately there was not sufficient time to transfect 
the DNA into cell culture.  Several attempts were made to purify sufficient DNA for 
transfection, however as this method does not involve the use of a plasmid 
backbone, obtaining large amounts of recircularised PCV2 DNA was very 
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difficult, as more DNA was lost with each purification step of the procedure.   
However, as the ligation process resulted in reasonable amounts of the desired 
recircularised PCV2 genome (Figure 6.3) it is anticipated that this method will be 
successful once sufficient infectious particles can be recovered from the final 
purification step. 
In this study, construction of a PCV2 infectious clone was attempted with the 
intention of providing a biologically pure inoculum for future animal experiments.  The 
reproduction of PCV-associated diseases (PMWS in particular) in gnotobiotic and 
conventional pigs using tissue homogenates or PCV2 isolates cultured in vitro has 
produced inconsistent results in the past (Fenaux et al., 2002).  Pigs infected with 
PCV2 alone may develop mild to moderate lesions typical of PMWS, such as 
lymphoid depletion (Allan et al., 1999b; Balasch et al., 1998), mild pneumonia, 
lymphoid inflammation (Ellis et al., 1999; Magar et al., 2000), multinucleated giant 
cells (Magar et al., 2000) and mild nephritis and hepatitis (Ellis et al., 1999).   
However, despite the large number of studies performed after the initial identification 
of PCV2 in association with PMWS, in the majority of cases it has not been possible 
to produce clinical signs of the disease by infecting gnotobiotic or colostrum-deprived
 
and caesarean-derived pigs (CD/CD) with PCV2 alone (Allan et al., 1999; Balasch et 
al., 1999; Allan et al., 2000c; Allan et al., 2000d; Kennedy et al., 2000; Krakowka et 
al., 2000; Pogranichnyy et al., 2000; Krakowka et al., 2001).  It is possible that some 
of the clinical signs and lesions induced, especially using tissue homogenates, could 
have been produced by contaminants and were incorrectly attributed to PCV2.   
Therefore when conducting experimental infection studies using PCV2 it is highly 
desirable to use a homogeneous and biologically pure virus stock, and in recent 
times this has been accomplished by the use of PCV2 infectious clones.  Infectious 
clones are also easier to quantify than virus grown in cell culture, and infectious 
clones overcome the problem of attenuation of virus or selection of variant viruses 
during serial passage in cell culture (Allan et al., 1994a).   
PCV infectious clones have been used in vivo as inoculum for animal experiments 
(Fenaux et al., 2002; Oppreissnig et al., 2004; Roca et al., 2004; Grasland et al., 
2005), although in 2 cases the infectious clone had to be administered 
intramuscularly or intraperitoneally or by injection directly into the liver and lymph 
nodes, as intranasal inoculation was not effective (Fenaux et al., 2002; Roca et al., 
2004).  The PCV2 infectious clones were shown to successfully infect young piglets, 
but none of the infected piglets showed any clinical signs of PMWS (Fenaux et al., 
2002; Roca et al., 2004) unless the infectious clone was combined with another   115 
agent (Oppreissnig et al., 2004) or if the pigs were artificially immunostimulated 
(Grasland et al., 2005).  When compared with PCV2 originating from infected tissue 
and propagated in cell culture, it seems that pigs infected with infectious clones 
seroconvert later than those infected with the cell culture isolate (Roca et al., 2004).   
Infectious clones are not only useful for providing pure inoculum for experimental 
work, but several of these constructs, whether in their original form or after 
manipulation, have also been used for studies on the kinetics and behaviour of PCV 
in culture and as possible vaccines.  PCV1 and PCV2 full-length infectious clones 
and cloned partial fragments have been used for studying viral gene function, kinetics 
and replication in vitro (Liu et al., 2001; Cheung and Bolin, 2002; Mankertz and 
Hillenbrand, 2002; Cheung, 2003c; Mankertz et al., 2003; Cheung, 2004b; Fenaux et 
al., 2004b), the ability of PCV1 and PCV2 to infect different continuous cell lines 
(Hattermann et al., 2004) and chimaeric clones constructed using PCV1 and PCV2 
DNA have provided information on potential PCV vaccines against PCV2-associated 
diseases such as PMWS (Fenaux et al., 2003; Fenaux et al., 2004).  In particular, the 
immunogenic PCV2 ORF2 gene cloned into the PCV1 backbone induced a specific 
antibody response to the PCV2 capsid protein when infected into piglets, but caused 
the pigs no ill effects (Fenaux et al., 2003).  While the chimaeric virus did not cause 
viraemia in all the infected pigs, 100% of infected animals developed antibodies, 
suggesting that the construct could be used as a potential vaccine against PCV2 and 
PMWS disease development (Fenaux et al., 2003).  The same chimaeric infectious 
clone was then demonstrated to give protective immunity to PCV2-challenged pigs, 
whether the infectious clone itself or the progeny virus was used (Fenaux et al., 
2004).  Vaccinated pigs had reduced or no PCV2 viral load and were found to have 
significantly less virus in the lymph tissues and less lymphoid depletion (LD) than 
unvaccinated challenged pigs (Fenaux et al., 2004).  This is significant because LD 
during initial PCV2 infection may be linked
 to the eventual occurrence of leukopenia 
prior to the development of PMWS (Segales et al., 2001; Nielsen et al., 2003).   
Therefore, the chimaeric
  vaccine may have the ability to stop the eventual 
progression
 to clinical PMWS by preventing the initial LD of lymphoid tissues. 
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CHAPTER 7.  GENERAL DISCUSSION 
The initial objective of this project was to determine whether PCV1 and PCV2 were 
present in the Australian pig herd, and this was achieved using PCR.  PCR was the 
assay selected for detection as these viruses are not cytopathic in cell culture, and it 
was considered a sufficiently practical and rapid method for a large scale survey.  An 
additional objective was to characterise the strains of virus present in Australia, with 
the DNA extracted from tissues and used as the PCR template also used for analysis 
of the entire genome of any viruses detected.  A previously published multiplex PCR 
was used for the initial detection of PCV1 and PCV2 as this would detect and 
differentiate both types of PCV in a single reaction.  Alternative serological tests were 
considered as a means of determining the prevalence of these viruses but at the time 
of initiating this study no type-specific serological tests were available in Australia, 
and even now the development of PCV1-specific serological tests has not been 
reported.   
The pigs and tissues selected for examination by PCR were biased toward the 
possible association of viruses with pathological lesions and pig mortalities, as they 
were predominantly from pigs found dead within piggeries, and from pigs originating 
from herds experiencing disease outbreaks such as unthriftiness and congenital 
tremors (CT).  While some of the tissues were from herds with illthrift problems, no 
evidence for the presence of PMWS had been reported in Australia during the period 
in which the survey was conducted.  It was considered that the survey and the 
genetic analysis of the PCV strains present in Australia during this period provided 
background data against which strains detected in association with any future 
outbreak of PMWS or other PCV2-associated disease could be evaluated. 
Tissues from approximately 350 pigs were tested for PCV genetic material in several 
Australian pig herds.  PCV1 was detected in pig tissue samples from WA, SA and 
NSW and PCV2 in pig tissue samples from WA, NSW and Queensland.  It was not 
possible to obtain tissues for examination from all States but there was no reason to 
believe that the results obtained in the States from which tissues were obtained and 
PCV was detected would not be similar to those detected in the States from which it 
was not possible to obtain tissues.   
When compared to similar studies performed overseas, the prevalence of PCV1 in 
Australia (20%) appeared high while the prevalence of PCV2 (18%) appeared low.  
The reasons for the lower than expected prevalence of PCV2 infection are not known 
but could be explained by the lack of PCV2-associated disease in Australia, as 
several studies showing very high rates of PCV2 infection have been reported in   117 
regions affected by PMWS (Onuki et al., 1999; Mankertz et al., 2000b; Calsamiglia et 
al. 2002).  The onset of PMWS has also been associated with high levels of virus 
replication in pigs (Ladekjaer-Mikkelsen et al., 2002; Okuda et al. 2003).  The reason 
for the higher than expected prevalence of PCV1 infection in Australian pigs is 
unknown: it could be due to the fairly small number of farms sampled, or the lack of 
competition with PCV2. 
The presence of PCV in association with production problems was also investigated. 
In one, a farm experiencing problems with unthrifty weaner pigs, PCV2 was detected 
by PCR in the tissues of all 12 unthrifty pigs examined, and several of these pigs had 
lesions previously observed in cases of PMWS (Sorden, 2000; Quintana et al., 2001; 
Harding et al., 1998), such as pneumonia, lymph node enlargement and the 
presence of multinucleated giant cells in tissues (Chapter 3).  However, on this farm 
there was only a small number of affected pigs, there was no particular increase in 
mortality rates over the low level experienced in many farms, the lesions in the 
unthrifty pigs were mild, and a diagnosis of PMWS was excluded.  Furthermore, no 
PCV2 antigen was detected by IPMA in association with lesions or indeed in any 
tissues from the affected pigs, even in those tissues positive by PCR, indicating that 
only low levels of virus were present in these pigs.   
While the role of PCV2 in PMWS is generally accepted, the role of PCV in other 
conditions is less certain.  PCV2 has been detected in neural tissue of newborn pigs 
with CT (Stevenson et al., 1999) but the association between PCV and CT has not 
been confirmed by others (Kennedy et al., 2003).   During the course of the studies 
reported in this thesis outbreaks of CT occurred in several Western Australian farms, 
and the association of PCV with these pigs was also investigated.  Both PCV1 and 
PCV2 were detected in neural tissues of newborn affected pigs examined from some 
but not all of the affected farms (Chapter 3).  The detection of virus in the newborn 
pigs indicated that both PCV1 and PCV2 are able to cause in utero infections in pigs, 
and that at least in some cases this results in infection of the brain and spinal cord of 
foetal pigs.  Attempts to detect virus antigen in the brain and spinal cords of the 
affected newborn pigs by IPMA were however, unsuccessful, indicating that the level 
of virus replication in the neural tissues was low.  It was concluded that while the 
results certainly do not confirm a causal role of PCV in CT the high prevalence of 
virus in affected pigs in some of the affected herds does suggest that the role of PCV 
in CT should be investigated further.  Factors such as the antibody status of the sow 
and the stage of gestation may be significant in determining whether there is 
persistence of the virus in the pig in utero.    118 
The data obtained on the prevalence of PCV1 and PCV2 in the 350 pigs examined 
do not provide sufficient information to draw a reliable conclusion regarding the 
prevalence of PCV in pigs in Australia, it is only indicative.  The detection of antibody 
by type-specific serological tests for both PCV1 and PCV2 are required for 
prevalence determinations.  A commercial PCV2-specific serological test is available 
(Synbiotics) but is extremely expensive and was therefore not used, and an 
alternative PCV2-specific serological test based on a recombinant PCV2 capsid 
antigen has been developed in this laboratory and results obtained using this test will 
be reported by others.  A similar PCV1-specific serological test based on a 
recombinant PCV1 capsid antigen is also being developed.   
Although there is evidence that PCV2 can cause or is associated with PMWS and a 
variety of other disease conditions in pigs (reviewed in Chapter 2), with the exception 
of the occasional occurrence of PDNS (Cameron, 1995) these conditions have not 
been reported in Australia.  The question is whether all strains of PCV2 are 
potentially able to cause disease, whether there may not be genetic variants that are 
capable of or more likely to be associated with disease , and particularly whether the 
strains present in Australia are potentially capable of causing disease.  It is also 
evident that PCV2 is possibly not the only factor involved, and it is unknown whether 
the strains of PCV2 present in Australia may perhaps be non-pathogenic, or whether 
they are potentially pathogenic but the accessory factors required for the 
development of PCV-associated disease may be absent in Australia.   
The genetic relationship between Australian strains of PCV and strains associated 
with PMWS and other disease conditions was determined (Chapter 4) as a basis for 
identifying any significant changes which might suggest differences in pathogenicity.  
Three Australian strains of PCV1 from WA and NSW were similar to the very small 
number of PCV1 field isolates sequenced overseas.  One of the WA strains was from 
a newborn pig with CT, and there was therefore no evidence that this strain was 
different from strains not associated with CT.  Of the 7 PCV2 strains sequenced, six 
were very similar to each other, and were most closely related to a Japanese PCV2 
isolate associated with an outbreak of PMWS.  The seventh PCV2 strain was also 
similar but distinct, and was most closely related to a Chinese isolate and a 
Japanese isolate, associated with an unspecified clinical syndrome and PMWS 
respectively.  There were, however, only minimal differences between the Australian 
isolates and strains from other countries and the absence of unique amino acid 
motifs in the genomes of Australian PCV2 do not suggest that Australian PCV strains 
differ significantly from those found overseas and in association with diseases such   119 
as PMWS.  There is no genetic evidence that Australian PCV2 strains would not be 
capable of causing diseases such as PMWS given suitable conditions, which are as 
yet unknown.   
One of the 7 Australian PCV2 isolates sequenced appeared genetically distinct from 
the other strains.  This could be the result of multiple introductions of PCV2 into the 
country: multiple introductions of pigs into Australia in colonial and recent times have 
been either documented or suggested using molecular evidence, and these separate 
introductions may be responsible for the diversity of PCV2 found in the Australian pig 
herd.  However, there was a very high conservation at the nucleotide and amino acid 
level with all the Australian strains and PCV2 strains from all locations throughout the 
world exhibit only minimal differences.  This conservation may be due to a low error 
rate in transcription associated with the small size of the PCV genome, perhaps the 
reliance of PCV on the low error host cell machinery for replication and possibly 
associated with the long term co-evolution of the virus with the porcine host.   
Infection of modern pigs with PCV may predate the development of pig populations in 
separate countries, resulting in several slightly different strains of PCV2 but no 
marked difference between strains in different countries.   
In earlier studies that have been conducted in this laboratory, an Australian strain of 
PCV2 was adapted to replicate in PK15 cells.  Persistence and presumably 
replication of the virus over several passages was confirmed by PCR and a semi-
quantitative PCR suggested the virus was present at a low titre.  Unfortunately, 
attempts to infect weanling pigs with this cell culture adapted virus were unsuccessful 
in a majority of the pigs that were inoculated and it appeared that the titre obtained in 
cell culture was insufficient to provide an adequate infectious dose.  A major 
contribution of the studies reported in this thesis that could overcome the problem of 
poor replication of virus in cell culture, was the construction of an infectious clone 
using an Australian PCV2 strain (Chapter 6).  It was anticipated that the clone could 
be used in a variety of applications for examining replication of PCV2 and also for 
generating higher titre virus stocks for animal experiments.  The use of infectious 
clones in animal experiments is common (Fenaux et al., 2002; Oppreissnig et al., 
2004; Roca et al., 2004), due to their advantages over other methods of inoculation 
such as cell cultured virus.  Infectious clones are biologically pure and particularly 
useful when the virus required cannot be cultured in vitro.  In the case of PCV2, the 
inconsistency of results produced when infecting pigs with cell culture isolates (Allan 
et al., 1994a) has meant that PCV2 infectious clones are highly desirable for use in 
animal experiments (Fenaux et al., 2001).   120 
Another major contribution arising from the results reported in this thesis which will 
assist in monitoring the Australian pig herd for PCV-associated diseases was the 
development of a PCV2-specific IPMA to enable PCV2 antigen to be seen in infected 
cells from tissue blocks and virus-infected cell cultures.  This test was based on the 
use of a PCV2-specific mAb against the capsid protein of the virus that was produced 
in this laboratory.  While similar assays have been developed elsewhere, these 
reagents have not been readily available commercially. At the commencement of this 
project, the only tools available for the detection of PCV were an IFA which detected 
both PCV1 and PCV2 without discriminating between the types of PCV, and PCR.  
The IFA was time-consuming and difficult to interpret, as well as cross-reacting with 
both PCV1 and PCV2, and while PCR does allow differentiation of the two viral types 
it did not allow the visualisation of PCV antigen within infected cells.   
Another significant contribution of the results reported in this thesis was the 
determination of the thermal stability of PCV2, on which there exists very little data.  
This has particular significance in Australia where imported pig meat has to be 
cooked to an internal  temperature of 70°C for 11 minutes (Australian IRA for pig 
meat, 2004) before release and sale and the industry has lobbied extensively to 
prevent the importation of pig meat on the basis that this treatment would perhaps be 
insufficient to inactivate PCV2 present in the meat, perhaps resulting in the 
introduction of PMWS (Australian IRA for pig meat, 2004).  To test this, an Australian 
strain of PCV2 strain was adapted to replicate in the PCV-free PK-15 cell line, and 
using a technique known as superinfection, the viral titre in the cell cultures was 
increased to approximately 1x10
4 virus particles per mL.  The results of the IPMA 
showed that while PCV2 genetic material could be readily detected by PCR and RT-
PCR from the PK-15 cells, the number of infected cells was extremely low, but 1% of 
cells infected increased to a maximum of 10% after superinfection.    
The adaption of the Australian PCV2 strain to replicate in cell cultures to a 
reasonable titre, and its detection and quantitation by a combination of titration and 
IPMA (Chapter 5) enabled the thermal stability of PCV2 to be investigated. The 
stability of PCV2 after exposure to heat had not been investigated previously, and as 
a small, environmentally stable virus, data on virus inactivation was considered 
important in the context of trade and also decontamination of infected premises.  Not 
unexpectedly, the Australian PCV2 strain resisted heat treatment at 56°C, 65°C and 
70°C for 15 minutes with no loss of infectivity, and heat at 70°C for 15 min actually 
resulted in an apparent increase in titre of the virus from infected material possibly 
because it assisted release of the virus from the nucleus of infected cells.  Heat   121 
treatment at 75°C and 85°C decreased the titre of virus but did not totally inactivate 
the virus, which was only destroyed after heat treatment at 95°C for 15 mins (Chapter 
5). These results could be important for trade, specifically the importation of pig meat 
in Australia from countries affected by PMWS, as the current heating conditions 
required for meat importation will not inactivate the virus present in pig meat.     122 
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